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Due	 to	 the	 resurgence	 of	 human	 African	 trypanosomiasis	 (HAT),	 the	 world	 health	
organization	 (WHO)	 and	 various	 non-governmental	 organisations	 NGO’s	 have	
implemented	 strategies	 that	 have	 led	 to	 a	 significant	 drop	 in	 disease	 incidence,	with	
only	~3,500	new	HAT	cases	recorded	in	2014.	However	the	causative	agent,	T.	brucei	is	
still	 responsible	 for	a	heavy	socio-economic	burden,	with	T.	brucei	 infections	 in	cattle	
representing	 an	 estimated	 billion	 dollar	 loss	 annually.	 Of	 the	 two	 human	 infective	T.	
brucei	subspecies,	T.b.	rhodesiense	is	responsible	for	less	than	3%	of	all	HAT	cases	and	
is	 primarily	 considered	 a	 zoonosis.	 It	 causes	 acute	 disease	 comparative	 to	 the	 T.b.	
gambiense	 subspecies	 and	 two	 strains	 of	 differing	 phenotypes	 have	 been	 used	 to	
establish	experimental	infections,	which	reproduce	the	clinical	manifestation	observed	
in	 natural	 infections.	 	 This	 project	 utilized	 technological	 advances	 in	 order	 to	




using	Whatman	FTA™	 card	 and	 sequence	 capture	 in	 combination,	 and	benchmarking	
the	 data	 against	 available	 whole	 genome	 sequence	 data.	 The	 resulting	 data	 showed	
both	successful	enrichment	and	 lack	of	allelic	drop	out	effect.	 	This	methodology	was	
subsequently	applied	to	multiple	other	strains	and	used	to	look	at	deleterious	variants	
potentially	 giving	 rise	 to	 these	 phenotypic	 differences.	 Gross	 differences	 in	 the	
abundance	of	bloodstream	forms	in	these	strains	were	also	observed,	which	indicated	
the	 phenotype	 of	 these	 strains	 may	 result	 from	 the	 regulation	 of	 differentiation.	
Transcriptomic	and	metabolomic	data	was	also	used	to	identify	differential	regulation	
driving	 these	 differences	 in	 virulence,	 and	 showed	 that	 only	 a	 small	 subset	 of	 genes	
were	 differentially	 regulated.	 Amongst	 these	 several	 candidate	 genes,	 which	 had	
previously	 been	 associated	 with	 drug	 resistance,	 were	 identified.	 Genomic	 and	
transcriptomic	 data	 also	 indicated	 that	 iron	 regulation	 is	 one	 of	 the	 key	mechanisms	
driving	this	phenotypic	change,	with	a	high	density	of	deleterious	SNPs	located	in	iron	



































































































































































































































































































































































































Trypanosomes	 are	 protozoan	 parasites	 responsible	 for	 a	 heavy	 health	 burden	
worldwide	 and	 the	 causative	 agent	 of	 several	 human	 and	 cattle	 diseases	 both	 in	
America	and	Sub	Saharan	Africa.	The	Trypanosoma	genus	has	 two	distinct	clades,	 the	
Salivarian	 and	 non	 Salivarian	 (Stercorarian)	 trypanosomes,	 which	 cause	 disease	 in	
Africa	and	America	respectively	and	were	first	described	by	Hoare	in	1972	(Stevens	et	
al.,	 1999;	 Hoare,	 1972;	 Stevens	 and	 Gibson,	 1999b;	 1999a).	 Although	 both	 are	
heteroxenous,	with	 an	 insect	 vector,	 the	method	of	 transmission	 and	 life	 cycle	 of	 the	






most	 well	 known	 of	 the	 Stercorarian	 trypanosomes	 (Truc	 et	 al.,	 2013;	 Teixeira	 and	
Soulsby,	1987;	Ramsey	et	al.,	2015).	Included	within	the	Stercorarian	trypanosomes	is	
Trypanosoma	 cruzi,	 which	 is	 well	 known	 for	 being	 the	 causative	 agent	 of	 Chagas	
disease	 in	 America,	 but	 also	 less	 well	 renowned	 trypanosomes	 such	 as	 	 T.	 rangeli	
(Ramsey	et	al.,	2015;	Truc	et	al.,	2013).	These	trypanosomes	complete	their	lifecycle	by	
transmission	through	a	Triatominae	host.	Similarly	to	the	Salivarian	trypanosomes,	the	
insect	 vector	 takes	 a	 blood	 meal	 from	 an	 infected	 mammalian	 host,	 ingesting	 the	











The	 Salivarian	 trypanosomes	 include	 one	 of	 the	most	 well	 studied	 trypanosomes,	 T.	
brucei,	 the	 causative	 agent	 of	 trypanosomiasis,	 and	 the	 less	 studied	but	 economically	
very	 important	T.	congolense	 and	T.	vivax		 (Stevens	and	Gibson,	1999b).	Compared	 to	






Human	African	 trypanosomiasis	 (HAT)	 is	 caused	by	 the	parasite	Trypanosoma	brucei.	
Its	vector,	the	tsetse	fly	(Glossina	spp)	restricts	the	distribution	of	infections	to	within	
the	 tsetse	 belt,	 which	 is	 situated	 in	 Sub-Saharan	 Africa.	 Human	 African	
Trypanosomiasis	 in	 East	 Africa,	 as	 caused	 by	 the	 species	 Trypanosoma	 brucei	
rhodesiense,	 is	 a	 particularly	 acute	 form	 of	 “sleeping	 sickness”,	 with	 patients	 often	
suffering	 severe	 symptoms	 sometimes	 only	 one	 week	 after	 infection	 (Giroud	 et	 al.,	
2009;	 Brun	 et	 al.,	 2010).	 There	 are	 other	 described	 subspecies	 of	T.	brucei	 in	 Africa,	
Trypanosoma	brucei	gambiense,	which	causes	sleeping	sickness	in	West	Africa	(usually	
resulting	 in	 chronic	 infections)	 and	 Trypanosoma	 brucei	 brucei,	 which	 infects	 cattle	
(Brun	et	al.,	2010;	Giroud	et	al.,	2009).	Collectively,	T.b.	gambiense	and	T.b.	rhodesiense	
account	 for	 all	 human	 African	 trypanosomiasis	 (HAT).	 	 Human	 infections	 are	







made	 from	 the	 sequencing	 of	 the	T.	brucei.	brucei	 strain	 Tb927	 in	 2005	 suggest	 that	












reporting	 ~3,500	 cases	 in	 2014,	 compared	 to	 30,000	 cases	 in	 1990	 (Simarro,	 2011;	
World	 Health	 Organization,	 2014).	 This	 has	 been	 done	 largely	 through	 improved	
surveillance	 and	 prevention	 strategies,	 and	 indicates	 that	 despite	 no	 current	 vaccine	
leads,	and	very	old	drug	treatments	which	are	becoming	more	redundant	with	surges	
in	 drug	 resistance,	 eradication	 of	 human	 African	 trypanosomiasis	 is	 conceivable	
(Bainbridge	et	al.,	2010;	Simarro,	2011;	Mardis,	2008).	Until	recently	there	hasn’t	been	
much	interest	in	understanding	the	interplay	between	parasite	and	host,	however	this	
is	 starting	 to	 change	as	 the	decreasing	 cost	of	 sequencing	and	other	high-throughput	
technologies	 is	allowing	for	more	robust	analysis	on	these	more	complicated	datasets	




and	 virulence	 is	 also	 being	 achieved	 by	 starting	 to	 combine	 data	 from	 these	
technologies,	as	seen	in	Chapter	4,	which	combines	RNAseq	and	metabolomics	analysis.	
The	 combination	 of	 these	 technologies,	 from	 genomic	 to	 transcriptomic	 and	
metabolomics	 analysis	 is	 far	 more	 powerful	 in	 providing	 biological	 insight.	 These	
advances	in	OMIC	technologies	and	the	decrease	in	price	has	also	allowed	for	analysis	




were	 previously	 largely	 unstudied,	 this	 includes	 T.	 congolense,	 T.	 vivax,	 which	 are	
responsible	for	the	majority	of	trypanosome	infections	in	cattle,	and	the	less	common	


















Figure	 1.1:	 Taken	 with	 permission	 from	 the	 centre	 of	 disease	 control	 and	 prevention	








virulent	 T.	 brucei	 strains	 (Matthews	 et	 al.,	 2004;	 Sternberg	 and	 Maclean,	 2010;	
MacLean	et	al.,	2010).	These	 injected	forms	then	differentiate	within	the	bloodstream	












	Differentiation	 from	 the	 long	 slender	 forms	 (LS)	 to	 the	 short	 stumpy	 forms	 (SS)	
requires	a	number	of	highly	regulated	morphological	changes.	Once	differentiated	into	
these	SS	stages,	the	parasite’s	cell	cycle	is	arrested	and	many	metabolic	pathways	and	
previously	 highly	 expressed	 genes,	 are	 downregulated	 (Rico	 et	 al.,	 2013;	 Seed	 and	
Wenck,	2003;	Duszenko	et	al.,	2006).	These	stages	last	48	hours	prior	to	apoptosis	and	
can	 be	 split	 into	 two	 populations.	 The	 younger	 population	 of	 SS	 forms	 are	 tsetse	 fly	
infective	and	are	adapted	to	survive	within	the	tsetse	fly	host.	The	older	population	of	
SS	 forms	 are	 no	 longer	 tsetse	 fly	 infective	 and	 improve	 the	 chances	 of	 uptake	 of	 the	
younger	 SS	 population,	 in	 what	 has	 previously	 been	 coined,	 an	 altruistic	 manner	
(Kennedy,	2004;	Rico	et	al.,	2013).		
	
The	highly	proliferative	LS	 forms	are	 capable	of	 either	 staying	 in	 the	bloodstream	or	
migrating	 to	 extravascular	 regions	 and	 passing	 the	 blood-brain	 barrier	 (BBB)	 and	
entering	 the	 central	 nervous	 system	 (CNS).	 This	 migration	 triggers	 a	 number	 of	
symptoms	within	the	host	and	signals	the	late	stage	of	infection	(Matthews	et	al.,	2004;	




The	 SS	 forms	 are	prepared	 for	 tsetse	 fly	 infection,	 and	 infect	 the	 tsetse	 fly	 during	 its	
blood	meal.	Initially	the	trypanosomes	colonize	the	midgut	of	the	tsetse	fly,	and	here	SS	





et	 al.,	 2009).	 Once	 differentiated	 to	 trypomastigotes,	 the	 trypanosomes	 resume	 cell	
division	and	multiple	by	binary	fission	as	shown	in	Figure	1.1.		
	
Midgut	procyclic	 trypanosomes	 then	migrate	 to	 the	salivary	gland	via	 the	peritrophic	
matrix,	the	foregut,	the	proventriculus	and	the	salivary	ducts,	as	can	be	seen	in	Figure	
1.2.	Whilst	 in	 the	 proventriculus,	 the	 procyclic	 trypomastigotes	 undergo	 asymmetric	
division	to	generate	a	short	and	long	epimastigote	(Van	Den	Abbeele	et	al.,	1999).	The	
short	epimastigote	attaches	to	the	epithelial	cells	of	the	salivary	gland.	Once	attached,	






















tsetse	 fly,	once	here	the	short	stumpy	forms	(SS)	differentiate	 into	procyclic	 trypomastigotes	and	
exchange	 a	 VSG	 coat	 for	 a	 procyclic	 coat.	 	 These	 then	 migrate	 to	 the	 salivary	 glands	 via	 the	








HAT	is	 transmitted	by	tsetse	 flies	 from	the	Glossinia	genus.	 	However	 less	 than	1%	of	
wild	flies	have	salivary	gland	infections,	which	suggests	that	trypanosomes	are	poorly	
adapted	 to	 their	 tsetse	host	 (Gibson	&	Bailey,	2003).	Although	T.	brucei	 takes	at	 least	















cattle.	 T.	 congolense	 and	 T	 .vivax	 are	 also	 responsible	 for	 animal	 African	
trypanosomiasis	 (AAT)	 and	 collectively	 lead	 to	 an	 estimated	 loss	 of	 a	 billion	 dollars	
annually	 (O'Gorman	 et	 al.,	 2009;	 Kristjanson	 et	 al.,	 1999).	 Over	 approximately	 60	
million	cattle	are	at	risk	from	AAT	in	37	endemic	countries,	which	significantly	reduces	
cattle	 productivity	 (Berriman,	 2005;	 O'Gorman	 et	 al.,	 2009).	 Despite	 its	 inability	 to	
infect	humans,	the	ease	at	which	T.b.	brucei	 is	manipulated	makes	it	a	common	model	
for	 human	 disease,	 particularly	 due	 to	 the	 high	 degree	 of	 similarity	 between	 sub	
species	 (~99%)	 (Berriman,	 2005;	 Jackson	 et	 al.,	 2010).	 	 The	 most	 commonly	 used	
reference,	Tb927,	 is	 a	T.b.	brucei	 strain	which	was	used	 in	 the	 first	 sequencing	of	 the	
trypanosome	 genome,	 and	 remains	 in	 use	 due	 to	 comparatively	 poor	 genome	






	T.b.	 brucei	 is	 unable	 to	 infect	 humans	 because	 it	 is	 susceptible	 to	 the	 trypanolytic	
factors	TLF-1	and	TLF-2.	These	are	 complexes	which	 contain	 the	haptoglobin	 related	
protein	 (Hpr)	 and	 apolipoprotein	 L1	 (ApoL1).	 These	 complexes	 differ	 in	 the	 protein	
components	 they	 contain,	 with	 TLF-1	 comprised	 primarily	 of	 apolipoprotein	 A-1	







The	 apolipoprotein	 L	 family	 (apoL),	 is	 comprised	 of	 six	 members,	 named	 apoL1-6,	
which	arose	as	a	result	of	tandem	duplication	(Pays	et	al.,	2006;	Vanhollebeke	and	Pays,	
2006).	Until	 recently,	 their	 function	was	unknown.	ApoL1	has	been	more	extensively	
studied,	 due	 to	 its	 known	 role	 in	 killing	 bloodstream	 trypanosome	 forms,	 and	 is	 a	
secreted	protein.	However	the	remaining	members	of	the	family	are	intracellular,	and	
their	 proposed	 roles	 were	 in	 lipid	 transport	 and	metabolism,	 due	 to	 ApoL1s	 known	









(Hpr)	 gene	 is	 a	 result	 of	 a	 gene	 triplication	 event.	 Hpr	 is	 primate	 specific,	 but	 apart	
from	 its	 protective	 role	 against	 T.b.	 brucei,	 its	 function	 is	 unknown	 (Langlois	 and	
Delanghe,	 1996;	 Drain	 et	 al.,	 2001;	 Shimamura	 et	 al.,	 2001;	 Seed	 et	 al.,	 2007).		
Haptoglobin	 (hp)	 is	 a	 tetrameric	 plasma	 protein	 comprised	 of	 two	 alpha	 and	 beta	
chains.	 Hp	 has	 a	 high	 affinity	 for	 haemoglobin	 and	 promotes	 its	 clearance	 	 from	 the	





HPR	 has	 a	 greater	 than	 90%	 homology	 to	 Hp,	 which	 is	 an	 abundant	 serum	 protein.	
However	its	abundance	in	human	serum	is	several	hundredfold	lower	than	haptoglobin	
(Hp)	(Drain	et	al.,	2001).	Interestingly,	Hp	naturally	inhibits	the	TLF-1	complex	and	the	
variation	 in	 trypanosome	 lytic	 activity	 is	 correlated	 with	 an	 individual’s	 serum	
concentration	 of	 Hp	 (Harrington	 et	 al.,	 2010;	 Drain	 et	 al.,	 2001).	 HPR	 contains	
hydrophobic	peptides	that	target	the	killing	of	specifically	bloodstream	forms,	 leaving	




Both	APOL1	and	HPR	are	currently	believed	 to	be	essential	 for	optimal	parasite	 lysis	
(Capewell	et	al.,	2011;	Widener	et	al.,	2007;	Vanhollebeke	et	al.,	2007).	The	mechanism	
has	 been	 characterized	 in	 the	 TLF-1	 complex,	 but	 in	 TLF-2	 is	 still	 not	 wholly	
understood.	The	TLF-1	complex	is	first	taken-up	by	the	parasite	by	the	binding	of	HPR	
to	 the	 parasite’s	 haptoglobin-hemoglobin	 receptor	 (HpHbR).	 Once	 internalized,	 the	
TLF-1	 complex	 is	 then	 targeted	 to	 the	 lysosome.	 pH	 changes	 within	 the	 lysosome	
trigger	 the	 activation	 of	 the	 APOL1	 element	 of	 the	 complex,	 which	 then	 undergoes	
conformational	 changes	 which	 result	 in	 pores	 forming	 within	 the	 lysosomes	
membrane.	 Lysis	 results	 from	 the	 subsequent	 osmotic	 changes	 (Vanhollebeke	 et	 al.,	
2008;	Capewell	et	al.,	2011;	Vanhollebeke	and	Pays,	2010).	Due	to	their	key	roles	in	the	
uptake	of	TLF-1,	and	their	presence	within	the	TLF-2	complex,	it	is	likely	that	they	have	




As	 previously	 mentioned,	 these	 trypanolytic	 complexes	 are	 found	 only	 in	 primates	
because	the	Hpr	and	ApoL1	genes	are	unique	to	the	primate	genome.	Due	to	this,	these	











HAT	 is	 caused	 by	 T.b.	 gambiense	 and	 T.b.	 rhodesiense.	 As	 previously	 mentioned,	 the	
majority	of	human	infections	are	caused	by	the	T.b.	gambiense	 subspecies.	These	sub-
species	 are	 broadly	 considered	 to	 cause	 chronic,	 and	 acute	 infections	 respectively,	















T.b.	gambiense	 causes	 African	 trypanosomiasis	 in	 western	 and	 central	 Africa,	 and	 is	
generally	 considered	 to	 cause	 slow	 onset	 chronic	 infections,	 however	manifestations	



































their	mechanisms	 of	 resistance	 to	 lysis,	 as	 described	 in	 2011	 (Capewell	 et	 al.,	 2011;	
2013b).	
	
Group	1	T.b.	gambiense	 strains	are	 clonal	 in	nature,	 and	have	an	 invariant	phenotype	
but	are	genetically	distinct	from	group	2	T.b.	gambiense	strains	and	T.b.	brucei	(Mehlitz	
et	al.,	1982;	Capewell	et	al.,	2011;	Balmer	et	al.,	2011;	Capewell	et	al.,	2013b;	Sternberg	
and	Maclean,	2010).	 In	 contrast,	 group	2	 strains	are	not	genetically	distinct	 from	T.b.	
brucei	and	have	variable	phenotypes	(Capewell	et	al.,	2011;	Mehlitz	et	al.,	1982;	Balmer	
et	 al.,	 2011;	 Sternberg	 and	 Maclean,	 2010).	 It	 has	 been	 suggested	 previously	 that	
mating	between	group	1	T.b.	gambiense	 and	T.b.	brucei	 could	give	rise	 to	group	2	T.b.	
gambiense	 strains,	but	 there	 is	no	current	evidence	to	support	 this.	However,	 there	 is	
evidence	of	mating	within	group	2	T.b.	gambiense	strains	and	between	group	2	strains	
and	T.b.	brucei,	which	may	explain	the	variability	in	phenotype	(Capewell	et	al.,	2013a;	
2011).	 This	 also	 suggests	 that	 human	 infectivity	 has	 evolved	 via	 independent	
mechanisms	in	each	group	(Goodhead	et	al.,	2013;	Capewell	et	al.,	2013a;	Gibson	et	al.,	
2015).	 However	 variable	 phenotypes	 have	 previously	 been	 described	 in	 T.b.	
rhodesiense	 and	 other	 species,	 with	 hybrid	 genomes	 resulting	 from	mating	 between	





d’Ivoire,	 Cameroon	 and	 Burkina	 Faso	 (Capewell	 et	 al.,	 2013b;	 Gibson,	 1986;	











regulation	 in	 trypanosomes	 is	 primarily	 controlled	 by	 the	 3’	 UTR,	 and	 Capewell	 and	
colleagues	 identified	 several	 polymorphisms	 unique	 to	 the	 group	 1	 T.b.	 gambiense	
	 12	
strains	within	the	3’UTR	of	HbHpR	which	could	explain	its	downregulation	(DeJesus	et	
al.,	 2013;	 Capewell	 et	 al.,	 2011).	 In	 2013,	 a	 group	 1	 specific	 leucine	 to	 serine	




a	T.b.	gambiense-specific	 glycoprotein	 (TgsGP),	which	 is	 absent	 from	 group	 2	 strains	
(Uzureau	 et	 al.,	 2013;	Gibson	 et	 al.,	 2010;	 Capewell	 et	 al.,	 2011).	 TgsGP	prevents	 the	













T.b.	 rhodesiense	 causes	 African	 trypanosomiasis	 in	 eastern	 and	 southern	 Africa.	
Similarly	to	T.b.	gambiense,	T.b.	rhodesiense	has	evolved	a	strategy	to	combat	the	effects	
of	 ApoL1	 binding.	 However,	 as	 illustrated	 in	 Figure	 1.1,	 it	 uses	 the	 serum	 resistance	
associated	protein	(SRA),	which	is	a	truncated	variable	surface	glycoprotein	(VSG)	like	
gene,	however	 it	only	has	 less	 than	25%	sequence	homology	 (Xong	et	al.,	1998;	Pays	







the	TLF	complex	 is	 in	close	proximity	to	SRA,	 it	binds	to	ApoL1	at	 its	SRA	interaction	





infection,	 with	 several	 characteristics,	 such	 as	 a	 tendency	 to	 cause	 a	 chancre,	 and	 a	
much	 quicker	 progression	 from	 the	 early	 bloodstream	 stages	 of	 the	 disease	 to	 the	
encephalitic	stage.	T.b.	rhodesiense	also	infects	both	human	and	animal,	however	unlike	
T.b.	gambiense,	the	majority	of	infections	occur	in	the	animal	not	human	reservoir,	with	
human	 infections	 considered	more	 coincidental	 (Radwanska	 et	 al.,	 2002;	Onyango	 et	
al.,	1966;	Picozzi	et	al.,	2008;	Hide	et	al.,	1996;	Noireau	et	al.,	1989;	Smith	and	Bailey,	
2000;	 Anderson	 et	 al.,	 2011).	 Unlike	 T.b.	 gambiense	 and	 T.b.	 brucei,	 T.b.	 rhodesiense	





As	 previously	mentioned,	 the	 burden	 of	 disease	 in	 terms	 of	HAT	 infections	 recorded	
annually	has	dramatically	decreased	within	the	 last	decade.	However	the	incidence	of	
non-human	 infections	 still	 results	 in	 a	 considerable	 socio-economic	 loss.	
Morphologically	 all	 three	 T.	 brucei	 sub-species	 are	 indistinguishable	 by	 microscopy,	
however	 T.b	 gambiense	 and	 T.b.	 rhodesiense	 infections	 primarily	 occur	 in	 different	
regions	of	Sub-Saharan	Africa,	and	are	only	co-endemic	in	Uganda,	which	means	that	a		
	strain’s	sub-species	can	often	by	identified	by	the	location	it	was	first	isolated	(World	




In	 2014,	 the	world	 health	 organization	 (WHO)	 recorded	 that	 the	most	 common	 sub-
species,	T.b.	gambiense,	 is	endemic	 in	24	countries	within	west	and	central	Africa	and	
was	 responsible	 for	 ~97%	 of	 reported	 HAT	 infections	 (World	 Health	 Organization,	
2014).	 T.b.	 rhodesiense	 was	 found	 to	 be	 endemic	 in	 13	 countries	 in	 eastern	 and	







in	 the	 1970s,	 when	 approximately	 300,000-500,000	 were	 infected	 (Simarro	 et	 al.,	
2010;	Bucheton	et	al.,	2011;	Simarro,	2011).		
	
	The	 localization	 of	 T.b.	 gambiense	 and	 T.b.	 rhodesiense	 is	 shown	 in	 Figure	 1.2,	 and	
shows	 T.b.	 gambiense	 to	 affect	 a	 larger	 region	 of	 Sub-Saharan	 Africa,	 and	 a	 higher	
density	of	 infections,	with	countries	recording	over	1000	cases	a	year.	Regions	where	
infections	 were	 recorded	 in	 previous	 years,	 but	 where	 none	 were	 recorded	 within	
2014	 are	 shown	 in	 red.	 In	 particular,	 T.b.	 gambiense	 infections	 have	 effectively	
disappeared	 from	 savannah	 regions	 as	 a	 direct	 effect	 of	 active	 surveillance	 and	
treatment	 (Picozzi	 et	 al.,	 2005;	 Simarro	 et	 al.,	 2010;	 Bucheton	 et	 al.,	 2011).	 All	 these	
countries	fall	within	the	tsetse	belt,	which	is	the	main	limiting	factor	in	the	distribution	























both	 subspecies,	 however	 Uganda	 has	 an	 overlap	 between	 T.b.	 rhodesiense	 and	 T.b.	 gambiense	









rhodesiense	 are	 known	 to	 co-exist	 (Bucheton	 et	 al.,	 2011;	 Picozzi	 et	 al.,	 2005;	
Jamonneau	et	al.,	2012).	Due	to	 the	phenotypes	of	group	2	T.b.	gambiense	 strains	and	
T.b.	rhodesiense	strains	being	more	variable,	this	led	to	the	idea	of	mating	between	and	
within	 sub-species	 leading	 to	 hybrid	 parasites	 with	 a	 more	 variable	 phenotype,	 as	
previously	mentioned.	The	strains	used	within	 this	body	of	work	are	T.	b.	rhodesiense	
strains	 originally	 isolated	 from	 Uganda.	 The	 phenotypes	 of	 these	 strains	 have	 been	
previously	 described	 and	 suggested	 introgression	 between	 T.	brucei	 subspecies	 was	







Trypanotolerance	 and	 susceptibility	 has	 been	 recorded	 both	 in	 human	 and	 animal	
populations		(Murray	et	al.,	1982;	Bucheton	et	al.,	2011;	Naessens,	2006;	Jamonneau	et	
al.,	 2012;	 O'Gorman	 et	 al.,	 2009).	 In	 cattle,	 the	 trypanosusceptible	 Boran	 and	
trypanotolerant	 N’Dama	 cattle	 breeds	 have	 been	 extensively	 studied	 in	 order	 to	
understand	 the	mechanisms	of	 trypanotolerance,	 and	 to	breed	 trypanotolerant	 cattle	
suitable	 for	meat	 and	milk	 production	 (Jamonneau	 et	 al.,	 2012;	 Murray	 et	 al.,	 1982;	
Naessens,	 2006;	O'Gorman	et	 al.,	 2009).	Until	 recently,	 little	 research	 effort	 has	been	
placed	into	understanding	the	mechanisms	of	resistance	in	across	human	populations	





with	 the	 infection.	HAT	 infections	were	considered	 invariably	 fatal	without	 treatment	
until	 recently	 (Bucheton	 et	 al.,	 2011;	 Jamonneau	 et	 al.,	 2012).	 However	 small	
populations	of	infected	persons	in	these	endemic	regions	were	found	to	spontaneously	
recover	 without	 medical	 intervention,	 or	 were	 asymptomatic	 despite	 being	 tested	
positive	 for	 parasite	 infection	 using	 one	 of	 the	methods	 discussed	 in	 the	 treatments	
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There	 is	 an	 overlap	 in	 the	 regions	 where	 both	 malaria	 and	 trypanosomiasis	 are	
endemic.	 As	 previously	 discussed,	 low	 haptoglobin	 levels	 are	 correlated	 with	 an	
increase	in	the	production	of	TLF	complexes	(Uzureau	et	al.,	2013;	Drain	et	al.,	2001).	
In	 regions	 of	 malaria	 infection,	 haptoglobin	 levels	 are	 generally	 low	 as	 a	 result	 of	
haemolysis	 caused	 by	 Plasmodium	 when	 it	 releases	 merozoites	 into	 the	 blood.	 The	
subsequent	 rupturing	 of	 the	 erythrocytes	 causes	 the	 release	 of	 free	 haem	 into	 the	
blood,	 which	 is	 removed	 by	 haptoglobin	 (Uzureau	 et	 al.,	 2013).	 The	 increase	 in	 TLF	
complex	 formation	 due	 to	 low	 haptoglobin	 levels	 is	 protective	 against	 trypanosome	
infection.	 Co-morbidities	 can	 also	 make	 the	 reporting	 of	 HAT	 cases	 more	 difficult	
because	particularly	in	the	earlier	stages	of	the	disease,	which	can	range	in	symptoms	












locations	 where	 they	 have	 not	 previously	 been	 identified,	 as	 has	 been	 suspected	
previously	 in	Tanzania	(Magnus	et	al.,	1978;	Kibona	et	al.,	2007).	One	of	 the	 issues	 in	




caused	 by	 T.b.	 gambiense	 or	 T.b.	 rhodesiense.	 The	 determination	 of	 the	 sub	 species	





card	 agglutination	 test	 (CATT)	 is	 a	 commonly	 used	 method	 of	 identifying	 T.b.	
gambiense,	an	example	of	which	is	shown	in	Figure	1.5.	Since	its	development	in	1978,	
the	CATT	 test	has	been	used	widely	 in	 endemic	 areas	because	of	 its	 inexpensive	 and	
easy	to	use	nature	(Truc	et	al.,	2002;	Magnus	et	al.,	1978;	Chappuis	et	al.,	2004).	Despite	
a	high	sensitivity,	which	detects	90%	of	serologically	positive	patients,	confirmation	of	
the	 diagnosis	 subsequent	 to	 the	 test	 is	 required	 and	 relies	 on	 detection	 of	
trypanosomes	either	in	the	blood	or	via	lumbar	puncture	(Truc	et	al.,	2002;	Picozzi	et	
al.,	 2002;	 Chappuis	 et	 al.,	 2004).	 However	 not	 all	 serologically	 positive	 patients	 are	
identified	as	positive	by	microscopic	methods	and	due	to	the	serious	side	effects	often	
exhibited	 by	 patients	 receiving	 treatment,	 a	 patient	 must	 be	 both	 serologically	 and	
parasitologically	confirmed	(Truc	et	al.,	2002;	Picozzi	et	al.,	2002).	The	success	of	 the	
CATT	test	has	led	to	the	development	of	other	related	diagnostic	methods	such	as	the	

























Due	 to	 lack	of	 specificity	 in	 the	parasitological	detection	methods,	effort	was	put	 into	
the	 development	 of	 more	 sensitive	 methods.	 These	 are	 primarily	 PCR	 based	 and	
markers	such	as	SRA	and	TgsGP	can	be	used	for	example	for	identifying	T.b.	rhodesiense	
and	 T.b.	 gambiense	 group	 1	 strains.	 SRA	 has	 been	 used	 for	 the	 detection	 of	 T.b.	
rhodesiense	 in	 cattle	 in	multiple	 studies	 (Picozzi	 et	 al.,	 2002;	Radwanska	 et	 al.,	 2002;	
Njiru	et	al.,	2004;	Ng'ayo	et	al.,	2005;	Picozzi	et	al.,	2008).	PCR	methods	have	also	been	
used	 to	 amplify	 trypanosome	 specific	 regions	 such	 as	 the	 expression	 site	 associated	







Beneath	 is	 a	 brief	 explanation	 of	 the	 methods	 that	 have	 been	 used	 previously	 for	
assigning	 taxonomy	 in	 T.	 brucei	 strains.	 Within	 this	 project,	 the	 strains	 used	 were	








sites.	The	DNA	 is	digested	by	a	combination	of	 restriction	enzymes,	and	 the	resulting	
fragments	are	separated	by	electrophoresis.	Multiple	previous	studies	have	used	these	
banding	 patterns	 to	 assign	 T.	 brucei	 isolates	 to	 groups	 and	 infer	 the	 population	
structure	(Geysen	et	al.,	2003;	Zhang	and	Baltz,	1994;	Kanmogne	et	al.,	1996;	Afework	
et	al.,	2006).	RFLP-PCR	has	also	been	used	to	identify	subgroups	within	trypanosome-









Mobile	 genetic	 element	 PCR	 (MGE-PCR)	 was	 used	 similarly	 to	 RFLP	 analysis	 on	 T.	
brucei	 strains	 to	 assign	 them	 to	 taxonomic	 groups.	 However	 this	 utilized	 RIME,	 a	
mobile	 genetic	 element.	There	 is	 a	higher	degree	of	 variability	between	 strains	using	






Tandem	 repeat	 sequences	 (micro	 and	 mini	 satellites)	 were	 also	 used	 for	 strain	
identification.	 Microsatellites	 consist	 of	 2-5	 nucleotide	 length	 sequences	 that	 are	
repeated	 typically	 between	 5-50	 times.	 Minisatellites	 are	 larger	 and	 the	 repeat	
sequences	are	generally	6-100	nucleotides	long	and	are	repeated	5-50	times	also	(Sloof	
et	 al.,	 1983;	 Vergnaud,	 2000;	Koffi	 et	 al.,	 2007;	 Simo	 et	 al.,	 2010;	 2011).	 Collectively,	
minisatellites	and	microsatellites	are	called	variable	number	 tandem	repeats	 (VNTR).		
Similarly	to	the	previous	methods,	multiple	studies	were	done	in	T.	brucei	using	these	








present	 in	a	 strain,	 in	conjunction	with	multilocus	enzyme	electrophoresis	 (MLEE)	 to	
generate	 banding	 patterns	 unique	 to	 a	 strain	 or	 set	 of	 strains.	 Typically,	 these	
isoenzymes	exhibit	Mendelian	 inheritance	 traits,	with	active	 isoenzymes	representing	
particular	 loci	 which	 behave	 as	 alleles.	 These	 are	 often	 referred	 to	 as	 alloenzymes	
(Banuls	 et	 al.,	 1999;	 Ben	 Abderrazak	 et	 al.,	 1993;	 Soccol	 et	 al.,	 2002;	Montilla	 et	 al.,	
2002).	 These	 isoenzyme	 patterns	 can	 be	 used	 to	 estimate	 strain	 relatedness	 and	
understand	population	structure.	The	strains	used	within	this	work	were	allocated	to	
zymodeme	 groups	 using	 this	 method,	 and	 the	 isoenyzme	 banding	 patterns	 were	
sensitive	enough	 to	group	strains	within	 the	T.b.	rhodesiense	 subspecies.	This	method	
of	characterization	was	highly	popular,	and	was	used	to	decipher	population	structure	
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Due	 to	host-parasite	 interplay,	a	whole	range	of	 symptoms	and	patient	outcomes	can	
arise	as	a	result	of	HAT	infection	(Nikolskaia	et	al.,	2006;	Giroud	et	al.,	2009;	Brun	et	al.,	
2010;	 Sternberg	 and	 Maclean,	 2010).	 However,	 the	 diseases	 natural	 progression	 is	
from	an	early	stage	when	the	parasites	are	within	the	bloodstream,	followed	by	a	late	
stage	which	 is	characterized	by	 the	parasites	passing	 through	the	blood	brain	barrier	
(BBB)	(Jamonneau	et	al.,	2012;	Nikolskaia	et	al.,	2006;	Brun	et	al.,	2010).	Both	stages	
exist	 in	 T.b.	 gambiense	 and	 T.b.	 rhodesiense	 infections,	 however	 depending	 on	 the	
severity	of	the	disease	a	patient	may	be	asymptomatic	for	a	long	period,	or	may	present	
with	 a	 severe	 early	 stage	 infection.	 Depending	 on	 the	 time	 from	 infection	 and	 the	
severity	 of	 the	 disease,	 different	 drug	 regimens	 can	 be	 given	 and	 if	 treated	 early	 in	
infection,	patients	do	not	necessarily	go	on	to	develop	the	late	stage	of	the	disease.	Until	




In	 the	 early	 stage	 of	 infection,	 depending	 on	 the	 virulence	 of	 the	 strain,	 localized	
swellings/chancres	 can	 occur	 around	 the	 bite	 region.	 Other	 recognizable	 symptoms	
include	 winterbottom’s	 sign,	 which	 is	 a	 result	 of	 lymphadenopathy,	 facial	 oedoma,	
muscle	weakness	and	general	malaise	(Kennedy,	2013;	Brun	et	al.,	2010).	The	parasites	
go	through	several	peaks	of	parasitaemia	and	these	correlate	with	relapsing	fever.	The	






The	 late	 stage	 of	 infection	 is	 diagnosed	 by	 lumbar	 puncture	 and	 identification	 of	
trypanosomes	within	 the	 cerebral-spinal	 fluid	 (CSF).	 This	 is	 the	 stage	 of	 the	 disease	
from	which	the	disease	derives	its	name,	sleeping	sickness.	At	this	stage,	parasites	pass	
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through	 the	 BBB	 and	 can	 enter	 the	 tissues	 here	 and	 interfere	with	 normal	 neuronal	
function	 (Kennedy,	 2004;	 de	 Atouguia	 and	Kennedy,	 2000).	 As	 a	 result,	 the	 patient’s	
cognitive	 ability	 may	 be	 impaired	 in	 multiple	 ways.	 Daytime	 sleeping	 is	 one	 of	 the	
common	results	of	the	late	stage,	in	which	between	relapsed	fevers,	patients	sleep	into	
atypical	sleeping	patterns,	which	without	treatment	typically	lead	to	coma.	In	part	this	
is	 caused	 by	 the	 metabolism	 of	 tryptophan,	 which	 induces	 sleep	 in	 the	 patients	 (de	
Atouguia	 and	 Kennedy,	 2000;	 Kennedy,	 2004).	 The	 suprachiasmatic	 nuclei,	 which	
control	circadian	rhythms	in	humans,	are	dysregulated	in	T.	brucei	 infections,	and	this	
also	affects	 the	neurological	 symptoms	observed.	This	 stage	 is	also	 referred	 to	as	 the	
encephalitic	 stage	 (Brun	 et	 al.,	 2010;	 de	 Atouguia	 and	 Kennedy,	 2000).	 At	 this	 stage	
other	major	 organs	 begin	 to	 fail,	 including	 commonly	 the	 liver,	 and	 other	 symptoms	
which	may	 also	 be	 present	 include	 splenomegaly,	 amenorrhoea	 and	 severe	 anaemia	
(Steverding,	2010;	Brun	et	al.,	2010).	Due	to	the	severity	of	the	late	stage	of	the	disease	
and	 the	multiple	 organs	 it	 affects,	 treatment	 prior	 to	 the	 passing	 of	 the	 BBB	 is	 both	
preferential	 and	 more	 successful.	 Due	 to	 the	 chronic	 nature	 of	 T.b.	 gambiense	






Treatment	 for	 HAT	 is	 severely	 limited,	 dependent	 on	 drugs	 that	 were	 discovered	
empirically	 decades	 ago,	 and	 their	 mechanisms	 of	 action	 not	 well	 understood	
(Fairlamb,	1990;	Steverding,	2010;	Pépin	et	al.,	1994;	Keating	et	al.,	2015).	The	need	for	
novel	treatments	is	also	urgent	due	to	the	low	efficacy,	increasing	resistance	and	severe	
side	effects	of	 these	current	 treatments	 (Kennedy,	2004;	Fairlamb,	1990;	Pépin	et	al.,	
1994;	Keating	et	al.,	2015).	In	T.	brucei,	treatment	of	the	late	stage	is	difficult	to	treat	in	
particular,	because	 the	drug	needs	 to	be	able	 to	pass	 through	the	blood-brain	barrier	
(Kennedy,	2004).	
	
Currently	 there	are	a	small	number	of	 reliable	 treatments,	however	 for	 the	 late	stage	
especially,	 treatment	 is	more	complex	and	 less	successful	and	resistance	 is	 increasing	
whilst	 there	 is	 no	 current	 prospect	 of	 a	 vaccine	 (Masocha	 and	 Kristensson,	 2012;	
Kennedy,	 2004).	 Very	 few	 pathogens	 are	 capable	 of	 passing	 the	 blood	 brain	 barrier,	
and	 antibodies	 are	 too	 large	 to	 pass	 (Masocha	 and	 Kristensson,	 2012;	 Barrett	 et	 al.,	
2007).	 This	 means	 that	 once	 T.	 brucei	 is	 within	 the	 CNS,	 it	 is	 protected	 from	 the	
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immunological	 challenges	 it	 faces	 as	 an	 extracellular	 parasite	 in	 the	 bloodstream.	
However	due	 to	 the	 impenetrability	of	 the	BBB,	once	T.	brucei	 reaches	 this	 stage,	 the	







Pentamidine	 is	 used	 in	 the	 treatment	 of	 early	 stage	 T.b.	gambiense	 infections	 and	 is	
given	 either	 intramuscularly	 or	 intravenously.	 Compared	 to	 some	 of	 the	 other	
treatment	 options,	 pentamidine	 is	 generally	 well	 tolerated,	 however	 intramuscular	
injections	 can	 still	 lead	 to	 symptoms	 such	 as	 gastrointestinal	 problems	 and	
hypoglycaemia	in	up	to	40%	of	patients	(Doua	et	al.,	1996;	Benaim	et	al.,	1993;	Barrett	







not	 used	 to	 treat	 stage	 one	T.b.	gambiense	 infections	 because	Onchocerca	 species	 are	
also	endemic	in	these	regions.	Onchocerca	species	elicit	a	high	immune	response	when	
exposed	 to	 suramin,	 and	 so	 suramin	 is	 not	 used	 to	 reduce	 the	 risk	 of	 severe	 allergic	







Melarsoprol	 is	 used	 for	 the	 treatment	 of	 both	 second	 stage	 T.b.	 gambiense	 and	 T.b.	
rhodesiense.	Although	the	most	toxic	of	treatments	due	to	it	being	an	arsenic	derivative,	
it	is	the	only	available	treatment	currently	for	late	stage	T.b.	rhodesiense	(Priotto	et	al.,	
2006;	 Babokhov	 et	 al.,	 2013;	 Chappuis,	 2007).	 Eflornithine	 or	 eflornithine	 in	
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combination	with	nifurtimox	are	preferable	treatments	for	late	stage	treatment	of	T.b.	
gambiense,	 however	 they	 are	 unaffordable	 in	 some	 of	 the	 poorer	 endemic	 countries	
(Babokhov	 et	 al.,	 2013;	 Priotto	 et	 al.,	 2006;	 Chappuis,	 2007).	 For	T.b.	gambiense,	 the	
course	 of	 treatment	 is	 shorter,	 however	 for	 T.b.	 rhodesiense	 the	 treatment	 course	 is	
longer	 and	 more	 complex.	 Adverse	 drug	 reactions	 to	 melarsoprol	 are	 frequently	
serious,	 if	not	 life-threatening	 (Gehrig	and	Efferth,	2008;	Babokhov	et	al.,	2013).	Post	
treatment	 encephalopathic	 syndrome	 is	 life	 threatening,	 and	 occurs	 in	 ~5%	 of	 T.b.	
gambiense	 infected	patients	and	~8%	of	T.b.	rhodesiense	 infected	patients	(Gehrig	and	








Eflornithine	 is	 the	 newest	 treatment	 for	 trypanosomiasis,	 and	 the	 only	 one	 to	 be	
developed	 within	 the	 last	 50	 years.	 It	 works	 by	 inhibiting	 ornithine	 decarboxylase,	
which	 is	essential	 for	differentiation	and	replication	(Babokhov	et	al.,	2013;	Bacchi	et	
al.,	1983;	Priotto	et	al.,	2007).	Eflornithine	can	be	used	in	place	of	melarsoprol	for	late	
stage	T.b.	gambiense	 treatment,	 and	 has	 been	 shown	 to	 both	 be	 effective	 and	 have	 a	
significantly	reduced	mortality	rate	after	 treatment	(Babokhov	et	al.,	2013).	However	
eflornithine	cannot	be	used	 for	T.b.	rhodesiense	 treatment	because	 the	parasite	 is	 less	
susceptible	 (Priotto	et	 al.,	 2009;	Babokhov	et	 al.,	 2013).	For	T.b.	gambiense	 infections	
treatment	lasts	two	weeks,	but	multiple	infusions	per	day	are	required,	limiting	the	use	
at	more	rural	centres.	Nifurtimox	can	also	be	used	in	conjunction	with	eflornithine	to	
increase	 treatment	 success.	 	 Nifurtimox	 was	 originally	 used	 only	 as	 an	 orally	
administered	 treatment	 for	 Chagas	 disease	 (Priotto	 et	 al.,	 2007;	 2009).	 For	 both	
eflornithine	solely,	and	 in	combination	treatment,	 the	side	effects	are	similar	 to	 those	





















T.	 brucei’s	 genome	 consists	 of	 11	 paired	 megabase	 sized	 chromosomes,	 several	




Daniels	 et	 al.,	 2010).	 Initial	 analysis	 of	 the	 sequenced	 large	 chromosomes	 in	 2005	
suggested	 T.	 brucei	 had	 approximately	 9,068	 protein	 coding	 genes	 and	 904	
pseudogenes	spanning	over	26	megabases	in	the	large	chromosomes	(Berriman,	2005).	








a	 T.brucei	brucei	 strain	 (Peacock	 et	 al.,	 2008;	 Berriman,	 2005;	 Jackson	 et	 al.,	 2010).	
Since	 then,	 other	 T.	 brucei	 strains	 have	 been	 sequenced	 including	 DAL972	 in	 2010,	
however	Tb927	 is	 generally	used	as	 a	 reference	 strain	because	unlike	 some	T.	brucei	
strains	such	as	T.	brucei	Lister	427,	Tb927	can	complete	all	stages	of	T.	brucei’s	natural	
life	cycle	(Berriman,	2005;	Peacock	et	al.,	2008;	Jackson	et	al.,	2010).	DAL972	is	a	T.b.	
gambiense	 reference,	 however	 this	 is	 far	more	 fragmented	 than	 the	 Tb927	 reference	
(Berriman,	2005;	 Jackson	et	 al.,	 2010).	Despite	being	different	 subspecies,	T.b.	brucei,	
T.b.	rhodesiense	and	T.b.	gambiense	can	all	be	mapped	to	the	Tb927	reference	because	
they	 share	 a	 greater	 than	 99%	 genome	 identity.	 Due	 to	 the	 unusual	 structure	 of	 T.	
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organization	 of	 the	 genome	 and	 the	 potential	 transcriptional	 and	 regulatory	
differences,	which	arise	as	a	result.		The	impact	of	sequencing	on	not	only	T.	brucei,	but	
on	 evolving	 the	 field	 of	 parasitology	 as	 a	whole	was	 reviewed	by	Forrester	&	Hall	 in	






As	 previously	 mentioned,	 T.	 brucei	 dedicates	 a	 high	 percentage	 of	 its	 genome	 to	
antigenic	variation,	approximately	20%,	in	order	to	evade	detection	in	the	mammalian	
host	 (Aitcheson	 et	 al.,	 2005;	 Donelson,	 2003).	 In	 T.	 brucei,	 antigenic	 variation	 is	
generated	by	variable	surface	glycoprotein	(VSG)	genes	(Pays	et	al.,	2001;	Aitcheson	et	
al.,	 2005).	 	 These	 are	 primarily	 located	 within	 the	 subtelomeric	 regions	 of	 the	
chromosomes	and	a	catalogue	of	over	a	1000	VSG	genes	can	be	activated	(Aitcheson	et	
al.,	 2005;	 Pays	 et	 al.,	 2001).	 The	 activation	 of	 these	 genes	 changes	 the	 glycoprotein	
covering	 the	 trypanosome	 surface.	 The	 host	 immune	 system	 can	 mount	 a	 response	
against	these	surface	antigens,	however	only	one	VSG	is	active	at	one	time,	and	so	once	
a	 host	 response	 is	 primed,	 VSG	 switching	 occurs.	 This	 silences	 the	 expression	 of	 the	
previously	expressed	VSG	gene	and	activates	the	expression	of	another	(Berriman	et	al.,	
2002;	 Aitcheson	 et	 al.,	 2005).	 This	 activation	 happens	 within	 polycistronic	
transcriptional	 units	 within	 bloodstream	 expression	 sites	 (BES),	 which	 contain	
multiple	expression	site	associated	genes	 (ESAGs)	and	VSGs	downstream	(Pays	et	al.,	
2004;	 Berriman	 et	 al.,	 2002).	 VSGs	 can	 be	 activated	 by	 either	 the	 transposition	 of	 a	
silent	 VSG	 into	 an	 active	 expression	 site,	 rearrangements	 between	 telomeres	 or	
mediated	by	a	change	 in	 transcriptional	 regulation	(Berriman	et	al.,	2002;	Pays	et	al.,	
2004;	Forrester	and	Hall,	2014).	The	structure	of	BESs	had	been	described	prior	to	the	
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release	 of	 Tb927’s	 genome,	 however	 the	 variations	 in	 structure	 and	 the	 number	 of	
BESs	 could	 only	 be	 elucidated	 using	 the	 sequencing	 data	 (Berriman	 et	 al.,	 2002;	
Forrester	 and	Hall,	 2014).	 Sequencing	also	demonstrated	 that	only	5%	of	 these	VSGs	
were	functional,	the	rest	are	pseudogenes	(Marcello	and	Barry,	2007).	The	mechanisms	
of	 VSG	 activation	 and	 switching	 and	 the	 structure	 the	 BESs	 have	 previously	 been	











with	 common	 complex	 DNA	 repeat	 units.	 In	 Plasmodium,	 the	 genomes	 of	 multiple	
Plasmodium	 species	 have	 been	 published	 and	 have	 been	 used	 to	 reveal	 much	 about	





divergent	 subtelomeres	 that	 contained	many	 of	 the	 surface	 antigens	 (El-Sayed	 et	 al.,	
2005b;	Berriman,	2005;	Parsons	et	al.,	2005;	El-Sayed	et	al.,	2005a;	Ivens	et	al.,	2005).	
The	 sequencing	 of	 the	 other	 trypanosomatid	 genomes,	 Leishmania	 major	 and	
Trypanosoma	cruzi	also	in	2005	also	enabled	cross	species	comparisons	to	be	made	and	
putative	 housekeeping	 genes	 to	 be	 identified	 (Parsons	 et	 al.,	 2005;	 El-Sayed	 et	 al.,	
2005b).	 Genes	 specific	 to	 T.	brucei	 were	 also	 used	 to	 identify	 genes	 responsible	 for	
antigenic	variation	and	enabling	an	extracellular	lifestyle.	
	
As	 expected,	 the	 lifestyles	 of	 these	 parasites	 are	 reflected	 in	 their	 genome,	 with	
intracellular	parasites	L.major	 and	T.cruzi	 displaying	a	 greater	degree	of	 similarity	 in	
comparison	 to	 extracellular	 parasite	 T.	brucei	(El-Sayed	 et	 al.,	 2005b;	 Parsons	 et	 al.,	
2005).	 These	 genomes	 allowed	 us	 to	 look	 at	 how	 differences	 in	 immune	 evasion	
strategies	 are	 reflected	 in	 the	 accessory	parts	 of	 the	 genome.	Due	 to	 its	 extracellular	
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Access	 to	 the	 genome	 also	 revealed	 details	 about	 several	 key	mechanisms	 that	were	
previously	 not	 wholly	 understood,	 for	 instance	 transcriptional	 regulation	 in	 the	
kinetoplastids.	 The	 kinetoplastids	 have	 an	 unusual	 genome	 structure,	 with	 genes	
organized	 into	 long	polycistronic	arrays	which	undergo	 trans-splicing	 to	excise	genes	
from	exons	and	attach	a	splice	leader	to	each	transcript	(Parsons	et	al.,	1984;	El-Sayed	
et	al.,	2003).	This	is	a	conserved	mechanism,	which	has	been	documented	and	reviewed	
in	 a	 variety	 of	 eukaryotes	 including	 nematodes,	 platyhelminthes	 and	 tunicates	




In	 2010,	Nilsson	 et	 al	 used	 this	 knowledge	 in	 order	 to	 sequence	T.	brucei	 transcripts	
containing	 this	 splice	 sequence	 in	 order	 to	 discover	 splice	 site	 locations,	 understand	
alternative	splicing	events,	and	analyze	the	effect	they	had	on	gene	expression	(Nilsson	




	Annotation	 of	 the	 Tb927	 genome	 has	 also	 been	 pivotal	 in	 understanding	 metabolic	
processes	present	 in	T.	brucei	 from	 the	genes	 found	 to	be	present.	Parasites	 typically	
reduce	their	genome	size	to	only	include	genes	encoding	for	essential	functions,	which	














Two	 sequencing	 methods,	 the	 Maxam-Gilbert	 and	 the	 Chain-termination	 methods,	
were	developed	in	1977	to	decipher	short	DNA	sequences	(Maxam	and	Gilbert,	1977;	
Sanger	 et	 al.,	 1977).	 However	 the	 chain-termination	method	 developed	 by	 Frederick	
Sanger	 quickly	 became	 the	 preferred	 method	 and	 dominated	 sequencing	 until	 the	
development	 of	 next	 generation	 sequencing	 methods	 in	 2005	 (Hutchison,	 2007).	
Advances	 in	 capillary	 sequencing	 enabled	 the	 automation	 of	 this	 process	 and	 made	
whole	 genome	 projects	 feasible.	 Sanger	 sequencing	 is	 still	 popular	 to	 date	 for	 small	
scale	 projects	 however	 with	 the	 introduction	 of	 next	 generation	 sequencing	 and	
subsequent	 advances	 to	 the	 technology,	 research	 has	 shifted	 towards	 much	 higher	





However	 prior	 to	 NGS,	 Sanger	 sequencing	 was	 developed	 to	 increase	 throughput	
through	 improvements	 such	 as	 increase	 the	 number	 of	 capillaries,	 increased	 read	
length	and	by	 increasing	 the	automation	of	 the	process.	 	This	 led	 to	many	 significant	
milestones	using	Sanger	sequencing	such	as	many	of	 the	 first	whole	genome	projects	
including	the	 first	human	genome	 in	2001	(McCourt	et	al.,	2013;	Lander	et	al.,	2001).	








have	heavily	 invested	 in	 the	development	of	chemistries	 that	can	produce	 longer	and	
greater	numbers	of	reads.		Typically,	Illumina	reads	are	now	at	least	100	base	pairs	in	
length,	 however	 initially	 reads	 lengths	 were	 as	 short	 as	 21	 bases,	 whereas	 Sanger	
	 29	





used	 emulsion	 PCR,	 in	 which	 DNA	was	 amplified	 inside	 water	 droplets	 containing	 a	
single	DNA	template	attached	 to	a	single	bead,	 in	an	oil	 solution.	Luciferase	was	 then	
used	 to	 decipher	 each	 nucleotide	 added.	 This	 technology	 was	 cheaper	 per	 base	
compared	 to	 Sanger	 sequencing,	 and	 gave	 much	 longer	 read	 lengths	 than	 other	
methods	such	as	SOLiD	and	Illumina	of	up	to	700	bases.	However	this	technology	was	





using	 reverse	 terminator	 bases,	 washing	 non-incorporated	 nucleotides	 away	 and	
imaging	 the	 fluorescently	 labeled	 nucleotides	 (Bentley	 et	 al.,	 2008).	 In	 SOLiD	











al.,	 2010;	Rusk,	 2011).	 Table	 1.2	 gives	 a	 summary	 of	 the	 aforementioned	 sequencing	
methods.		
	
As	 was	 seen	 previously	 with	 Sanger	 sequencing,	 Illumina	 sequencing	 currently	
dominates	 the	 sequencing	 field	with	 454,	 SOLiD	 and	 ion	 torrent	 technologies	 largely	
becoming	 redundant.	 Sequencing	 methodologies	 are	 advancing	 towards	 the	
development	of	more	tailored	sequencing	applications,	and	are	moving	away	from	the	
traditional	 methods	 of	 sequencing	 an	 individual	 genome.	 	 Examples	 of	 newer	
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sequencing	 strategies	 include	 the	 sequencing	 of	 multiple	 strains	 to	 infer	 population	
structure,	 enrichment	 sequencing	 to	 resolve	 target	 organisms	 from	 a	 mixture	 of	




Table	 1.2:	 This	 compares	 traditional	 Sanger	 sequencing	 with	 four	 next	 generation	 sequencing	
technologies	on	the	basis	of	read	 length,	accuracy,	number	of	reads	and	time	per	run.	Illumina	 is	
the	forerunner	in	next	generation	sequencing	currently,	with	SOLiD,	454	and	ion	torrent	becoming	
















































































tools	have	either	had	 to	be	 adapted	 to	be	or	 created	 to	deal	with	 these	 changes.	Key	






expensive	 due	 to	 the	 ever	 increasing	number	 of	 reads	 produced	per	 sequencing	 run,	
and	the	difficulty	in	concatenating	only	short	sequences	together.	However	there	have	






Several	 isolates	 of	 T.	 brucei	 rhodesiense	 have	 been	 described	 that	 have	 distinct	 and	
reproducible	phenotypes	when	used	to	infect	mice.	Two	of	these,	which	form	the	basis	
for	 this	 body	 of	 work,	 are	 strains	 from	 the	 zymodeme	 groups	 B17	 and	 Z310.	 These	
names	 are	 derived	 from	 the	 regions	 where	 these	 zymodeme	 groups	 were	 first	
described,	Busoga	 and	Zambesi.	 Their	 phenotypes	have	been	previously	described	 in	
2000	and	are	interesting	in	part	because	both	are	Ugandan	strains	which	show	striking	
phenotypic	 differences	 despite	 belonging	 to	 the	 same	 subspecies	 (Smith	 and	 Bailey,	
2000).	Patients	 infected	with	a	B17	strain	generally	presented	with	particularly	acute	
forms	 of	T.	rhodesiense	 sleeping	 sickness,	 a	 severe	 early	 stage	 infection	 and	 chancre	
(Smith	and	Bailey,	2000).	In	contrast	to	this,	Z310	isolates	caused	a	particularly	chronic	
form	of	T.	rhodesiense	 sleeping	sickness	and	patients	where	often	unaware	 they	were	
infected	 (Beament,	 2002;	 Smith	 and	 Bailey,	 2000).	 Immunological	 studies	 on	 the	
disease	 manifestation	 in	 mice	 infected	 with	 B17	 and	 Z310	 strains	 have	 also	 been	
discussed	previously	 (Goodhead	et	al.,	2013;	Beament,	2002).	One	B17	and	one	Z310	
strain	 were	 shotgun	 sequenced,	 and	 subsequent	 analysis	 indicated	 introgression	





The	 primary	 aim	 of	 this	 project	 was	 to	 utilize	 recent	 advances	 in	 different	 OMIC	
approaches	to	phenotype	multiple	T.b.	rhodesiense	strains,	in	order	to	correlate	genetic	
differences	with	differences	 in	 clinical	manifestation.	This	was	done	 in	 an	 attempt	 to	
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determine	 the	 genetic	 factor(s)	 controlling	 virulence	 (as	 defined	 in	 this	 case	 by	 the	
clinical	presentation	of	symptoms),	to	understand	the	difference	in	virulence	between	
two	Ugandan	T.b.	rhodesiense	 strains,	 belonging	 to	 two	 zymodeme	 groups,	 Z310	 and	











genome	 sequence	 data.	 This	 discusses	 the	 use	 of	Whatman	 FTA™	 cards	 as	 a	 sample	
collection	 method	 for	 clinical	 samples,	 and	 the	 preparation	 of	 these	 samples	 for	
downstream	 sequencing	 preparation.	 FTA™	 cards	 have	 been	 used	 previously	 as	 a	
method	for	cataloging	and	preserving	field	samples	but	have	only	been	used	in	limited	
downstream	applications.	The	analysis	within	this	chapter	focuses	on	the	feasibility	of	
FTA™	 card	 derived	 samples	 for	 enrichment	 sequencing,	 and	 how	 the	 resulting	
sequence	 data	 compares	 to	 whole	 genome	 sequence	 data	 using	 a	 number	 of	
parameters	 for	 sequence	quality.	 	This	 looks	at	both	 the	actual	enrichment	observed,	
the	 evenness	 of	 coverage,	 potential	 allelic	 drop-out	 effects,	 and	 compares	 two	 target	






Chapter	 three	uses	multiple	 strains	 from	zymodeme	groups	B17	and	Z310	 to	 look	at	
both	conserved	variants	both	zymodeme	groups,	which	may	contribute	to	a	conserved	
“core”	T.b.	rhodesiense	genome,	and	at	variants	unique	to	each	zymodeme	group.	This	
chapter	 looks	 at	 the	 functional	 implications	 of	 these	 variants	 and	 what	 potential	
impacts	deleterious	variants	may	have,	and	whether	these	can	explain	the	phenotypic	
variation	 seen	 in	 these	 strains.	 Additional	 human	 clinical	 samples,	 which	 were	 also	









This	 chapter	 uses	 both	 transcriptomic	 and	 metabolomic	 data	 to	 look	 regulatory	
differences	 between	 both	 strains.	 Differentially	 expressed	 genes	 (DEG)	 within	 the	
transcriptomic	data	can	be	used	to	understand	what	pathways	are	being	up	or	down-
regulated.	Similarly,	metabolomic	data	is	generated	by	measuring	the	abundance	of	the	
end	 products	 of	 metabolic	 processes,	 and	 so	 the	 differential	 regulation	 of	 certain	



























genomes	 of	 many	 parasites,	 both	 multicellular	 and	 protozoan.	 Primarily,	 the	
sequencing	of	parasites	has	been	done	from	cultured	material,	mostly	due	to	one	of	the	
first	 obstacles	 in	 sequencing	parasites,	 obtaining	 enough	parasite	DNA	 to	 construct	 a	
library.	 Ease	 of	 access	 to	 this	 amount	 of	 starting	 material	 varies	 wildly	 on	 the	
availability	 of	 samples,	 and	 the	 nature	 of	 the	 sample.	 In	RNAseq,	 particularly	 in	 high	
parasitiaemia	 infections,	 because	 the	 level	 of	 mRNA	 expression	 is	 very	 high	 in	 the	
parasite,	the	imbalance	in	host	to	parasite	transcripts	is	not	as	exaggerated.	In	addition,	







Whatman	 FTA™	 classic	 cards	 have	 been	 used	 for	 many	 years	 in	 order	 to	 catalogue	
samples,	 particularly	 in	 regions	 where	 a	 cold	 chain	 cannot	 be	 maintained	 between	
sample	 collection	 and	 downstream	 processing.	 Within	 this	 chapter,	 I	 will	 be	
determining	 whether	 blood	 samples	 collected	 on	 Whatman	 classic	 cards	 are	 viable	
samples	 for	 preparing	 sequencing	 libraries	 from.	 This	 chapter	 will	 make	 use	 of	
available	 whole	 genome	 sequence	 (WGS)	 data	 and	 compare	 this	 to	 sequence	 data	













Natural	 T.	 brucei	 infections	 typically	 have	 much	 lower	 parasitaemias	 than	 those	
observed	 in	 experimental	 mouse	 infections.	 This	 is	 seen	 especially	 in	 more	 chronic	
infections	 such	 as	 T.b.	gambiense	 infections	 or	 during	 the	 early	 stage	 of	 the	 disease	
(Jamonneau	 et	 al.,	 2012;	 Chappuis	 et	 al.,	 2005).	Here,	 the	parasite	 can	 represent	 less	
than	 1%	of	 the	 total	 DNA.	 This	 is	 because	 the	 parasite	 is	 outnumbered	 by	 the	white	













in	 P.	 falciparum	 have	 shown	 there	 is	 a	 distinct	 difference	 in	 the	 transcriptomes	 of	
parasites	 in	 vivo	 and	 vitro	 (Koumandou	 et	 al.,	 2008;	 Daily	 et	 al.,	 2005).	 Daily	 et	 al	
discovered	 that	 in	 in	vivo	 samples,	 there	was	 overexpression	 of	 entire	 gene	 families,	
which	 was	 not	 observed	 in	 in	 vitro	 samples.	 These	 gene	 families	 encoded	 surface	
antigens,	which	as	in	T.	brucei,	are	essential	for	the	propagation	and	maintenance	of	an	




impacted	(Koumandou	et	al.,	2008).	However	 the	 fitness/	virulence	of	 the	strain	may	
be	 impacted,	and	this	has	been	seen	 in	parasites	where	they	are	no	 longer	capable	of	
completing	the	entire	life	cycle	because	they	have	adapted	to	culture,	for	example	the	T.	
brucei	 strain	 Lister	 427,	 which	 is	 incapable	 of	 differentiating	 into	 fly	 transmissible	
stages	(Koumandou	et	al.,	2008;	Cross	and	Manning,	1973;	Peacock	et	al.,	2008).		Some	
strains	are	also	 less	 likely	 to	propagate	 in	culture,	 limiting	sequencing	 to	only	strains	
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libraries	 to	 be	 prepared	 from	 1ng	 of	 starting	 DNA	 and	 the	 NEBnext	 ultra	 kit,	 which	
requires	only	5ng	(Caruccio,	2011).	However	 in	 this	 instance	alternative	methods	are	
required	due	to	the	DNA	imbalance	as	mentioned	above.		
	
These	 limitations	 are	 not	 restricted	 to	 Trypanosoma,	 but	 highlight	 difficulties	 faced	
across	 the	whole	spectra	of	parasites.	However	 there	are	other	considerations,	which	
are	more	specific	to	T.	brucei.	Amongst	these,	the	human	infective	T.	brucei	subspecies.	
T.b.	 rhodesiense	 and	 T.b.	 gambiense	 are	 a	 CAT3	 level	 organisms,	 and	 unlike	 CAT2	
organisms,	 this	 places	 further	 restrictions	 on	 culture	 conditions,	 experimental	
infections	 used	 to	 raise	 parasites,	 and	 the	 transportation	 of	 samples	 from	 infective	
sources,	i.e.	blood.	However	the	transportation	of	DNA	is	far	less	difficult.	Whole	blood	
samples,	either	from	an	experimental	or	patient	sample,	can	be	immobilized	to	prevent	
sample	 degradation	 using	Whatman	 FTA™	 cards	 (Mirchamsy	 et	 al.,	 1968;	 Smith	 and	
Burgoyne,	2004;	Moscoso	et	al.,	2004;	Muthukrishnan	et	al.,	2008).	Dried	blood	spots	
have	 been	 used	 to	 overcome	 these	 difficulties	 in	 a	 variety	 of	 parasitic,	 viral	 and	
bacterial	samples	(Morrison	et	al.,	2007;	Mirchamsy	et	al.,	1968;	Moscoso	et	al.,	2004;	
Muthukrishnan	 et	 al.,	 2008).	 Preventing	 the	 degradation	 of	 samples	 is	 a	 key	
consideration	 for	 trypanosomes	because	 the	 source	of	natural	 infections	 is	 limited	 to	
within	 sub-Saharan	 Africa,	 where	 there	 may	 be	 greater	 difficulty	 in	 maintaining	 the	
cold	chain,	or	preserving	the	sample	between	collection	and	processing	time	(Lonsdale-





Several	 collection	 methods	 have	 been	 used	 routinely	 to	 collect	 and	 purify	
trypanosomes	 for	 downstream	 processing.	 Previously,	 DEAE	 columns	 were	 used	
widely	as	a	method	for	purifying	the	parasites,	however	the	popularity	of	this	method	





















from	cloacal	 swabs	 in	 influenza	 infected	birds,	 to	detecting	porcine	 reproductive	 and	
respiratory	syndrome	virus	from	pig	blood,	to	human	DNA	for	GWAS	studies	(Fowler	et	
al.,	 2012;	 Safar	 et	 al.,	 2010;	 Inoue	 et	 al.,	 2007;	 Kraus	 et	 al.,	 2011).	 More	 recently	
alternative	 downstream	 applications	 have	 become	 a	 previously	 unexplored	 interest,	
with	 Fowler	 and	 colleagues	 looking	 at	 the	 potential	 of	 using	DNA	 from	 FTA™	 classic	
cards	 to	 sequence	 the	 DNA	 captured	 on	 them	 (Fowler	 et	 al.,	 2012).	 This	 not	 only	
reflects	a	shift	 from	changes	 in	methodology,	as	sequencing	becomes	more	affordable	
and	sequence	data	more	accessible,	but	also	a	change	to	experimental	design,	with	the	




	In	 parasitology,	 a	 by	 product	 of	 this	 is	 the	 sequencing	 of	more	 parasites	 endemic	 to	
regions	 such	 a	 Sub-Saharan	 Africa.	 In	 regions	 like	 this	 collection	 methods	 such	 as	
Whatman	 FTA™	 cards	 are	 essential	 and	 so	 technology	 capable	 of	 being	 used	 in	
combination	 with	 FTA™	 cards	 are	 becoming	 more	 popular	 for	 processing	 clinical	
isolates.	 	 As	 previously	 mentioned,	 FTA™	 cards	 are	 useful	 for	 cataloguing	 T.	 brucei	
because	transport	for	CAT3	organisms	is	highly	regulated.	Kraus	et	al.	used	FTA™	cards	








damaging	products	 such	as	 free	 radicals	 for	up	 to	17.5	years	 (Picozzi	et	al.,	2002;	GE	




were	 exposed	 to	UV	 in	 order	 to	 simulate	 aging	 and	DNA	 damage	 over	 time,	with	 no	
visible	change	in	quality	following	exposure	(GE	Healthcare,	2010b	).		
	
Due	 to	 the	 limited	nature	of	 the	 classic	 cards,	Whatman	 subsequently	 released	FTA™	
elute	 cards	which	 allow	 DNA	 to	 be	 easily	 eluted	 from	 the	 card	 and	 allows	 the	main	
contaminant,	 protein,	 to	 remain	 bound	 after	 elution.	 This	 is	 achieved	 by	 using	 a	
chaotrophic	salt	 in	 the	cellulose	matrix,	which	denatures	 the	proteins	and	dissociates	
them	 from	 nucleic	 acids,	 allowing	 them	 to	 be	 eluted	 off	 the	 card	 (Sawyer	 and	
Puckridge,	1973;	Damodaran	and	Kinsella,	1983).		
	
Field	 samples	 have	 been	 traditionally	 and	 continue	 to	 be,	 collected	 and	 sampled	 on	
classic	cards,	resulting	in	a	vast	catalogue	of	samples.	However	downstream	analyses	of	
the	 samples	 of	 these	 cards	 has	 been	 predominantly	 restricted	 to	 PCR,	 with	 card	
punches	used	directly	in	the	PCR	reaction.		Although	this	is	fine	for	PCR,	this	limits	the	
number	of	downstream	applications	these	samples	are	viable	for,	such	as	sequencing.	









In	 1992	Telenius	&	 Zhang	 and	 colleagues	 published	 papers	 on	 the	 development	 of	 a	
technique,	which	non-specifically	amplified	DNA	using	a	degenerate	primer	(Zhang	et	
al.,	1992;	Telenius	et	al.,	1992).	This	has	since	been	coined	whole	genome	amplification	
(WGA),	 and	 there	 are	 three	 main	 types,	 multiple	 displacement	 amplification	 (MDA),	
degenerate	 oligonucleotide	 PCR	 (DOP	 –PCR)	 and	 primer	 extension	 preamplification	
(PEP).	 	 The	 DOP-PCR	 and	 PEP	methods	 have	 largely	 been	 replaced	 by	MDA	 and	 are	
based	on	traditional	PCR.		
	
PEP	 works	 by	 using	 a	 preamplification	 step	 to	 attach	 primer-binding	 sites	 to	 DNA	
fragments	which	can	then	be	used	during	subsequent	WGA.	Random	primers	and	Taq	
DNA	 polymerase	 are	 then	 used	 at	 a	 low	 annealing	 temperature	 during	 the	 WGA	
reaction.	Whereas	DOP-PCR	has	no	preamplification	step	and	ligates	adaptors	to	DNA	
fragments	to	create	primer-binding	sites.	Similarly	to	PEP,	Taq	DNA	polymerase	is	used	
in	 the	 WGA	 reaction,	 however	 unlike	 PEP,	 DOP-PCR’s	 primers	 are	 semi	 degenerate	
oligonucleotides	and	 the	annealing	 temperature	 increases	during	 the	reaction	(Lee	et	
al.,	 2008;	 Zhang	 et	 al.,	 1992;	 Arneson	 et	 al.,	 2008).	 Both	methods	 are	 limited	 due	 to	
their	use	of	Taq	DNA	polymerase	which	limits	the	maximum	size	of	fragments	to	only	
3kb,	and	on	average	produces	400-500bp	fragments	(Dean	et	al.,	2002;	Lee	et	al.,	2008;	
Arneson	et	al.,	2008).	This	also	 introduces	errors	 into	 the	sequence	and	bias	 into	 the	
coverage	(Dean	et	al.,	2002).	This	polymerase	 is	also	sensitive	 to	secondary	structure	
and	these	structures	can	result	in	dissociation	of	the	enzyme	from	the	DNA	template	or	








template,	and	 the	 template	needs	 to	be	denatured	prior	 to	amplification.	Many	of	 the	
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limitations	of	the	previous	methods	are	solved	by	MDA	because	the	Phi29	polymerase	
can	 generate	 fragments	 of	 upto	 100kb	 without	 dissociation	 or	 sequence	 bias.	 This	
enzyme	also	has	3’	-5’	exonuclease	proofreading	activity,	which	reduces	the	error	rate	
to	less	than	a	1000	times	lower	than	Taq	DNA	polymerase	(Handyside	et	al.,	2004;	Lee	
et	 al.,	 2008;	 Spits	 et	 al.,	 2006).	 	 The	 Phi29	 polymerase	 also	 resolves	 secondary	
structures	without	enzyme	dissociation,	which	greatly	reduces	allele	drop	out.	
	
Since	 the	 development	 of	MDA	 as	 a	method	 of	WGA,	 it	 has	 been	 commercialized	 by	
several	 companies,	 producing	 Picoplex	 by	 rubicon	 genomics,	 Genomiphi	 by	 GE	
healthcare	and	Repli-G	by	Qiagen.	Multiple	studies	have	used	all	three	of	these	kits,	all	
of	 which	 suffer	 from	 the	 same	 drawbacks	 in	 occasional	 allelic	 drop	 out	 of	
heterozygotes,	 however	 this	 is	mostly	 an	 issue	 for	 single	 cell	 sequencing,	with	 these	
effects	reduced	by	using	greater	than	5	cells	(Voet	et	al.,	2013;	Handyside	et	al.,	2004;	








analyses	downstream	of	 sequencing,	 including	 copy	number	variation	analysis	 (CNV)	
and	 single	 nucleotide	 polymorphisms	 (SNPs)	 (Paez	 et	 al.,	 2004;	 Treff	 et	 al.,	 2011;	
Hellani	et	al.,	2008).	Several	studies	have	shown	that	WGA	prior	to	sequencing	does	not	






lots	 of	 strains	 in	 order	 to	 do	 population	 studies,	 is	 still	 in	 some	 cases	 prohibitively	
expensive.	New	sequencing	technology	also	means	that	more	data	 is	being	generated,	
and	 this	 can	 make	 analysis	 both	 computationally	 demanding	 and	 harder	 to	 analyse	
(Chilamakuri	et	al.,	2014;	Sboner	et	al.,	2011).	Often	sequencing	is	not	hypothesis	free,	
and	only	 certain	 regions	are	of	 interest.	 In	 these	cases	 sequencing	can	be	 targeted	 to	
just	certain	regions	of	the	genome,	significantly	reducing	the	cost	and	data	to	analyse.	
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Targeted	 sequencing	 is	 also	 referred	 to	 as	 target	 enrichment	 as	 the	 process	 of	
sequencing	 does	 not	 remove	 contaminating	 DNA,	 it	 just	 selectively	 enriches	 for	 the	
target.	 In	 solution	 based	 systems	 the	 process	 is	 also	 known	 as	 sequence	 capture,	
because	the	target	sequence	is	captured	by	effectively	being	pulled	out	of	the	mixture	
of	 non	 target	 and	 target	 DNA	 in	 the	 sample	 by	 becoming	 physically	 bound	 to	
streptavidin	beads	(Chilamakuri	et	al.,	2014).	
	
	One	way	of	 doing	 targeted	 sequencing	 is	 to	 just	 focus	 on	 the	 exome	of	 an	organism.	
Multiple	studies	have	been	done	on	library	preparation	comparisons,	with	Chilamakuri	
et	al.	(2014)	focusing	on	the	comparison	between	four	commercially	available	solution	
based	 exome	 capture	 systems	 (Chilamakuri	 et	 al.,	 2014).	 These	 are	 the	 Agilent’s	
sureselect	 human	 all	 exon,	 Nimblegen’s	 seqcap	 ez	 exome	 library,	 Illumina’s	 truseq	
exome	 enrichment	 and	 Illumina’s	 nextera	 exome	 enrichment.	 All	 of	 these	 exome	







ability	 to	 capture	SNPs	 (Bodi	et	 al.,	 2013).	A	key	difference	 in	 the	 two	systems	 is	 the	
Agilent	 uses	 RNA	 probes	 to	 complement	 the	 target	 region,	 whereas	 Nimblegen	 uses	
DNA	 probes	 (Chilamakuri	 et	 al.,	 2014;	Margulies	 et	 al.,	 2005;	 Bodi	 et	 al.,	 2013).	 The	
Illumina	truseq	human	exome	and	nextera	exome	technologys	also	use	baits	made	from	
DNA	 (Bainbridge	 et	 al.,	 2010;	 Chilamakuri	 et	 al.,	 2014).	 	 Nimblegen’s	 probes	 are	 the	
shortest	 (between	 60-90	 nucleotides)	 compared	 to	 Illumina’s	 truseq	 and	 nextera	
designs,	 which	 are	 95bp	 long	 and	 Agilent’s	 probes	 which	 are	 120	 nucleotides	 by	
default,	or	longer	for	instance	in	AT	rich	genomes	such	as	P.	falciparum	(Melnikov	et	al.,	
2011;	 Bainbridge	 et	 al.,	 2010;	 Chilamakuri	 et	 al.,	 2014).	 Melnikov	 et	 al.,	 2011	 used	
Agilent’s	 sequence	 capture	 but	 used	 140	 nucleotide	 baits	 to	 compensate	 for	 this	
(Melnikov	et	al.,	2011).	Similarly	Gnirke	et	al	demonstrated	in	2009	the	reproducibility	









60-90bp,	 to	 help	 enrichment	 in	 more	 difficult	 to	 sequence	 regions	 of	 the	 genome	
(Bainbridge	et	al.,	2010).		Agilent	boosts	performance	in	these	regions	by	increasing	the	













library.	 The	 prepared	 DNA	 is	 then	 hybridised	 to	 a	 library	 of	 designed	 biotinylated	 sequences	
which	bind	to	the	target	DNA	in	the	sample,	and	can	subsequently	be	removed	using	streptavidin	
beads.	The	bound	DNA	then	amplified	and	prepard	for	sequencing.	The	biotinylated	library	baits	












by	 repetitive	 sequence	 is	 often	 even	 more	 pronounced	 and	 so	 software	 such	 as			
Windowmasker	can	be	used	to	find	these	regions	in	the	target,	and	mask	them	so	that	
they	aren’t	 included	 in	 the	 final	design	 (Tarailo-Graovac	and	Chen,	2009;	Morgulis	 et	
al.,	 2006).	 Unlike	 its	 predecessor,	 Repeatmasker,	 Windowmasker	 requires	 only	 the	
genome	sequence	you	are	using	to	find	low	complexity	and	repetitive	regions	(Tarailo-
Graovac	 and	 Chen,	 2009).	 In	 comparison,	 Repeatmasker	 required	 the	 alignment	 of	
subsections	 of	 the	 genome	 of	 interest	 to	 a	 curated	 repeat	 library.	 This	was	 not	 only	
computationally	 intensive,	 but	 meant	 that	 only	 select	 genomes	 could	 be	 used	 in	
conjunction	with	the	program	(Morgulis	et	al.,	2006;	Tarailo-Graovac	and	Chen,	2009).	
Windowmasker	 uses	 an	 algorithm	 that	 works	 in	 two	 parts,	 first	 by	 calculating	 the	









aligners,	 the	 two	 preferred	 and	most	 commonly	 used	 ones	 being	 BWA	 (the	 burrows	
wheeler	aligner)	and	Bowtie.	These	tools	are	primarily	used	because	they	handle	data	
in	 a	 very	 memory	 efficient	 manner,	 which	 significantly	 decreases	 the	 time	 taken	 to	
complete	 an	 alignment.	 They	 do	 this	 by	 using	 programming	 functions,	 known	 as	
hashes.	 A	 hash	 is	 a	 memory	 efficient	 method	 of	 storing	 data,	 with	 every	 data	 value	











al.,	 2009).	 BWT	has	 been	used	 in	 the	 development	 of	 other	 aligners	 such	 as	 SOAPV2	
(http://soap.genomics.org.cn/).			
	
In	BWA,	partial	 alignments/sequences	with	 imperfect	matches	are	 scored.	This	 score	
reflects	any	penalties	given	for	mismatches	or	gaps	and	is	used	to	prioritise	alignments	
in	 order	 to	 find	 the	most	 confident	 intervals	 (Smith	 and	Bailey,	 2000;	 Fonseca	 et	 al.,	





confidence	of	 the	alignments	because	 it	makes	 fewer	 confident	matches	 compared	 to	
BWA	 and	MAQ	 and	 it	 also	misses	 the	 best	 imperfect	matches	 (Li	 and	 Durbin,	 2009;	
Smith	 and	 Bailey,	 2000;	 Langmead	 et	 al.,	 2009).	 Both	 Bowtie	 and	 BWA	 use	 the	 FM	
index,	which	 is	 a	deviation	of	 the	burrows-wheeler	 transformation	 (BWT)	 (Ferragina	
and	 Manzini,	 2001;	 Li	 and	 Durbin,	 2009;	 Langmead	 et	 al.,	 2009).	 This	 allows	 the	
algorithm	 to	 be	 accurate	 and	 memory	 efficient	 and	 was	 first	 described	 in	 2001	 by	
Ferragina	 and	Manzini	 (Ferragina	 and	Manzini,	 2001).	The	BWT	 transforms	 the	DNA	
sequence	 into	 a	 sorted	 matrix,	 which	 can	 then	 be	 stored	 more	 compactly,	 and	 be	
reversed	to	provide	the	 full	DNA	sequence	again	(Li	and	Durbin,	2009;	Ferragina	and	






BWA	 supports	 gapped	 alignments,	whereas	 the	 original	 version	of	Bowtie	 didn’t	 and	
MAQ	 is	 incapable	 of	 doing	 so	 for	 single	 end	 sequencing	 reads	 (Li	 and	Durbin,	 2009).	
BWA	 also	 gives	 mapping	 quality,	 as	 does	 MAQ,	 whereas	 Bowtie	 doesn’t,	 which	 also	
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accounts	for	the	additional	time	it	takes	to	map	in	BWA	(McKernan	et	al.,	2009;	Li	and	
Durbin,	 2009).	 However	 the	 main	 advantage	 to	 both	 Bowtie	 and	 BWA	 is	 that	 their	
standard	output	is	a	SAM	file,	rather	than	the	MAP	file	created	by	MAQ.	
	
	SAM	 files	 are	 now	 used	 universally,	 and	 are	 amenable	 to	 conversion	 into	 multiple	
other	 file	 formats,	and	use	by	a	high	number	of	bioinformatic	 tools.	 In	contrast,	MAQ	
was	 initially	 used	 as	 a	 pipeline	 for	 quality	 control	 of	 reads,	 alignment	 and	 variant	




better	 at	 assessing	 qualities	 such	 as	 basecall	 qualities.	 Improvements	 in	 sequencing	
chemistry	also	mean	that	new	bioinformatic	software	is	essential	for	handling	changes	
to	sequence	data,	such	as	the	greater	volume	of	reads	generated,	and	increased	reads	
lengths,	 which	MAQ	 is	 less	 capable	 of	 analyzing	 because	 it	 is	 not	 still	 being	 actively	
developed.	Both	BWA	and	Bowtie	also	support	both	base	space	and	colour	space	reads.	
Illumina	reads	are	all	 in	base	space,	however	SOLiD	data	 is	 in	colour	space	and	is	not	




data	 has	 been	 aligned	 using	 the	 BWA	 aln	 algorithm.	 This	 is	 a	 short	 read	 aligner	


















The	 Genome	 Analysis	 Toolkit	 is,	 similarly	 to	 Samtools,	 a	 collection	 of	 tools	 to	 help	
analyse	NGS	data	 (McKenna	et	 al.,	 2010;	DePristo	et	 al.,	 2011).	However	 the	primary	
focus	of	the	tools	in	GATK	are	for	variant	detection,	validation	and	genotyping.	GATK’s	
main	function	is	to	call	single	nucleotide	polymorphisms	from	the	BAM	file	produced	in	
Samtools	 (Liu	 et	 al.,	 2013;	McKenna	 et	 al.,	 2010).	 Samtools	 also	 has	 a	 variant	 caller,	
samtools	mpileup,	however	GATK	is	more	stringent	when	calling	SNPs	and	so	because	
the	primary	focus	behind	this	chapter	is	not	variant	discovery,	but	the	validity	of	SNPs	








Agilent’s	 sequence	 capture	 technology	was	used	 to	 sequence	DNA	 from	experimental	
mouse	infections,	which	contained	a	mixture	of	both	host	and	parasite	DNA.	In	order	to	
test	 the	 effectiveness	 of	 this	 technology	 a	 target	 region	was	designed	 containing	985	
target	genes.	These	target	genes	were	selected	so	that	all	of	the	11	megachromosomes	
were	equally	represented,	and	genes	were	selected	from	regular	 intervals	along	each.	
The	11	megachromosomes	are	approximately	26Mb	 in	 combined	 length,	 and	 initially	
1000	genes	were	identified	and	selected	from	the	whole	genome	to	be	part	of	the	first	




that	 they	 were	 from	 non-repetitive	 regions,	 and	 so	 the	 telomeric	 regions	 are	
underrepresented	 due	 to	 their	 highly	 repetitive	 nature.	 Annotations	 from	 the	 Tb927	
v4.1	version	of	the	genome	were	used	in	this	selection,	and	to	reduce	the	introduction	
of	 repetitive	 regions	 into	 the	 design,	 genes	 that	 had	 been	 identified	 as	 leucine	 rich	
repeats	 (LRRPs),	 VSGs	 or	 ESAGs	 were	 removed.	 However,	 as	 you	 can	 see	 from	
subsequent	analysis,	several	of	the	genes	in	the	first	design	were	enriched	successfully,	
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were	 obtained	 from	 the	 Tritrypdb	 website	 (www.tritrypdb.org)	 from	 the	 reference	
















	Figure	 2.2:	 	 The	 120nucleotide	 biotinylated	 baits	 were	 designed	 by	 selecting	 genes	 at	 regular	
intervals	 from	 the	 Tb927	 v4.2	 genome	 (accessed	 from	 www.Tritrypdb.org).	 For	 each	 of	 these	





nucleotide	 long	 baits	 were	 designed	 so	 that	 they	 overlapped	 each	 over	 by	 40	
nucleotides	 each,	 in	 order	 to	 reduce	 the	 chances	 of	 regions	 of	 low	 coverage/	 allelic	
drop	 out.	 The	 baits	 were	 all	 blasted	 against	 themselves	 and	 any	 identical	 were	
removed.	 	In	total	there	were	49,161	120nucleotide	long	baits,	over	a	target	region	of	
~2.9Mb,	 which	 is	 approximately	 12%	 of	 the	 genome	 (Melnikov	 et	 al.,	 2011).	 	 These	
were	custom-made	biotinylated	baits,	which	were	synthesized	by	Agilent	technologies	













Table	 2.1	 shows	 the	 breakdown	 of	 the	 number	 of	 baits	 per	 chromosome	 and	 the	
number	 of	 genes	 targeted	 along	 each	 chromosome.	 The	 last	 column	 shows	 the	
percentage	 of	 the	 each	 chromosome	 covered,	 which	 is	 relatively	 uniform	 across	 the	
chromosomes	 (between	8-15%).	The	percentage	covered	per	chromosome	 is	derived	
by	 the	 percentage	 the	 length	 the	 baits	 cover	 of	 the	 whole	 chromosome	 length.	 The	
chromosome	 and	 gene	 lengths	were	 generated	 from	Tritrypdb	 annotation	 data	 from	
the	Tb927	reference	version	4.1.	The	newest	version	of	this	genome	v8.1	was	not	used	















Number	 of	 genes	 targeted		







1	 50	(532)	 2896	 12	
2	 56	(352)	 3167	 15	
3	 79	(623)	 4074	 12	
4	 54	(587)	 2121	 8	
5	 60	(579)	 2719	 10	
6	 52	(622)	 2662	 9	
7	 70	(774)	 3835	 9	
8	 92	(906)	 4919	 10	
9	 118	(1602)	 6986	 9	
10	 170	(1762)	 9797	 12	




The	 target	region	was	subsequently	redesigned	and	nested	within	 the	original	 target.	
This	 second	 design	 used	 genes	 that	 were	 enriched	well	 within	 the	 first	 design.	 This	
second	design	also	 included	oligopeptidase	B,	which	 is	a	known	virulence	 factor	 in	T.	
brucei.	Although	 this	 target	was	nested	within	 the	original	 target	 region,	 and	 so	non-
repetitive	 sequence	 should	 have	 been	 removed,	 Windowmasker	 was	 used	 as	 an	
additional	check	to	remove	any	repetitive	sequence	 from	the	 final	design.	This	masks	
low	 complexity	 and	 highly	 repetitive	 regions.	 As	 before,	 120	 nucleotide	 length	 baits	
were	 used	 and	 tiled	 3	 times	 to	 provide	 a	 40	 nucleotide	 overlap.	 	 Unlike	 the	 original	
design,	these	baits	were	designed	against	the	Tb927	genome	version	8.1.	
	
This	 design	 was	 considerably	 smaller	 than	 the	 previous	 design,	 with	 731	 genes	
included	 and	 a	 total	 target	 covering	 2Mb	 and	 a	 total	 of	 43,298	 probes,	 with	 a	 40	
nucleotide	overlap	as	before.	These	targets	were	chosen	from	the	original	design	based	
on	their	level	of	coverage	within	the	sequence	data.	The	level	of	coverage	was	based	on	
an	 average	 across	 the	 whole	 gene	 rather	 than	 by	 each	 individual	 120	 nucleotide	
sequence.	Genes	that	had	an	average	depth	of	coverage	greater	than	five	and	less	than	
500	across	6	 strains	 (the	other	 samples	discussed	 in	Chapter3),	were	 chosen.	 	These	
cutoffs	 were	 chosen	 because	 poorly	 performing	 baits	 either	 unsuccessfully	 enriched	
and	 had	 a	 coverage	 depth	 of	 1,	 or	 excessively	 overenriched,	 and	 had	 a	 very	 high	
coverage	of	1000	or	more.	Suredesign	XT™	software	was	used	to	generate	the	baits	in	
this	 design	 and	 regions	 of	 sequence	 with	 a	 GC	 content	 higher	 than	 65%	 or	 at	 the	










14%	when	 the	 average	was	 approximately	 8%	 in	 the	 second	 design).	 Table	 2.2	 also	
shows	the	change	 in	 the	percentage	of	 the	chromosome	covered	by	the	target	region.	
The	 second	 design	 is	 smaller,	 and	 so	 a	 decrease	 in	 the	 percentage	 covered	 per	
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chromosome	 is	 expected,	 and	 this	 is	 between	 1-2%	 per	 chromosome	 except	 for	




and	 shows	 that	 the	 genes	 targeted	 are	 at	 regular	 intervals	 along	 each	 chromosome,	
with	 no	 bias	 towards	 particular	 regions	 of	 the	 chromosome,	 or	 a	 particular	
chromosome.	 	Figure	2.3B	shows	the	positions	of	the	genes	that	were	included	within	
the	 first	 design	 but	 excluded	 from	 the	 second	 design	 due	 to	 poor	 performance.	 This	
figure	shows	that	those	genes	that	performed	poorly	were	not	solely	from	one	strand,	
or	 to	 one	 specific	 region,	 with	 those	 underperforming	 spread	 relatively	 evenly	
throughout	 the	mega	 chromosomes	 except	 for	 as	previously	mentioned	 chromosome	
11,	 where	 genes	 predominantly	 at	 the	 3’	 end	 of	 the	 chromosome	 consistently	
performed	poorly.	Figure	2.3C	shows	the	chromosomal	position	of	the	genes	included	















































Number	 of	 baits	 per	
chromosome	









1	 43	(532)	 2232	 107425	 10	 2	
2	 48	(352)	 3475	 165278	 14	 2	
3	 65	(623)	 3506	 166688	 10	 2	
4	 39	(587)	 1817	 95765	 6	 2	
5	 40	(579)	 2692	 132017	 7	 2	
6	 45	(622)	 2426	 120614	 7	 1	
7	 56	(774)	 3100	 156000	 7	 2	
8	 73	(906)	 4035	 209597	 8	 2	
9	 102	(1602)	 5872	 264796	 7	 1	
10	 138	(1762)	 9154	 428910	 10	 2	
11	 82	(1878)	 4989	 241530	 5	 6	
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Figure	 2.3:	 	 Shown	 are	 the	 positions	 of	 genes	 in	 both	 target	 regions.	 Genes	 positioned	 on	 the	
forward	strand	are	coloured	blue,	red	on	the	reverse.	Dark	individual	blue	or	red	bars	represent	
one	 gene	 on	 either	 the	 forward	 or	 reverse	 strand,	 respectively.	 Genes	 that	 are	 adjacent	 to	 each	
other	are	shown	collapsed	into	a	lighter	bar.		The	position	is	shown	starting	from	the	first	position	
of	each	chromosome.	 	A	shows	the	position	of	all	the	genes	in	design	one,	with	relatively	uniform	
intervals	covered	across	each	chromosome.	 	B	shows	only	 the	 locations	of	 the	genes,	which	were	
included	 in	 the	 first	 design,	 but	 excluded	 from	 the	 second	 due	 to	 poor	 performance.	 Those	
performing	 poorly	 were	 found	 on	 both	 strands,	 and	 at	 regular	 intervals,	 suggesting	 equal	
































































The	 two	 strains	 used	 in	 the	 initial	 design	 were	 blood	 samples	 taken	 from	
experimentally	 infected	 mice,	 and	 had	 previously	 been	 whole	 genome	 shotgun	
sequencing	using	SOLiD	sequencing.	These	strains	are	referred	to	as	B	and	E	here	and	
belong	 to	 zymodeme	 groups	 Z310	 and	 B17	 respectively.	 Additional	 metadata	 is	
included	 in	 Table	 2.3	 below.	 These	 parasites	 are	 T.b.	 rhodesiense	 parasites	 isolated	
originally	 	 in	 1997	 and	 the	 phenotypes	 have	 been	 previously	 described	 (Smith	 and	
Bailey,	2000).	These	strains	originate	from	Uganda,	one	of	the	few	locations	where	T.b.	
rhodesiense	 and	T.b.	gambiense	 infections	 co-exist	 (Picozzi	 et	 al.,	 2005).	This	presents	
an	 unusual	 circumstance	 in	 that	 these	 usually	 geographically	 isolated	 have	 the	
potential	 to	 recombine.	 These	 strains	 were	 selected	 due	 to	 their	 difference	 in	





Table	 2.3:	 The	 two	 strains	 listed	 below	 were	 used	 in	 target	 enrichment	 sequencing	 and	 are	
discussed	in	this	Chapter.	Additional	strains	were	used	in	the	targeted	sequencing	however	these	
are	mentioned	in	Chapter	3.	These	two	strains	were	used	to	benchmark	enrichment	sequencing	in	
this	 chapter	 because	 there	 is	whole	 genome	 sequence	data	 available	 for	 these.	 The	 strains	were	
assigned	to	a	zymodeme	group	based	on	the	iso-enzymes	they	have	and	determined	via	multi	locus	













Z310	 B	 Chronic	 Patients	 had	 either	 asymptomatic	 first	













(IP)	with	 104ml-1	 parasites	 in	 0.2ml	 of	 infected	murine	 blood	 from	 frozen	 stabilates.	





magnification	 on	 a	 light	 microscope,	 and	 using	 a	 haemocytometer	 to	 calculate	
parasitaemia.	Terminal	bleeds	were	taken	by	cardiac	puncture	using	2mM	EDTA	as	an	
anticoagulant.	1	x104	parasites	were	then	passaged	into	C57BL/6	female	8-10	week	old	






	Following	 collection	 by	 cardiac	 puncture,	 the	whole	 blood	was	 spun	 at	 6,000g	 for	 2	
minutes,	the	plasma	removed,	and	the	resulting	pellet	resuspended	in	an	equal	volume	
of	 PBS.	 To	 this	 1ml	 of	 Ammonium-Chloride-Potassium	 (ACK)	 lysis	 buffer	 (Life	






For	 the	 initial	 two	strains	 in	 the	pilot	study,	blood	prepared	as	described	above	 from	
the	C57BL/6	terminal	bleeds	was	diluted	to	104	with	phosphate	buffered	saline	(PBS)	
pH	7.0	presuming	an	undiluted	parasitaemia	of	approximately	106	parasites	ml-1.		This	




















Prior	 to	 extraction,	 any	discs	 from	 the	 FTA™	 cards	must	 first	 be	washed	 adhering	 to	
Whatman’s	 protocol	 (GE	 Healthcare,	 2010a).	 This	 removes	 any	 erythrocytes	 on	 the	
cards,	 removing	 many	 potential	 contaminants	 from	 the	 subsequent	 DNA	 extraction.	
Despite	little	evidence	for	cross	contamination	when	cutting	discs	from	different	cards,	
due	to	the	multiple	amplification	and	other	processes	downstream,	in	between	punches	
the	 hole	 punch	 was	 rinsed	 with	 70%	 ethanol,	 dried,	 and	 punches	 were	 taken	 from	
blank	pieces	of	FTA™	card	to	reduce	potential	carryover	(GE	Healthcare,	2010a).	Several	
methods	 were	 used	 to	 extract	 DNA	 from	 the	 classic	 FTA™	 cards,	 of	 these,	 the	 most	









and	 left	 to	 incubate	 for	 a	 further	 10	 minutes,	 also	 at	 room	 temperature.	 This	 was	
subsequently	 flash	 vortexed	 10	 times	 after	 which,	 the	 punch	 was	 squeezed	 and	
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removed.	 This	 eluate	was	 then	used	directly	 in	 subsequent	 PCR	 reactions	 and	whole	
genome	 amplifications.	 The	 recovery	 of	 parasite	 DNA	 from	 the	 card	 was	maximized	
using	single	discs	per	extraction,	and	subsequently	pooling.		
	
The	 samples	 used	 for	 library	 preparation	 were	 prepared	 from	 two	 2mm	 diameter	
punches	 of	 card;	 the	 eluates	 of	 these	were	 then	pooled.	 Yields	 from	DNA	extractions	




	These	 crude	 extractions	 were	 then	 quality	 checked	 using	 their	 260/280,	 230/260	
ratios	on	the	Nanodrop™,	and	concentration	by	HS	DNA	Qubit™	(Fisher	Scientific,	UK;	




2x	 Bioline’s	 Biomix™	 red	 and	 2μl	 of	 1.5pmol	 forward	 primer	 and	 2μl	 of	 1.5pmol	 of	
reverse	primer	(Bioline,UK).	Primers	5’	GATGAATCTCCCGGCAGTAA	3’	and	5’	CTGCCT	
TTGCATCACCACTA	 3’	 were	 used	 to	 detect	 trypanosome	 DNA	 and	 5’	
GGAACATCGACATGGGGTAA	3’	and	5’	GTAGCCTGTGCATCCTC	3’	to	detect	mouse	DNA.	
These	 primers	 were	 designed	 and	 used	 previously	 (unpublished	 work),	 against	







Even	 in	 high	 parasitaemia	 infections,	 the	 proportion	 of	 the	 total	 DNA	 that	 is	
trypanosome	DNA	is	so	small	(0.01%	in	a	106ml-1	 infection),	and	the	concentration	of	
the	 DNA	 extract	 relatively	 low,	 that	 the	 eluate	 from	 the	 extraction	 requires	 whole	
genome	 amplification	 before	 it	 can	 be	 detected.	 This	was	 done	 using	 the	 Genomiphi	
whole	genome	amplification	kit	and	followed	according	to	manufacturer’s	instructions	
(GE	 Healthcare,	 2010a;	 Seth-Smith	 et	 al.,	 2013).	 2μl	 of	 DNA	 were	 used	 in	 a	 40μl	




at	 30	 degrees	 because	 a	 3	 hour	 incubation	 did	 not	 provide	 sufficient	 amplification.	















AMPure	 beads	 were	 used	 to	 remove	 residual	 enzymes	 from	 the	 WGA	 reaction	 and	
improve	 the	quality	of	 the	sample	(Agencourt,	Cat	no:	A63880).	The	ratio	of	beads	 to	
DNA,	based	on	volume,	not	concentration,	determines	the	size	fragments	removed	from	
the	 sample.	 This	method	 can	 be	 used	 as	 an	 alternative	 to	 size	 selection	 through	 gel	
excision	and	can	reduce	the	percentage	of	sample	loss.	The	bead	volume	was	1.8	times	
the	 volume	 of	 the	 DNA,	 which	 only	 removes	 fragments	 of	 200bp	 or	 less.	 To	 ensure	




was	performed	as	per	manufacturer’s	 instruction.	 500μl	 of	 70%	 ethanol	was	 used	
per	 wash	 and	 samples	 were	 resuspended	 and	 eluted	 in	 20μl	 of	 sterile	 H20.	 The	












yield	 of	 AMPure	 purified	 end	 repaired	 DNA	 was	 decreased.	 Increasing	 the	 starting	
template	 concentration	did	not	 reduce	 the	yield	of	 successfully	 end	 repaired	DNA.	 In	
order	 to	 generate	 enough	 total	 DNA	 for	 this	 input,	 these	 samples	were	WGA’d	 from	
10ng	 aliquots	 of	 the	 cleaned	 WGA’d	 DNA	 and	 pooled	 and	 cleaned	 as	 previously	
mentioned.	This	did	not	adversely	effect	the	quality	of	the	DNA,	which	was	determined	
by	1.5%	agarose	gel,	PCR,	260/280	and	230/260	values.	The	 libraries	were	prepared	
according	 to	 the	manufacturer’s	 instructions	 using	 the	 Sureselect	 for	 Illumina	 paired	
end	 libraries	 protocol	 (Illumina,	 inc).	 The	 chosen	 PCR	 cycling	 and	 hybridization	
conditions	used	are	given	beneath.	
	
Pre	 capture	 PCR	 was	 done	 using	 6	 cycles	 in	 the	 following	 programme,	 98°C	 for	 2	
minutes	for	initial	denaturation	and	then	6	cycles	of	98	°C	for	30	seconds,	65°C	for	30	
seconds	then	72°C	for	1	minute	then	a	final	extension	of	72°C	for	10	minutes.	For	the	




beads.	 The	 libraries	 were	 single	 indexed.	 The	 sequencing	 for	 the	 first	 design	 was	
performed	on	one	Miseq	run,	and	sequencing	for	the	second	design	was	performed	on	a	
rapid	 run	 of	 the	 Hiseq,	 the	 prepared	 libraries	 were	 given	 to	 the	 Centre	 of	 Genomic	


















Tb927	 version	 8.1,	 accessible	 from	 (www.tritrypdb.org).	 Prior	 to	mapping,	 the	 short	





Due	 to	 the	 small	 size	 of	T.brucei’s	 genome,	 the	 reads	were	 first	 indexed	using	BWA’s	
algorithm,	 is.	 BWA’s	 aln	 algorithm	 was	 then	 used	 to	 align	 the	 Illumina	 reads	 to	 the	
reference	 using	 default	 settings	 and	 generate	 sequence	 alignment	 (SA)	 co-ordinates.	
The	default	parameters	were	optimal	for	this	dataset	analysis.		The	effect	of	decreasing	
the	number	of	mismatches	allowed	per	read	(decreasing	from	the	default	of	4%	of	the	
















colourspace	 data	 needs	 to	 be	 converted	 from	 a	 csfasta	 (colourspace	 fasta)	 and	 qual	
(quality	 scored)	 files	 into	 a	 fastq	 format,	 which	 contains	 the	 sequencing	 reads	 and	
quality	 data	 combined.	 This	was	 done	 in	 BWA	 using	 the	 solid2fastq.pl	 script.	 	 These	
reads	 were	 also	 indexed	 using	 BWA	 is	 algorithm	 and	 aligned	 using	 BWA	 aln.	 These	





The	 SAM	 files	 generated	 by	 BWA	 samse/sampe	were	 then	 converted	 into	 BAM	 files.	
The	raw	number	of	unmapped	and	mapped	reads	were	calculated,	both	by	extracting	
reads	 with	 a	 bitwise	 score	 of	 4,	 which	 are	 unmapped,	 and	 using	 samtools	 flagstat	
function,	which	gives	additional	mapping	information.	
	
For	 single	 ended	mappings,	 the	BAM	 file	was	 first	 extracted	 and	 then	 sorted.	Unique	
reads	 were	 then	 extracted	 from	 this	 BAM	 file	 using	 reads	 with	 a	 X:T:A:U	 tag.	 The	
number	of	uniquely	mapping	reads	was	also	counted.	This	removes	reads	that	map	to	
more	 than	one	place	on	 the	reference,	however	 this	does	not	remove	PCR	duplicates.	
PCR	 duplicates	 are	 often	 caused	 by	 the	 additional	 PCR	 cycles	 needed	 to	 produce	 a	
library.	 PCR	 can	 often	 bias	 a	 library	 by	 causing	 excessive	 amplification	 in	 certain	
regions	of	the	genome.	This	is	often	exacerbated	in	low	input	samples	where	a	greater	





then	used	 to	 generate	 information	on	 the	number	 of	 paired	 and	unpaired	 reads,	 and	
singlet	 information.	 	Another	BAM	file	was	created	from	a	filtered	version	of	the	SAM	
file.	 In	 this	 file	 only	 reads	with	 a	 SAM	bitwise	 flag	 of	 either	99,	 147,	 83	or	 163	were	
extracted,	 these	meant	 that	 the	 reads	were	 paired,	mapped	 and	 correctly	 orientated.	
This	 filtered	BAM	file	 then	had	the	unique	reads	extracted	using	the	X:T:A:U	flag,	and	




The	 alignment	 files	 were	 then	 filtered	 for	 only	 positions	 within	 the	 target	 region	 to	
ascertain	the	off	target	effect	using	Samtools	view	–L	and	providing	an	interval	list.	For	
design	one,	these	intervals	were	determined	by	using	blastn	with	the	Tb927	version	4.1	










































SNPs	 were	 called	 using	 the	 Genome	 Analysis	 Toolkit	 (GATK)	 version	 3	 using	 the	
process	outlined	in	Figure	2.5	below.	The	SNPs	were	called	on	the	BAM	files	generated	
by	BWA,	that	had	been	filtered	(only	uniquely	mapping	reads	and	no	duplicates).	The	
BAM	 file	 was	 locally	 realigned	 using	 the	 GATK	 walkers	 RealignerTargetCreator	 and	
IndelRealigner.	RealignerTargetCreator	identifies	regions	that	need	to	be	masked	prior	
to	 realigning	 by	 identifying	 INDELs.	 This	 is	 because	misalignments	 near	 INDELs	 are	
often	mistaken	for	SNPs.		Raw	SNPs	were	then	called	from	this	realigned	BAM	using	the	
UnifiedGenotyper	 walker.	 These	 SNPs	 were	 then	 filtered	 using	 the	 VariantFiltration	
walker,	 and	 SNPs	 that	were	 hard	 to	 validate,	were	 in	 a	 SNP	 cluster	 or	 had	 a	 quality	
score	 (MQ0),	 were	 identified	 and	 removed	 in	 subsequent	 analysis.	 SNPs	 were	 also	
filtered	by	coverage,	this	varied	per	dataset,	and	the	parameters	for	this	are	specified	in	




























Mutate_reference.pl	 script	 provided	 by	 Laura	 Gardiner,	 was	 used	 to	 incorporate	 the	
SNPs	found	in	the	WGS	data	into	the	reference.	This	was	done	for	each	strain,	and	then	
once	 the	 SNPs	 were	 incorporated,	 the	 Illumina	 reads	 from	 the	 enrichment	 libraries	











percentage	 shows	 the	 total	 percentage	 of	 the	 trypanosome	 DNA	 in	 the	 sample.	
However	this	data	also	includes	reads	mapping	to	the	Tb927	reference,	which	are	not	






the	whole	genome	 in	designs	one	and	 two	respectively	because	 this	would	 indicate	a	
high	proportion	of	off	target	reads.		The	starting	percentage	of	host	DNA	in	the	sample	
prior	to	enrichment	is	also	very	high	(>99%)	and	so	we	would	also	expect	a	significant	
proportion	 of	 the	 reads	 to	 map	 to	 the	 host	 rather	 than	 the	 parasite.	 This	 can	 be	





the	 second	 design).	 A	 high	 proportion	 of	 the	 uniquely	mapping	 reads	were	 removed	






due	 to	 the	 small	 design	 region,	 the	 number	 of	 high	 quality	 reads	 is	 usable.	 If	 we	
compare	 this	 to	 the	 whole	 genome	 sequence	 data,	 which	 was	 sequenced	 from	 pure	
trypanosome	 cultures,	 we	 can	 see	 that	 enrichment	 sequence	 data	 doesn’t	 adversely	
affect	 the	 quality	 from	 a	mapping	 perspective.	 Despite	 far	 less	 amplification	 prior	 to	
sequencing,	 a	 significant	 number	 of	 reads	 are	 still	 filtered	 out	 due	 to	 low	 quality,	
however	this	is	expected	with	older	chemistries	such	as	SOLiD		(Ratan	et	al.,	2013).		
	
















The	 capture	 array	 was	 designed	 to	 enrich	 each	 chromosome	 approximately	 equally,	
and	so	the	on	target	percentages	for	each	chromosome	should	be	approximately	12%	









relatively	 consistent	 between	 strains,	 with	 the	 off	 and	 on	 target	 reads	 covering	 on	
average	~20%	of	each	chromosome.	The	target	region	was	largest	for	chromosome	1,2	
and	 3,	 and	 Figure	 2.6	 shows	 the	 highest	 percentage	 of	 the	 chromosome	 covered	 in	
these,	which	 suggests	 uniform	 off	 target	 effects	 throughout	 the	 genome.	 	 The	 lowest	
mapping	 percentage	 was	 seen	 in	 chromosome	 11,	 and	 this	 reflects	 the	 design.		
Chromosome	11	is	the	largest	chromosome	and	has	a	greater	percentage	of	repetitive	
sequence,	 and	 so	 the	 target	 region	 covers	 a	 much	 smaller	 percentage	 of	 the	 whole	
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Figure	 2.6:	 A-C	 show	 the	 mean	 coverage	 per	 chromosome	 of	 the	 WGS	 data,	 enrichment	 data	 from	 design	 one,	 and	 enrichment	 data	 from	 design	 two,	
respectively.	 Strain	 E	 is	 the	 representative	 B17	 strain	 and	 is	 shown	 in	 blue,	 strain	 B	 is	 the	 representative	 Z310	 strain	 and	 is	 shown	 in	 red.	 D-F	 show	 the	













































































































































































The	 reads	 from	 the	 enrichment	 data	 that	 mapped	 within	 the	 target	 region	 for	 both	
designs	 was	 used	 so	 that	 SNPs	 could	 be	 called	 from	 data	 within	 the	 same	 region,	
because	different	 libraries	 could	be	enriching	off	 target	 regions	non-uniformly.	 	 SNPs	
called	against	data	mapped	to	off	and	on	target	regions	showed	a	large	difference	in	the	









Strain	 B	 E	 B	 E	



























4,330,694	 3,381,152	 27,537,191	 3,762,260	
Percentage	paired	
and	mapped	(%)	









As	 seen	 in	Table	 2.5,	 a	 high	percentage	 of	 the	 reads	mapped	on	 target	 in	 design	one	
(between	78-80%)	and	 this	 on	 target	mapping	 increased	marginally	with	 the	 second	
design	 (83%).	This	was	consistent	even	 in	 library	E	second	design,	where	 the	 library	
appears	to	not	have	hybridized	as	well.	Even	for	this	library,	because	of	the	small	target	
region	(2.0Mb)	 in	 the	second	design,	and	 the	read	 length	of	100bp,	 there	 is	 sufficient	











120	 nucleotide	 bait.	 	 The	 percentages	 of	 genes	mapped	 to	 in	 column	 1	 are	 from	 the	
non-filtered	mapping,	the	subsequent	columns	are	generated	from	the	data	filtered	for	
uniqueness	 and	 PCR	 duplicates.	 In	 the	 first	 design	 there	 were	 985	 genes	 in	 total	
targeted	 across	 the	11	megachromosomes,	 and	greater	 than	92%	of	 the	 gene	 targets	
were	 uniquely	mapped	 to	 in	 both	 of	 the	 first	 design	 libraries.	 This	was	 increased	 to	
greater	than	99%	in	the	second	design,	where	there	were	731	gene	targets.		70-75%	of	
the	gene	targets	uniquely	mapped	to	in	design	one	had	a	coverage	of	greater	than	50,	
whereas	 for	 the	 same	 strain	 in	 design	 two,	 because	 almost	 all	 targets	were	 uniquely	
mapped	to,	over	99%	of	the	total	target	genes	had	a	coverage	of	greater	than	50x.	
	
	In	 the	 unfiltered	 data,	 there	 are	 several	 extreme	 outliers	 in	 coverage,	 in	 design	 one	
certain	targets	had	coverage	greater	than	5000	x	(not	shown),	and	this	illustrates	how	
important	 data	 filtering	 is,	 because	 these	 are	 not	 seen	 in	 the	 data	 filtered	 for	 PCR	
duplicates	 and	non	uniquely	mapped	 reads.	 	 Although	 the	number	 of	 genes	uniquely	
mapped	 to	 in	 Strain	 E	 design	 two	 is	 comparable	 with	 Strain	 B	 in	 design	 two,	 the	
number	of	genes	uniquely	mapped	to	with	a	high	level	of	coverage	is	much	lower,	with	
only	68%	of	the	target	genes	having	a	coverage	greater	than	5.	However,	as	discussed	
in	Chapter	3,	 this	 is	a	reflection	of	poor	hybridization	 in	the	sample,	rather	than	poor	





























































B	 941	 96	 931	 95	 861	 701	 0	





B	 730	 99.9	 730	 99.9	 730	 727	 0	








B	 986	 100	 986	 100	 N/A	 N/A	 N/A	




The	coverage	per	gene	 is	also	 illustrated	 in	Figures	2.7	and	2.8	below	and	shown	per	
design	and	strain	for	comparison.	 	In	the	first	design,	you	can	see	from	both	Table	2.6	
and	Figures	2.7	 and	2.8,	 that	 the	 coverage	profile	 is	 similar	between	 the	 two	 strains.		
The	coverage	slopes	off,	as	is	expected	and	the	majority	of	genes	have	a	coverage	of	less	
than	 1000x.	 Due	 to	 the	 lower	 frequency	 of	 these	 extreme	 outliers,	 with	 in	 excess	 of	
5000x	 coverage,	 only	 those	with	 a	 coverage	of	 less	 than	1000x	are	 shown	 in	Figures	
2.7A	and	C.	There	are	also	a	high	frequency	of	genes	that	have	a	much	lower	coverage	
in	the	data	for	this	design.	This	illustrates	that	although	the	majority	of	the	genes	have	a	







































shown	 because	 the	majority	 of	 the	 genes	 have	 a	 coverage	 less	 than	 1000x,	 and	 including	 these	
outliers	reduces	the	ability	to	see	the	gene	coverage	distribution.	A	and	B	show	the	mean	coverage	
for	genes	with	a	coverage	between	1-1000x.	The	tailing	of	coverage	is	observed	in	both,	strain	B	is	











Histogram of mean coverage

















Histogram of mean coverage

















Histogram of mean coverage
















Histogram of mean coverage



























































filtering	of	outliers.	The	distribution	of	 coverage	 is	much	 tighter	 than	seen	 in	Figures	
2.7A	 for	 the	 first	design.	 	Figure	2.8B	 illustrates	 that	strain	E	had	much	 lower	overall	
coverage	compared	to	strain	B	in	the	second	design,	and	so	only	coverage	up	to	1000x	
is	 shown.	The	 target	 region	 for	 the	 second	design	was	generated	based	on	 the	 genes	
that	performed	the	best	in	the	first	design,	and	so	it	is	expected	that	there	would	be	less	
variability	in	the	performance	of	the	probes.	Strain	E	shows	a	distribution	very	similar	
to	 that	seen	 in	 the	 first	design,	with	a	 tailing	off	 the	of	 the	coverage,	and	a	significant	
number	(~30%	in	this	library)	having	a	much	lower	coverage	than	the	rest	of	the	genes	
in	 the	target	region.	However	as	mentioned	before,	 this	 is	more	to	do	with	 individual	
library	 performance	 than	 the	 design	 region,	 and	 strain	 B	 performs	well,	 with	 tightly	






filtered	 data,	 or	 targets	 that	 excessively	 over	 enrich.	 Instead	 for	 both	 libraries,	 gene	
coverage	 lies	 between	 0-200x	 for	 all	 targets.	 Even	 though	 there	 is	 low	 coverage	 for	






the	 unfiltered	 coverage	 for	 genes	 in	 the	 second	 design	 in	 strain	 E.	 Due	 to	 much	 lower	 overall	
coverage;	only	genes	up	to	a	coverage	of	1000x	are	shown	in	B.	C	and	D	show	just	the	filtered	data	
for	srains	B	and	E	respectively.	The	majority	of	the	coverage	lies	between	0-200x	coverage.		Strain	E	
in	 B	 and	 D	 show	 a	 profile	 similar	 to	 that	 seen	 in	 the	 first	 design,	 with	 more	 variability	 to	 the	
coverage,	and	a	tailing	off	in	the	data.		However	overall	the	data	has	a	much	tighter	distribution	and	




The	 lower	 degree	 of	 inter-target	 variability	 in	 design	 two	 is	 shown	 in	 Figure	 2.9.	 It	
shows	 the	 distribution	 of	 coverage	 across	 each	 design	 for	 the	 two	 strains,	 which	 is	
more	variable	 in	both	 strains	 in	 the	 first	design,	 than	observed	 in	 the	 second	design.	
This	 shows	 that	 the	 redesign	 of	 the	 target	 region	 has	 had	 a	 significant	 effect	 on	 the	
performance	of	the	probes,	with	all	of	the	probes	enriching	relatively	uniformly	in	the	
second	 design.	 The	 decrease	 in	 variability	 between	 designs	 is	 reflected	 by	 the	
comparative	length	of	the	whiskers	and	the	inter	quartile	range	(IQR),	which	are	both	
greater	 in	 the	 first	 design	 for	 both	 strains.	 In	 Figure	 2.9,	 the	whiskers	 represent	 the	
furthest	data	point	within	1.5x	the	IQR.	In	the	second	design,	the	IQR	is	greatly	reduced	
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Despite	a	very	variable	coverage	across	 targets,	 the	majority	of	 the	 targets	 for	design	
one	have	a	good	level	of	coverage,	with	the	1st	quartile	being	in	excess	of	50x	coverage	












































































From	 the	difference	 in	 performance	 in	 terms	of	more	 even	 coverage	 and	 greater	 on-
target	percentage	of	 reads,	 it	 is	evident	 that	probe	design	has	a	 significant	 impact	on	
the	performance	of	 the	design.	The	 target	 region	 for	 the	second	design	was	based	on	
the	targets	which	had	a	coverage	of	between	5-500	in	both	these	strains	and	additional	
strains	 discussed	 in	 Chapter	 3	 in	 design	 one.	 However,	 in	 the	 first	 design,	 how	
comparable	was	the	performance	of	 individual	targets	between	samples?	 	Figure	2.10	
demonstrates	how	the	targets	where	enriched	in	Strain	E	and	B	in	the	first	design.	Each	
point	 represents	 a	 gene	 target,	 and	 the	 targets	 are	 ranked	 based	 on	 their	 coverage.	




























not	 observed.	 	 	 In	 the	 second	 design,	 there	 is	 very	 little	 difference	 in	 the	 coverage	
between	genes	ranking	between	1	and	419	in	Strain	B	in	the	second	design		(190-	170x	
coverage)	 and	 so	 large	 fluctuations	 between	 the	 ranked	 performance	 in	 the	 second	
design	 equate	 to	 very	 little	 actual	difference	 in	 the	 coverage.	 	 In	 contrast,	 in	 the	 first	


















and	 B	 are	 both	 Ugandan	 T.b.	 rhodesiense	 strains,	 a	 low	 number	 of	 SNPs	 and	 a	 high	




strains	 B	 and	 E,	 respectively.	 These	 SNPs	 were	 generated	 using	 the	 GATK	 pipeline	
mentioned	previously,	and	are	the	filtered	SNPs,	which	had	a	depth	between	5-100.	As	
shown	 in	 Figure	 2.6,	 the	 mean	 coverage	 in	 the	 WGS	 data	 is	 30x;	 no	 SNPs	 were	
discovered	above	the	100x	threshold.	 	Similarly,	the	numbers	of	SNP	positions	unique	




Table	 2.7	 Summary	 of	 SNP	 calls	 generated	 in	 GATK	 and	 then	 analysed	 in	 vcftools	 compare.	 This	
data	 demonstrates	 the	 very	 high	 degree	 of	 similarity	 between	 these	 two	 strains.	 SNPs	 were	
generated	after	mapping	to	the	Tb927	version	8.1	reference,	available	 from	(www.tritrypdb.org).	









B17	 11,939	 10.8	 98,564	 89.2	





same	 position.	 This	 is	 shown	 in	 Table	 2.8	 and	 done	 using	 VCFcompare.	 A	 high	
proportion	of	 these	SNPs	have	 the	same	zygosity	at	 the	same	position,	and	with	93%	
(91,546	SNPs)	out	of	the	98,564	SNPs	shared	between	the	strains,	see	Table	2.7,	have	
heterozygous	 and	 homozygous	 SNPs	 at	 identical	 positions.	 Table	 2.8	 also	 shows	 the	
degree	of	uniqueness	in	the	heterozygous/homozygous	SNPs,	and	in	both	strains	there	
are	a	greater	percentage	of	heterozygous	SNPs	unique	to	one	strain	(~30%)	compared	




Table	 2.8:	 This	 shows	 the	 number	 of	 heterozygous	 and	 homozygous	 SNPs	 per	 strain.	 It	 also	
illustrates	 that	 the	 percentage	 of	 unique	 SNPs	 per	 zygosity	 is	 relatively	 uniform.	 The	 degree	 of	
uniqueness	 is	 higher	 for	 the	 heterozygous	 SNPs	 (~30%)	 than	 for	 the	 homozygous	 SNPs	 (~11%).	
















































SNPs	 seen	 in	 the	 enrichment	 data	 correlated	with	 the	whole	 genome	 sequence	 data.	
















to	 B,	 the	 percentage	 uniqueness	 would	 be	 much	 closer	 to	 that	 observed	 in	 the	 first	




data	 the	 two	 zymodeme	 groups	 appeared	 to	 have	 approximately	 equal	 numbers	 of	 homozygous	




As	 before,	 VarientFiltration	 was	 used	 to	 determine	 the	 zygosity	 of	 the	 SNPs,	 and	 to	
compare	 whether	 the	 zygosity	 was	 preserved	 between	 strains	 at	 the	 same	 position.	







One	 B	 8109	 31.5	 17,667	 68.5	
E	 3733	 17.4	 17,667	 82.6	
Two	 B	 71,655	 87.6	 10,138	 12.4	























When	 including	 the	 non-target	 data,	 there	 appears	 to	 be	 unequal	 enrichment	 across	
non-target	 regions	 of	 the	 genome,	 and	 this	 resulted	 in	 an	 overrepresentation	 of	
heterozygous	 SNPs	 in	 strain	 B	 for	 design	 two.	 However	 it	 is	 also	 important	 to	 see	




	 First	Design	 	 	 Second	design	
	 	 	 	 	 	 	






















































































As	 before,	 SNPs	 were	 generated	 using	 the	 same	 parameters	 in	 BWA	 and	 GATK,	 but	
were	instead	mapped	against	a	custom	Tb927	reference,	for	both	WGS	and	enrichment	
data,	in	order	to	look	just	at	SNPs	within	the	target	region	for	design	one	and	two.	SNPs	
shared	 between	 these	 strains	 could	 indicate	T.b.	rhodesiense	 specific	 differences,	 and	

















































As	 shown	 in	 Table	 2.11,	 the	 high	 percentage	 of	 conserved	 SNP	 positions	 in	 the	
enrichment	data	 	~90%,	agrees	with	 the	degree	of	SNP	conservation	observed	 in	 the	
WGS	data.	 Illumina’s	 sequencing	 chemistry	 is	more	 sensitive	 than	 SOLiD’s	 chemistry,	
and	so	you	would	expect	some	SNP	positions	conserved	within	the	Illumina	data	to	be	
novel	 to	 those	observed	within	 the	same	region	of	 the	WGS	data	generated	by	SOLiD	
sequencing.	However	in	Table	2.11,	the	number	of	SNPs	discovered	in	the	first	design	
region	is	slightly	lower	in	the	enrichment	data	than	observed	in	the	WGS	data.	 	There	
are	 fewer	 conserved	 sites	 in	 the	 second	 design,	 however	 this	 is	 another	 artefact	 of	
strain	E’s	lower	coverage.	However	despite	this	lower	coverage,	the	similar	percentage	
identity,	and	the	raw	number	of	conserved	and	unique	sites	observed,	compared	to	the	





















Z310	 400	 7.9	 4,656	 92.1	
B17	 389	 7.7	 4,656	 92.3	
Second	
Design	
Z310	 941	 10.1	 8,419	 91.5	
B17	 783	 8.5	 8,419	 89.9	
First	design	 B	 445	 6.5	 6,453	 93.5	
E	 685	 9.6	 6,453	 90.4	
Second	design	 B	 5846	 40.9	 8,461	 59.1	





in	 both	WGS	 and	 enrichment	 sequencing	 data,	 see	 Table	 2.12.	 As	 expected	 from	 the	
second	 design	 strain	 E	 data	 and	 Table	 	 2.10,	 the	 homozygous	 SNP	 percentage	 was	
higher	than	seen	within	the	rest	of	the	data	(85%).	Despite	the	homozygous	SNP	count	
of	 this	 strain	 being	 only	 30%	 lower	 than	 in	 strain	 B	 for	 the	 same	 design,	 the	
heterozygous	SNP	count	was	69%	lower	than	observed	in	strain	B.	In	comparison,	the	





Conservation	 in	 the	zygosity	of	 the	SNPs	was	 comparable	between	 the	WGS	and	 first	
design	data	(92-93%)	and	there	were	a	greater	number	of	total	SNPs	called	compared	












	 First	Design	 Second	design	 WGS	
First	design	 Second	design	




























































































Total	SNPs	 6,898	 7,138	 6,000	
(93%)	
	 14,307	 9,049	 7,603	
(90%)	
	 5,086	 5,045	 4,320	
(93%)	











Figure	 2.11	 showed	 that	 over	 the	 entire	 dataset,	 there	 was	 no	 significant	 difference	
between	 the	 relative	 abundance	 of	 different	 SNP	 varieties,	 and	 this	 is	 also	 true	 for	









SNPs	 called,	 the	 percentage	 of	 SNPs	 that	 are	 transversions	 and	 transitions	 remain	 the	
approximately	equal	between	the	two	sequencing	methods.	The	WGS	data	for	the	target	region	can	
be	used	as	an	approximation	to	the	expected	SNP	ratios.		












































Table	 2.13	 provides	 an	 overview	 of	 the	 similarity/key	 differences	 found	 in	 the	
comparison	 of	WGS	 and	 enrichment	 data.	 Each	 column	 shows	 the	 comparison	 of	 the	
performance	 in	 each	 strain/design	 combination	 of	 enrichment	 data	 to	 the	WGS	data.	
There	 is	 an	 increase	 in	 the	 total	 number	 of	 SNPs	 called	 within	 both	 target	 regions	
compared	 to	 the	 same	 region	 in	 the	 WGS	 data.	 In	 the	 second	 design,	 despite	 much	
lower	coverage	for	strain	E	compared	to	the	strain	B,	an	increase	in	the	total	number	of	




result.	 For	 the	other	 three	 libraries,	 an	approximate	30%	 in	 the	 total	number	of	 SNP	































	 Z310	 B17	 Z310	 B17	
SNPs	called	in	
target	region	









































































alignment	 of	 the	 corresponding	 WGS	 data	 from	 the	 Z310	 strain.	 As	 is	 indicated	 in	
Figure	2.13,	the	coverage	is	greater	at	this	SNP	position	in	the	enrichment	data,	and	the	
SNP	 in	 the	 center	 is	 heterozygous,	 with	 approximately	 half	 of	 the	 reads	 having	 the	
reference	allele,	C,	and	the	remainder	the	alternative	allele,	A.	The	coloured	bars	on	the	
coverage	 track	show	the	ratio	of	C/A	alleles	by	 the	percentage	of	 the	bar	coloured	 in	
blue/green	respectively.	 	Due	 to	 the	high	depth	of	 coverage,	not	all	 reads	aligned	are	
shown	 in	 the	 enrichment	 data.	 The	 same	 is	 shown	 for	 the	 heterozygous	 SNP	 to	 the	











contained	 the	 alternative	 allele,	 respectively.	 The	 coverage	 in	 the	WGS	 data	 at	 these	
positions	was	33x.	Due	to	their	homozygous	nature,	you	would	expect	these	SNPs	to	at	
least	 be	 represented	 in	 a	 proportion	 of	 the	 WGS	 reads.	 Both	 the	 homozygous	 and	
heterozygous	examples	suggest	that	the	enrichment	sequence	data	is	more	sensitive	to	



























level	 of	 coverage	 in	 the	 enrichment	 data,	 shows	 two	 colours	 representing	 the	 different	 alleles	 in	 this	 heterozygous	 SNP.	 The	 ratio	 of	 the	 colours	 shown	












































The	analysis	of	 the	data	 in	this	chapter	has	highlighted	several	 things.	One	of	 these	 is	
that	 it	 is	 possible	 to	 generate	 high	 quality	 sequence	 data	 from	minute	 quantities	 of	
starting	 DNA,	 and	 this	 means	 that	 this	 method	 of	 library	 preparation	 would	 be	
amenable	 to	 clinical	 or	 field	 samples,	where	 sample	 quantity	may	 be	 a	 hindrance	 to	
collecting	 enough	 DNA	 to	 prepare	 the	 sample	 in	 a	 traditional	 library	 preparation	
manner.	 It	 has	 also	 shown	 that	 MDA	 and	 Whatman	 FTA™	 cards	 can	 be	 used	 in	
conjunction	with	target	enrichment	without	adversely	affecting	the	quality	of	the	data.		
	
The	 comparisons	 between	 the	 designs	 show	 that	 design	 is	 very	 important	 in	
determining	the	success	of	the	enrichment.	Good	design	can	improve	the	percent	of	on	
target	 DNA	 sequenced,	 reduce	 variability	 in	 terms	 of	 coverage	 between	 targets	 in	 a	
design,	 and	 is	 reproducible	 between	 samples	 and	 designs.	Data	 from	 the	 enrichment	
sequencing	 also	 does	 not	 appear	 to	 highly	 over	 or	 underrepresent	 either	 certain	
varieties	of	SNPs	nor	heterozygous/homozygous	SNPs,	compared	to	the	WGS.	Despite	
only	 ~80%	 of	 the	 SNPs	 found	 in	 the	WGS	 data	 being	 found	 in	 the	 enrichment	 data,	
more	total	SNPs	are	called	within	the	target	region	unique	to	the	enrichment	data	and	





Despite	 poor	 performance	 of	 one	 of	 the	 libraries	 in	 the	 second	 design,	 a	 high	
percentage	of	the	SNPs	were	still	identified	despite	low	coverage.	Considering	less	than	






















diversity	 using	 sequence	 data	 is	 to	 look	 at	 SNP	 patterns	 and	 their	 functional	
consequences,	 in	 order	 to	 determine	 variations	 causing	 phenotypic	 differences.	 In	
parasites,	 SNPs	 can	be	used	as	genetic	markers	 for	 identifying	potential	 resistance	 in	
strains	and	 looking	at	 loci	potentially	under	positive	 selection.	 	 In	extreme	examples,	
this	can	lead	to	mutations	conferring	an	advantage	dominating	in	a	population;	this	is	
known	 as	 a	 selective	 sweep.	 Often	 this	 results	 in	 a	 greatly	 reduced	 level	 of	 diversity	
surrounding	 these	 highly	 positively	 selected	 SNPs	 (Kim	 and	 Stephan,	 2002;	 Fay	 and	
Wu,	 2000).	 	 In	 Plasmodium,	 variants	 called	 following	 sequencing	 were	 used	 to	
determine	SNPs	associated	with	artemisinin	(ART)	resistance	(Cheeseman	et	al.,	2014).		
Similar	 studies	 have	 also	 used	 SNP	 variants	 to	 investigate	 diversity	 arising	 under	




This	 chapter	 will	 primarily	 look	 at	 the	 genetic	 diversity	 amongst	 three	 zymodeme	
groups	 within	 Ugandan	 T.b.	 rhodesiense	 strains.	 Seven	 strains	 belonging	 to	 three	
zymodeme	 groups	 B17,	 Z366	 and	 Z310	 are	 compared	 across	 two	 enrichment	 target	
regions.	 Additional	 strains	 as	 discussed	 in	 the	methods	were	 also	 used	 to	 check	 the	
validity	 of	 the	 enrichment	 method	 discussed	 in	 Chapter	 2,	 for	 use	 on	 very	 low	
parasitaemia	 human	 T.	 brucei	 infections.	 However	 primarily	 the	 analysis	 will	 be	
focused	on	the	seven	strains	used	in	both	sequence	captures,	particularly	as	the	most	






This	 chapter	 aims	 to	 look	 at	 variation,	 in	 this	 case	 SNPs,	 looking	 at	 both	 SNP	
conservation	 across	 strains	 and	 regions	 of	 unique	 SNPs,	 in	 order	 to	 decipher	 the	






against	multiple	 strains	 per	 zymodeme	 group	 in	 order	 to	 try	 and	 elucidate	 potential	
genetic	variants	causing	 the	phenotypic	differences	seen	 in	 these	sets	of	strains.	First	
the	 localization	 of	 unique	 and	 conserved	 variants	 will	 be	 used	 to	 observe	 any	 SNP	
dense	regions	of	 the	genome.	Secondly	 these	variants	will	be	annotated	 to	determine	
the	 functional	 effect	 of	 these	mutations,	 in	 order	 to	 generate	 candidate	 genes,	which	
through	mutation,	 are	 involved	 in	 the	 generation	 of	 these	 phenotypes.	 The	 genomic	
location	of	low-high	impact	SNPs	will	also	be	investigated	to	see	whether	there	is	any	
clustering	 of	 any	 particular	 type	 of	 variant.	 Unique	 variants	 identified	 through	 this	
process	will	be	assigned	GO	terms	and	undergo	GO	term	enrichment	analysis	in	order	
to	 decipher	whether	 particular	 pathways	 correlate	with	 an	 abundance	 of	 deleterious	
SNPs,	as	these	may	be	under	selection.	The	proportion	of	non-proliferative	stages	has	








considered	 to	 give	 rise	 to	 the	 most	 acute	 infections,	 and	 T.b.	 gambiense	 typically	
causing	more	chronic	infections.	However	within	these	subspecies	there	is	great	inter-






et	 al.,	 1992;	Bertram	et	 al.,	 1983).	However	 significant	 intra-zymodeme	variation	has	
also	 been	 observed	 in	 Leishmania	 and	 T.	 cruzi	 (Baptista-Fernandes	 et	 al.,	 2007;	
Mendonça	et	al.,	2002).		
	
The	 virulence	 of	 a	 parasite	 can	 be	 defined	 in	multiple	 ways.	 This	 can	 be	 defined	 by	
characteristics	 in	 the	 clinical	 manifestation,	 as	 has	 been	 done	 with	 these	 T.b.	
rhodesiense	 strains,	 in	 which	 presence	 or	 absence	 of	 chancre	 is	 one	 of	 the	 defining	
characteristics	 of	 a	 virulent	 infection.	 Differences	 in	 clinical	 manifestation	 can	 also	
include	 variations	 in	 the	 length	 of	 the	 prepatent	 period,	 the	 parasitaemia	 at	 the	 first	
peak	 of	 parasitaemia,	 and	 the	 progression	 from	 early	 to	 late	 stage	 of	 the	 disease,	 as	
signified	by	parasites	present	in	the	cerebrospinal	fluid	(CSF)	(Smith	and	Bailey,	2000;	
Morrison,	2011).	 	 In	 these	 terms,	 a	parasite	would	be	 classed	as	highly	 virulent	 if	 its	
prepatent	 period	 was	 short	 and	 its	 first	 peak	 of	 parasitaemia	 was	 high	 (Morrison,	
2011).		
	
However	 the	virulence	of	a	parasite	can	also	be	defined	by	 it’s	ability	 to	 infect	a	host	
and	be	 transmitted	 to	 its	 vector.	 In	T.	brucei,	 only	 short	 stumpy	 forms	are	 capable	of	
being	transmitted	to	the	vector	(Matthews	et	al.,	2004).	These	transmissible	parasites	
can	also	be	divided	into	two	discrete	populations,	the	older	short	stumpy	forms,	which	





By	 defining	 virulence	 by	 transmissibility,	 strains	 with	 the	 optimal	 number	 of	
transmissible	forms	are	the	most	virulent.		
	
Proliferative	 life	stages	often	differentiate	 into	 the	stumpy	stage	as	a	quorum	sensing	
measure,	but	also	 in	altruism,	 to	allow	the	 infection	 to	be	maintained	within	 the	host	
for	 a	 longer	 duration,	 and	 optimize	 younger	 short	 stumpy	 stages	 to	 be	 transmitted	
(Reuner	et	al.,	1997;	Seed	and	Wenck,	2003).		The	idea	of	this	self-sacrifice	to	maintain	
a	 longer	sustained	 infection	 in	 the	host	 is	 reviewed	 in	more	depth	by	Duzsenko	et	al,	
2006	(Duszenko	et	al.,	2006).	 It	 is	the	immune	reaction	to	the	apoptotic	events	 in	the	
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older	short	stumpy	population,	which	causes	the	most	immunogenic	response,	and	so	a	
high	 population	 of	 these	 non-proliferative	 forms	 could	 cause	 the	 greatest	 immune	
response	 (Seed	and	Wenck,	2003).	Once	 strains	 lose	 their	 ability	 to	differentiate	 into	
these	 short	 stumpy	 stages	 and	become	monomorphic,	 this	 alters	 their	 virulence,	 and	





within	 this	chapter	are	 initially	used	 to	 infect	a	 trypanosusceptible	mouse	strain,	A/J,	
and	 are	 subsequently	 passaged	 into	 a	more	 trypanotolerant	mouse	 strain,	 C57BL/6.	
Primarily	studies	on	host	resistance	in	trypanosomes	have	been	focused	on	the	effect	in	
cattle,	 with	 studies	 on	 trypanotolerant	 breeds	 N’Dama	 and	 the	 trypanosuspectible	
Boran	 breeds	 (Naessens,	 2006;	 Orenge	 et	 al.,	 2012).	 However	 the	 interplay	 between	
host	 resistance	 and	 trypanosome	 infection	 in	 strains	 with	 differing	 levels	 of	
susceptibility,	has	also	been	explored	(Morrison	et	al.,	2010).		
	
Using	 the	 aforementioned	 methods	 for	 the	 determination	 of	 virulence,	 the	 strains	
discussed	in	this	chapter	can	be	divided	into	three	distinct	phenotypic	groups.	Strains	
from	 zymodeme	 group	 Z310	 typically	 present	 with	 a	 chronic	 infection.	 Patients	
infected	 with	 these	 strains	 are	 either	 asymptomatic,	 or	 present	 with	 a	 low	 grade	
infection	after	a	long	prepatent	period.	Initial	peaks	of	parasitaemia	are	higher	than	the	
B17	 zymodeme	 group	 strains,	 however	 these	 then	 lapse	 into	 very	 low	 parasitaemia	
chronic	 infections.	 In	contrast,	patients	 infected	with	strains	 from	the	B17	zymodeme	
group	 often	 present	with	 a	 late	 stage	 infection,	 as	 confirmed	 by	 parasites	within	 the	
cerebrospinal	 fluid.	 Infections	 with	 this	 parasite	 have	 a	 short	 prepatent	 period,	 and	
infection	 with	 these	 strains	 results	 in	 a	 more	 severe	 clinical	 manifestation,	 with	 a	






The	 parasites	 used	 in	 this	 chapter	 are	 bloodstream	 forms,	 generated	 through	
experimental	 infection	 in	mice.	Due	 to	 this,	 only	 the	mammalian	 stages	 in	Figure	3.1,	
are	 considered.	 In	 natural	 infections,	 in	 order	 to	 complete	 its	 life	 cycle,	 the	 parasite	
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must	complete	both	stages	in	its	vector	host,	the	tsetse	fly,	and	in	it’s	mammalian	host,	













salivary	 glands	 are	 injected	 into	 the	 mammalian	 host.	 These	 trypomastigotes	 then	
differentiate	 into	 bloodstream	 forms.	 The	 initial	 bloodstream	 forms	 are	 the	 highly	
proliferative	 slender	 forms,	 however	 as	 the	 burden	 on	 the	 host	 increases,	 and	 the	
parasitaemia	 increases,	 these	 stages	 undergo	 extensive	 structural	 reorganization	 and	
become	 the	 short	 stumpy	 forms	 shown	 in	 Figure	 3.1	 (Matthews,	 1999).	 These	 are	
incapable	 of	 proliferation	 and	 are	 adapted	 for	 transmission	 into	 the	 vector,	 as	
previously	 mentioned	 (Rico	 et	 al.,	 2013).	 	 This	 slender	 to	 stumpy	 transition	 varies	
between	strains,	and	in	this	chapter	will	be	used	in	association	with	other	phenotypic	
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stumpy	 stage	 parasite.	 There	 are	 multiple	 physical	 differences	 between	 the	 two,	








show	reduced	antigen	switching,	 and	so	 the	host	 is	more	capable	of	mounting	a	host	






In	 the	 stumpy	 form	of	 the	 parasite,	 the	 parasite	 has	 a	 shortened	 rotund	 appearance,	
with	a	short	 flagellum	and	a	more	posterior	kinetoplast	position	compared	to	what	 is	
observed	in	the	 long	slender	 form.	 	Mitochondrial	biogenesis	begins,	with	the	slender	
mitochondria	 becomes	 enlarged	 and	 restructured	 in	 the	 stumpy	 form	 (Reuner	 et	 al.,	


















et	 al	 finding	85%	of	 all	 annotations	 consistent	between	all	 software	 (McCarthy	et	 al.,	
2014).	 However	 this	 consistency	 is	 largely	 restricted	 to	 the	 exonic	 regions,	 with	
concordance	 between	 annotations	 dropping	 to	 44%	 in	 non-coding	 regions.	 These	
inconsistences	are	primarily	due	to	how	the	software	deals	with	loss	of	function	effects,	







built	 databases	 for	 non-model	 organisms,	 SNPeff	 was	 used	 for	 the	 analysis	 in	 this	
chapter.	 SNPeff	 is	 compatible	with	GATK,	which	was	used	 to	generate	 these	variants,	
however	 it	 also	 supports	 Samtools	 mpileup	 (Cingolani	 et	 al.,	 2012b).	 It	 calculates	





GO	 terms	 are	 used	 to	 assign	 functions	 to	 genes	 and	 were	 constructed	 by	 the	 Gene	
Ontology	Consortium	to	fit	within	three	types,	biological	processes,	molecular	functions	
and	cellular	components.	Biological	process	refers	to	the	pathway	or	process	the	gene	
contributes	 to,	 molecular	 function	 describes	 the	 biochemical	 activity	 of	 the	 gene	
product	 and	 cellular	 components	 describes	 the	 location	 where	 the	 gene	 product	 is	













SNPRelate	 is	 a	 R	 package	which	 can	 be	 used	 to	 generate	 phylogenetic	 analysis	 from	
SNP	data	(Zheng	et	al.,	2012)	.	It	does	using	another	R	package,	gdsfmt,	which	is	used	to	
generate	a	genomic	data	structure	(GDS)	file,	 instead	of	relying	on	multiple	alignment	
methods	 of	 fasta	 sequences,	 such	 as	 those	 employed	 by	 software	 such	 as	 MUSCLE	








All	 of	 the	 samples	 used	 in	 the	 initial	 design	 were	 blood	 samples	 taken	 from	
experimentally	 infected	 mice.	 These	 parasites	 are	 T.b.	 rhodesiense	 parasites	 isolated	
originally	by	Wendy	Bailey	 in	1997	and	 the	phenotypes	described	 in	 Smith	&	Bailey,	
1997	(Smith	and	Bailey,	2000).	These	strains	originate	from	Uganda,	the	importance	of	
this	being	that	 it	 is	one	of	the	few	locations	where	T.b.	rhodesiense	and	T.b.	gambiense	




The	strains	used	 in	 this	 study	were	picked	on	 the	basis	of	 their	phenotype	 in	natural	
human	 infections.	The	strains	picked	were	 from	three	zymodeme	groups,	Z366,	Z310	
and	B17,	 produce	 an	 intermediate,	 chronic	 and	 acute	phenotype	 in	human	 infections	
respectively	 (Smith	 and	 Bailey,	 2000).	 In	 humans,	 B17	 infections	 were	 commonly	
associated	with	a	chancre,	and	patients	presented	with	an	acute	early	stage	 infection,	
whereas	 in	 Z310	 infections,	 chancres	 were	 rarely	 present,	 patients	 had	 an	
asymptomatic	 early	 stage,	 and	 presented	 with	 late	 stage	 disease	 (Smith	 and	 Bailey,	
2000).	 In	 murine	 infections,	 the	 Z310	 infected	 individuals	 presented	 with	 higher	









used,	3	of	 these	were	 from	the	Z310	zymodeme,	3	 from	the	B17	zymodeme,	and	one	







































G5	 Symptomatic	 but	 no	
parasites	 in	 blood.	









Sample	 collection	 from	 the	 mice	 used	 for	 enrichment	 sequencing	 were	 taken	 as	
described	 in	 Chapter	 2.	 This	 outlines	 the	 sample	 collection	 for	 the	 QPCR,	 and	
microscopy	data	shown	in	this	chapter.		Samples	were	collected	by	initially	infecting	2	
female	A/J	mice	intraperitoneally	with	104	parasites	from	a	blood	stabilate	of	B17	and	
2	 female	 A/J	 mice	 with	 Z310.	 This	 mouse	 strain	 is	 particularly	 susceptible	 to	
trypanosome	infection,	which	is	important	in	order	to	obtain	a	high	parasitaemia	blood	
sample	 with	 which	 to	 infect	 subsequent	 mice.	 They	 were	 subsequently	 humanely	
sacrificed	following	positive	results	for	parasites	from	microscopy	screening.			
	
Blood	 was	 then	 collected	 from	 these	 mice	 and	 104	 parasites	 were	 passaged	 into	
C57BL/6	mice,	5	 for	each	 isolate.	Mice	were	bled	prior	 to	 infection	and	25µl	of	blood	
was	 then	 taken	 twice	weekly	 for	metabolomic	 analysis,	 10µl	 of	 blood	was	 also	 taken	
every	 other	 day	 for	 qPCR	 analysis,	 and	 daily	 spots	 were	 used	 for	 recording	 the	
presence	of	the	trypanosomes,	and	used	to	create	thin	films	for	staining	purposes.	The	
mice	used	for	metabolomic	and	QPCR	analysis	were	culled	prior	to	schedule	due	to	ill	







Differences	 in	 the	presentation	of	 symptoms	 following	 from	 infection	with	 these	 two	
strains	are	potentially	related	to	a	difference	in	cell	cycle	progression.	This	was	tested	








seconds,	 and	 stained	 using	 a	 reverse	 Field’s	 Stain	 protocol	 as	 follows	 (Prolab	
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diagnostics™,	UK).	Slides	were	fixed	in	methanol	using	8	dips	at	a	rate	of	1sec/dip,	then	






counting	 the	 parasites	 and	 ensuring,	 where	 possible,	 at	 least	 20	 parasites	 were	
counted.	Due	 to	 the	 fluctuation	of	parasite	numbers	during	 infection,	occasions	when	







QPCR	was	used	 to	validate	 the	microscopy	data	 for	 frequency	of	 slender	and	 stumpy	
forms,	(see	Table	3.2),	because	although	the	microscopy	data	illustrates	a	very	striking	
difference	 between	 strains,	 microscopy	 is	 limited	 because	 of	 its	 qualititative	 nature.	
Positive	 parasitaemia	 was	 confirmed	 by	 using	 a	 constitutive	marker	 TbZFP,	 and	 the	





10µl	of	blood	was	 collected	by	 tail	 snip	 into	a	microtube	 containing	2µl	of	22.5mmol	
EDTA,	which	was	centrifuged	at	6000g	to	remove	the	plasma.	Following	the	removal	of	
the	 plasma,	 an	 equal	 volume	 of	 PBS	 (phosphate	 buffered	 saline)	 was	 added	 to	 the	
pelleted	cells	and	resuspended.		An	equal	volume	of	ABI	purification	lysis	solution	(ABI	
4305895)	was	then	added	to	the	resuspended	cells	and	stored	at	-80	degrees	until	use.	









RNA	 was	 extracted,	 using	 samples	 processed	 as	 above,	 using	 the	 protocol	 from	 the	
Purelink™		RNA	Micro	Kit,	using	the	RNA	extraction	from	suspended	cells	protocol	(ABI	
12183016).	 	 The	 only	 deviations	 from	 the	 protocol	were	 that	 only	 5µl	 of	 the	 sample	
was	used	and	diluted	 into	35µl	of	PBS	prior	 to	 the	 first	step.	This	was	due	to	 the	 low	
sample	 volume	 obtained	 from	 tail	 snips,	 and	 samples	 were	 subject	 to	 6000g	 in	 the	
initial	 centrifugation	 step.	 Samples	were	DNase	 treated	 on	 column	 using	 Purelink™’s	
on-column	DNase	 treatment.	 Following	 extraction,	 the	 samples	were	 resuspended	 in	
20µl	nuclease	free	H2O.	The	quality	was	checked	using	A260/280	and	A260/230	values	







kit	 (ABI	4387406)	according	 to	manufacturer’s	 instructions	and	 then	amplified	on	an	
ABI	 RT-PCR	 machine.	 5µl	 of	 total	 RNA	 was	 used	 in	 a	 20µl	 reaction	 and	 reverse	
transcription	 was	 performed	 using	 once	 cycle	 of	 37°C	 for	 60	 minutes	 and	 95°C	 for	
5minutes.	 The	 posttranscriptional	 regulator	 TbZFP3	 was	 used	 as	 a	 constitutively	
expressed	 control,	 and	 a	 ΔΔCT	 method	 was	 used	 to	 compare	 the	 expression	 of	 the	
constitutively	 expressed	 posttranscriptional	 regulator	 TbZFP3	 against	 the	 stumpy	
marker	PAD1	(Paterou	et	al.,	2006).	Primers	used	for	the	amplification	of	PAD1	cDNA	
were	 5’-GACCAAAGGAACCTTCTTCCT-3’	 and	 5’-CACTGGCTCCCCTAAGCT-3’.	 For	
TbZFP3,	 the	 primers	 5’-	 CAGGGGAAACGCAAAACTAA-3’	 and	 5’-TGTCACCCCAAC	
TGCATTCT-3’	were	used	(MacGregor	et	al.,	2011).	
	
Power	 SYBR™™	 green	 PCR	 master	 mix	 was	 used	 in	 25µl	 reactions	 (ABI	 4367659).	































however	 in	 addition	 variants	 were	 filtered	 to	 make	 sure	 they	 fell	 within	 the	 target	
region	using	GATK’s	select	variants	walker	(DePristo	et	al.,	2011).	The	zygosity	of	these	
SNPs	was	determined	as	mentioned	in	Chapter	2,	and	in	conjunction	with	vcf-isec,	was	











Seven	 of	 the	 strains	were	 used	 in	 both	 designs.	 In	 order	 to	 generate	 the	 largest	 SNP	
dataset	 for	 these	 strains,	 the	 SNPs	 were	 compiled	 from	 those	 that	 were	 conserved	
between	 designs,	 and	 those	 that	were	 unique	 to	 one	 design.	 This	 increases	 the	 total	
number	of	 SNPs	because	 some	of	 the	 genes	 in	design	one	were	 reannotated,	 and	 the	
second	 design	 probe	 set	 was	 extended	 into	 these	 newly	 annotated	 regions.	 In	
comparisons	to	the	G7	strain,	SNPs	from	both	designs	were	used,	but	only	those	within	
the	 second	design	 target	 region	were	used	 for	 comparison.	This	was	because	G7	was	
not	 used	 in	 the	 first	 design.	 Vcf-compare	 was	 also	 used	 for	 across	 strain	 SNP	











the	 many	 potential	 impacts	 the	 SNP	 can	 have,	 dependent	 on	 the	 reading	 frame	 or	
splicing.	 A	 variant	 can	 affect	 more	 than	 one	 gene	 if	 it	 is	 in	 a	 regulatory	 region,	 and	




These	 were	 assigned	 to	 four	 impact	 groups,	 low,	 moderate,	 modifier	 and	 high	
depending	on	the	predicted	SNP	effect.	They	were	also	annotated	for	the	particular	SNP	
type	for	instance	stop	gained,	or	stop	lost,	the	range	of	potential	SNP	effects	within	this	
data	 set	 is	 shown	 in	 the	 results.	 These	 effects	 were	 also	 grouped	 into	 synonymous,	
missense	and	nonsense	effects.	Snpsift	was	used	to	calculate	the	abundance	of	different	







were	separated	 into	 impact	groups	 (low,moderate,modifier	and	high),	 and	were	used	
with	Tritrypdb’s	GO	term	analysis	package	to	assign	GO	terms	to	the	genes	with	these	
SNPs	(Aslett	et	al.,	2010).	This	was	an	attempt	to	understand	if	certain	pathways	were	






cellular	 component	 they	 are	 associated	with,	 the	molecular	 function	 the	 gene	has,	 or	
the	 biological	 process/pathway	 the	 gene	 is	 involved	 in.	 For	 these,	 the	 genes	 were	







total	number	within	this	pathway	 i.e.	 the	number	of	genes	within	this	background,	 to	
give	the	percentage	of	pathway	included	within	the	dataset.	The	percentage	of	the	total	





The	 fold	 enrichment	 per	GO	 term	was	 visualized	 per	 strain	 for	 unique	 SNPs	 by	 each	
impact	 group	 using	 REVIGO	 software	 (Supek	 et	 al.,	 2011).	 The	 axes	 shown	 in	 the	
REVIGO	plots	are	irrelevant;	it	is	the	distance	between	these	GO	terms	which	shows	the	
relationship.	 The	 degree	 of	 uniqueness	 per	 GO	 term	 is	 determined	 by	 1-(average	
semantic	similarity)	over	a	 list	of	GO	terms.	GO	terms	are	collapsed	when	they	aren’t	
considered	 to	 be	 unique.	 Any	 terms	 with	 a	 greater	 than	 0.7	 degree	 similarity	 were	
collapsed	 into	 broader	 GO	 terms,	 and	 uniprot’s	 database	 was	 used	 to	 determine	
uniqueness	 between	 GO	 terms.	 Closely	 related	 pathways	 cluster	 and	 overlap	 each	
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other,	 a	 large	 distance	 between	 points	 demonstrates	 a	 great	 degree	 of	 uniqueness	
between	GO	terms.	Plotted	GO	terms	are	coloured	according	 to	 their	 log10	P	value.	P	
values	were	taken	from	the	bonferroni	adjusted	values	because	multiple	comparisons	




The	 GO	 terms	 are	 given	 a	 dispensability	 score,	 this	 uses	 the	 adjusted	 P-value	 and	
semantic	 similarity	 between	GO	 terms	 to	 determine	 how	 indispensible	 a	 GO	 term	 is,	
and	whether	 this	 can	be	 collapsed	 into	 a	 larger	GO	 category	 (Supek	 et	 al.,	 2011).	GO	
slims	 could	 also	 have	 been	 used	 as	 alternatives,	 however	 the	 broadness	 of	 these	








using	 VCFtools	 merge	 function.	 Non	 bi-allelic	 SNPs	 and	 conserved	 SNPs	 between	
samples	were	removed.	The	resulting	file	was	then	transformed	into	a	matrix	using	the	
snpgdsDiss	 function	 of	 the	 package,	 and	 subsequently	 snpHCluster,	 to	 generate	 z-









from	 B17	 and	 Z310	 mice	 infected	 as	 aforementioned	 did	 exhibit	 the	 symptoms	
previously	associated	with	these	strains.	Striking	characteristics	include	a	difference	in	
the	 level	 of	 parasitaemia,	 the	 prepatent	 period,	 and	 the	 symptoms	 exhibited	 by	 the	









Microscopy	 was	 used	 to	 ascertain	 the	 ratio	 of	 stumpy	 to	 slender	 forms	 in	 order	 to	
observe	 if	 there	 was	 a	 significant	 difference	 between	 the	 two	 isolates.	 Figure	 3.4	
demonstrates	that	there	is	a	significant	difference	in	terms	of	the	relative	abundance	of	
the	 two	 stages	 both	 during	 the	 infection	 and	 between	 the	 two	 isolates,	 which	 may	




Figure	 3.3	 shows	 the	 mean	 parasitaemia	 through	 days	 three	 to	 nine	 post	 infection,	
based	 on	 count	 data	 from	 daily	 tail	 snips.	 Z310	 infections	 have	 a	 short	 prepatent	
period,	 with	 the	 first	 peak	 in	 parasitaemia	 observed	 at	 day	 four,	 and	 a	 high	
parasitaemia	 from	day	 three.	 In	 contrast,	 B17	 infections	 do	not	 peak	until	 day	 seven	
post	infection,	and	the	parasitaemia	is	both	lower	than	the	Z310	peak,	and	falls	quicker	
post	 peak	 compared	 to	 the	 Z310	 infections.	 Both	 strains	 have	 the	 highest	 degree	 of	
variability	between	 individuals	at	day	 six,	 just	 as	 the	B17	 infection	parasitaemias	are	
entering	 into	 their	 first	 peak	 and	 the	 parasitaemia	 in	 Z310	 infections	 are	 lowering	






for	 each	 strain.	 Standard	 error	 bars	 show	 the	 degree	 of	 variation	 in	 the	 parasitaemia	 between	
individuals,	 which	 is	 greatest	 at	 day	 six	 post	 infection.	 Mean	 parasitaemia	 is	 shown	 for	 Z310	
infections	 in	 red	 and	B17	 infections	 in	 blue.	 The	 first	 peak	 of	 parasitaemia	 for	 B17	 infections	 is	
seen	at	day	seven,	and	for	Z310	infections		at	day	three.	The	peak	of	parasitaemia	is	higher	in	Z310	
infections,	 and	 occurs	 after	 a	 much	 shorter	 prepatent	 period,	 and	 takes	 longer	 to	 lower	 the	
parasitaemia	compared	to	B17	infections	post	the	first	peak	of	parasitaemia.		














































































number	of	mice	this	occurred	in	 is	shown	in	brackets.	Throughout	the	 infection	the	parasites	 in	the	Z310	 strain	are	primarily	slender	 forms,	a	stage,	which	 can	still	 proliferate	
unlike	 the	 non-dividing	 stumpy	 stage.	 This	 may	 account	 for	 the	much	 higher	 parasitic	 load	 compared	 to	 the	 B17	 strain,	 which	 primarily	 consists	 of	 stumpy	 stage	 parasites	
Following	a	great	decline	after	the	first	peak	of	parasitaemia	is	it	interesting	to	note	that	for	the	first	time	during	infection	the	percentage	of	stumpy	parasites	is	greater	than	that	of	








positive	 for	 parasites.	 	 The	mice	 in	 this	 experiment	 had	 to	 be	 sacrificed	 earlier	 than	
anticipated	 due	 to	 the	 sudden	 decline	 in	 the	 Z310	 infected	mice,	 so	 only	 three	 time	
points,	days	6,	8	and	9	post	infection	were	available	for	QPCR	analysis.	Sacrifice	prior	to	





Z310	 strains	 is	 suspected	 to	 be	 related	 to	 a	 difference	 in	 the	 ability	 of	 the	 parasites	
present	 to	 differentiate	 or	 the	 proportion	 of	 non-differentiating/non	 proliferative	
stages	 present,	 it	 is	 unsurprising	 that	 infections	 with	 the	 more	 acute	 isolate,	 Z310,	
contained	a	higher	percentage	of	proliferative	stage	parasites,	compared	to	B17.	These	
observations	 were	 also	 confirmed	 by	 the	 QPCR	 data	 	 (Table	 3.2).	 B17	 infections	
contained	 fewer	 highly	 proliferative	 stages,	 and	 caused	 a	 chronic	 infection	 in	 these	
mice.	
	
Trypanosomes	 differentiate	 into	 the	 stumpy	 form	 in	 response	 to	 population	 density	
(Reuner	et	al.,	 1997).	Table	3.2	 shows	 the	 level	of	 expression	of	PAD1	relative	 to	 the	
housekeeping	post-transcriptional	regulator,	TbZFP3.		B17	infected	patients	commonly	




	Due	 to	 the	 greater	 number	 of	 parasites,	 and	 the	 propensity	 of	 trypanosomes	 to	
differentiate	into	the	stumpy	form	in	response	to	population	density,	the	proportion	of	










Table	 3.2-	 This	 table	 shows	 the	 relative	 expression	 of	 PAD1	 compared	 to	 a	 housekeeping	 gene	
TbZFP3	 from	CT	 scores.	 	These	are	based	on	blood	 samples	 taken	at	days	6,8,9	post	 infection	as	
indicated,	and	the	values	represent	the	fold	increase	as	average	over	the	five	mice	infected	with	the	
same	strain.	As	suspected,	B17	has	a	much	higher	level	of	expression	compared	to	the	Z310	strain,	
with	 a	 104	 difference	 in	 fold	 increase	 during	 the	 first	 peak	 of	 parasitaemia	 for	 Z310	 (day	 6).		
Following	 the	 peak	 of	 parasitaemia,	 particularly	with	 such	 an	 acute	 isolate,	we	would	 expect	 an	
increase	in	the	relative	levels	of	PAD1	expression	as	the	parasites	differentiate	to	the	stumpy	form	





The	 3’	 UTR	 of	 PAD1,	 which	 is	 in	 the	 intergenic	 region	 between	 PAD1	 and	 PAD2	 is	
thought	to	control	the	expression	of	PAD1	(MacGregor	and	Matthews,	2012).	Given	that	
PAD1	is	differentially	expressed	in	B17	and	Z310,	this	would	suggest	that	perhaps	that	
this	 may	 be	 the	 reason	 for	 a	 difference	 in	 regulation	 between	 these	 two	 strains.	
However	 sequence	data	 for	 both	 of	 these	 two	 strains	 in	 the	 3’	UTR	of	 PAD1	 and	 the	
intergenic	region	between	PAD1	and	PAD2	contained	no	SNPs	and	had	a	100%	identity.	
This	 is	 unsurprising	 given	 the	 high	 percentage	 of	 similarity	 between	 T.	 brucei	
rhodesiense	strains.	This	is	consistent	with	the	theory	that	although	PAD1	is	present	on	
the	surface	of	stumpy	forms	and	not	slender	forms,	it	is	not	a	factor	important	for	the	






Sixteen	 samples	 were	 used	 in	 the	 second	 enrichment	 design,	 seven	 of	 which	 were	
strains	also	used	in	the	first	design.	These	were	mapped	using	BWA	aln	on	its	default	
settings	against	the	Tb927	reference	version	8.1.	Where	mentioned,	the	data	was	also	
mapped	 to	 the	DAL972	reference	version	8.1.	The	associated	metadata	 is	 included	 in	
Table	3.1	for	these	strains.	 	The	strains	used	in	both	designs	were	enriched	from	DNA	




	 Day	6	 Day	8	 Day	9	
Z310		 5.50e10	 9.64e10	 2.51e3	

















less	 than	 1ngμl-1	prior	 to	 amplification.	 In	 murine	 infections,	 the	 parasite	 DNA	 only	
represented	less	than	0.1%	of	the	sample	prior	to	enrichment,	in	a	parasitaemia	of	106	
parasites	ml-1.	The	pre-enrichment	percentage	 in	 the	human	 infections	 is	much	 lower	
than	 this,	 due	 to	 lower	 parasitaemia	 and	 increased	 host	 genome	 size.	 Despite	 only	 a	
small	percentage	of	reads	mapping	to	Tb927,	this	still	correlates	with	an	approximate	
100-fold	 enrichment.	 This	 shows	 that	 even	 very	 low	 parasitaemia	 samples	 are	
successfully	 enriched,	 however	 a	 higher	 depth	 of	 sequencing	 may	 be	 required	 to	
generate	 sufficient	 coverage	 for	 analysis.	 G7’s	 original	 concentration	 was	 less	 than	






Figure	3.4:	This	shows	the	mapping	percentages	 for	 the	strains	used	 in	both	enrichment	designs.	
With	the	second	design	including	all	the	of	the	strains	used	in	the	first	design.	The	percentages	of	
non-uniquely	mapped	 are	 shown	 in	 purple	 and	 red,	 uniquely	mapped	 in	 red,	 and	 unmapped	 in	
blue.	The	samples	derived	from	experimental	mouse	infections	(B,M,T,O,K,E,N),	which	were	used	in	
both	designs,	enriched	well,	but	more	uniformally	in	design	two	compared	to	design	one,	with	the	
exception	 of	 strain	 E.	 Samples	 from	 human	 infections	 had	much	 lower	 parasitaemias,	 and	 even	






SNP	 conservation	 between	 different	 groups	 of	 strains	 can	 be	 used	 to	 indicate	 the	
degree	 of	 overlap	 between	 strains.	 	 Only	 the	 strains	 used	 in	 both	 designs	 with	 an	
assigned	 zymodeme	 group	 were	 used	 in	 the	 subsequent	 analysis.	 Strain	 B,	 which	 is	
assigned	to	zymodeme	group	Z310,	and	strain	E,	which	is	assigned	to	zymodeme	group	



























































Figure	 3.5	 shows	 the	 degree	 of	 variation	 as	 determined	 by	 SNP	 diversity,	 between	
zymodeme	 groups.	 	 The	 strains	 shown	 in	 Figure	 3.5A	 and	 B	 are	 B,E	 and	 O	 and	
represent	zymodeme	groups	Z310,B17	and	Z366	respectively.			
	
When	 comparing	 just	 Z310	 and	B17	 strains,	 as	 discussed	 in	Chapter	2	 and	 shown	 in	




In	 a	 three-way	 comparison,	 a	 high	 percentage	 of	 SNPs	 were	 conserved	 in	 all	 three	
strains	 (62-75%),	 as	 shown	 in	 Figure	 3.5B.	 	 Despite	 a	 relatively	 equal	 proportion	 of	
SNPs	being	conserved	between	all	 three	strains,	 there	 is	a	higher	degree	of	similarity	
between	zymodeme	groups	Z310	and	B17	than	to	Z366.	This	is	reflected	in	the	lower	
percentage	 of	 SNPs	 unique	 to	 each	 strain,	 which	 was	 ~6%	 in	 both	 Z310	 and	 B17,	
compared	to	the	14.3%	of	unique	SNPs	in	strain	Z366.	The	overlap	between	Z310	and	
B17	 in	 the	 three-way	 comparison	 was	 also	 higher,	 with	 4,211	 SNPs	 conserved	 just	
between	 Z310	 and	 B17,	 in	 addition	 to	 the	 11,771	 SNPs	 conserved	 between	 all	 three	
strains.	 However	 there	 is	 a	 greater	 degree	 of	 overlap	 between	 Z310	 and	 Z366	 than	
Z366	and	B17,	with	only	258	SNPs	conserved	between	B17	and	Z366,	compared	to	the	
1,721	 conserved	 between	 Z310	 and	 Z366	 strains.	 Z366	 and	 Z310	 result	 in	 the	





























but	 a	 low	 percentage	 of	 uniqueness	 per	 strain	 (3-7%).	 The	 strain	 with	 the	 highest	
degree	of	uniqueness	is	strain	T	with	1,257	unique	SNPs	(6.7%),	and	less	overlap	with	
strain	B,	with	399	SNPs	shared,	and	strain	M,	with	457	SNPs	shared.	 	 In	 comparison,	
strains	B	and	M	share	1,291	SNPs	and	have	only	769	and	643	SNPs	unique	respectively.		
	








The	 SNPs	 conserved	 between	 all	 three	 strains	 within	 a	 zymodeme	 group	 could	 be	
considered	a	 core	genome	 for	 that	particular	group.	 SNPs	additional	 to	 this	 ‘core’	 set	
could	potentially	have	very	little	impact	on	the	virulence	of	the	strain,	as	there	is	a	high	
degree	 of	 similarity	 between	 all	 three	 zymodeme	 groups,	 and	 despite	 marked	
differences	in	disease	manifestation	between	zymodeme	groups,	there	aren’t	between	


































identical	 to	 those	 used	 in	 the	 intra-zymodeme	 comparison	 in	 Figure	 6.	 Zymodeme	
group	Z366	is	represented	by	only	one	strain,	strain	O.		Only	SNPs	conserved	within	the	
zymodeme	group	were	used	 for	 the	comparison.	As	was	seen	 in	Figure	3.4,	 there	 is	a	







68	 and	 81%	 in	 groups	 Z366,	 Z310	 and	 B17	 respectively.	 	 A	 large	 proportion	 of	 the	
remaining	SNPs	were	overlapped	between	B17	and	Z310,	with	1,862	SNPs	present	 in	
both	 of	 these,	 and	 1,784	 SNPs	 present	 in	 both	 Z310	 and	 Z366.	 Only	 247	 SNPs	were	
found	 in	 both	 Z366	 and	 B17.	 Despite	 to	 the	 comparison	 being	 derived	 from	 SNPs	






was	 from	 an	 acute	T.b.	gambiense	 infection,	 and	 so	we	would	 expect	 the	majority	 of	
these	SNP	differences	to	arise	because	all	of	 the	other	strains	belong	to	separate	sub-
species.	 	G7	was	only	used	in	the	second	design,	and	so	the	SNPs	used	for	comparison	
were	 only	 those	 found	 within	 the	 second	 design	 for	 all	 strains.	 A	 high	 degree	 of	
similarity	is	known	amongst	T.	brucei’s	three	subspecies,	and	so	it	is	unsurprising	that	
62%	 of	 G7’s	 SNPs	 were	 identical	 to	 those	 found	 in	 all	 the	 T.b.	 rhodesiense	 strains	
compared.	 	 In	 total	 there	were	 9,226	 SNPs	 conserved	 between	 G7	 and	 the	 7	 strains	
represented	 in	 these	 three	 zymodeme	 groups.	 G7	 did	 have	 a	 higher	 number	 of	 SNPs	
unique	compared	to	the	other	strains	as	expected,	with	2,638	SNPs	representing	17.6%	
of	 the	 total	 SNPs	 for	 that	 strain.	 	However	 this	 is	 comparable	 to	 the	number	of	 SNPs	
unique	 to	 strain	 O	 in	 the	 cross	 zymodeme	 comparison	 in	 Figure	 3.5A,	 and	 so	 this	
	 123	
demonstrates	 a	 level	 of	 variation	 across	 subspecies	 similar	 to	 that	 seen	 between	
zymodeme	groups.		
	
In	 this	 comparison,	 the	 number	 of	 SNPs	 unique	 to	 Z366	 is	 actually	 1,607	 SNPs	 and	
represents	 10.4%	 of	 the	 total	 SNPs	 called	 for	 that	 strain.	 The	 number	 of	 SNPs	
overlapping	 between	 Z366	 and	G7	 is	 substantially	 higher	 than	 seen	 between	G7	 and	





Figure	 3.8	 shows	 this	 variation	 between	 zymodeme	 groups	 using	 a	 rooted	 tree	
generating	using	R	package	SNPRelate.	The	SNPs	used	in	this	analysis	are	the	same	as	
those	 used	 in	 Figure	 3.7.	 SNPs	 were	 taken	 from	 both	 designs	 for	 the	 seven	 strains	
assigned	 zymodeme	 groups.	 As	 evident	 from	 Figures	 3.5-7,	 there	 is	 a	 high	 degree	 of	
similarity	between	all	seven	of	these	strains,	and	conserved	SNPs	between	strains	are	






seen	 by	 the	 branching	 of	 strain	 O	 separate	 to	 the	 remaining	T.b.	rhodesiense	 strains.	

























both	 designs	 for	 the	 7	 strains	 used	 in	 both	 designs.	 Due	 to	 the	 high	 degree	 of	 conserved	 SNPs	
between	strains,	which	are	redundant	in	generating	a	phylogeny,	very	few	SNPs	are	unique	to	each	
strain,	and	inferring	a	relationship	from	less	than	a	thousand	SNPs	over	seven	strains	is	ill	advised.	
This	 could	 be	 resolved	 if	WGS	 data	 was	 available	 for	 all	 of	 the	 seven	 strains.	 As	 is	 observed	 in	
Figure	3.4	and	3.6,	zymodeme	groups	B17	and	Z310	have	a	higher	degree	of	similarity	compared	to	
the	Z366	strain,	strain	O.	This	is	seen	above.	Strains	K	and	E,	and	strains	B	and	M	also	cluster,	which	






13,044	 SNPs	 were	 shared	 between	 all	 Z310	 and	 B17	 strains.	 However	 the	 genetic	
differences	 resulting	 in	 this	 difference	 in	 phenotype	 should	 be	 in	 the	 SNPs	 not	
conserved	to	both	group,	and	so	Figure	3.9	shows	the	number	of	SNPs	unique	to	each	
zymodeme	 group	 per	 chromosome.	 Actual	 SNP	 counts	 are	 shown	 in	 bold	 in	 each	


























































diverse	 and	 so	 less	 SNPs	 are	 conserved	between	 strains.	 In	 comparison,	 there	 is	 less	




differences	 in	 zygosity	 can	 be	 observed.	 	 Large	 deviations	 in	 this	 ratio	 are	 seen	 on	
chromosome	 5,6	 and	 8.	 In	 chromosome	 5,	 35%	 of	 the	 SNPs	 unique	 to	 B17	 are	
heterozygous,	 compared	 to	75%	 in	Z310.	 Similarly	 in	 chromosome	6,	 14%	of	 unique	
SNPs	were	 heterozygous	 compared	 to	 42%	 in	 Z310.	 However	 in	 chromosome	 8,	 the	
heterozygotes	 found	 in	B17	greatly	outnumber	 those	 in	Z310,	and	here	 is	 the	 largest	






























































































In	 order	 to	 ascertain	whether	 the	 genes	with	 these	 unique	 SNPs	 are	 under	 selective	





























Figure	 3.10:	 Shows	 the	 number	 of	 frequency	 of	 SNPs	 within	 genes	 with	 SNPs	 unique	 to	 each	
zymodeme	group.	 SNPs	 from	Z310	are	 shown	 in	blue,	B17	 in	 red.	B17	had	 less	unique	SNPs,	but	




The	genes	with	 the	highest	number	of	unique	SNPs	are	 shown	 in	Table	3.3.	Only	 the	
genes	with	the	five	highest	unique	SNP	frequencies	are	included.	 	In	Z310,	all	of	these	
genes	include	greater	than	35	unique	SNPs,	whereas	the	gene	with	the	highest	number	
of	unique	SNPs	 in	B17	has	26.	The	majority	of	 these	genes	have	no	assigned	 function	
and	so	it	is	hard	to	predict	the	potential	effect.	The	genes	with	the	highest	frequency	of	
SNPs	in	both	zymodeme	groups	are	both	hypothetical.	In	each	zymodeme	group,	there	





















are	 a	 high	 number	 of	 SNPs	 in	 a	 leucine	 rich	 repeat	 protein	 (LRRP)	 and	 these	 are	
important	in	the	facilitation	of	protein-protein	interactions	and	are	commonly	present	
at	 expression	 sites.	 However	 Z310	 also	 has	 50	 SNPs	 present	 in	 the	 transmembrane	
component	 of	 a	 ferric	 reductase,	 and	 iron	 transport	 has	 previously	 been	 studied	 in	
trypanosoma	 and	 other	 species	 in	 relation	 to	 its	 importance	 in	 virulence.	 Iron	 is	








subsequent	 down-regulation	 of	 pathways	 and	 effect	 virulence.	 	 Interestingly,	 a	 high	
proportion	of	the	genes	containing	the	greatest	number	of	SNPs	in	B17	are	located	on	










Chromosome	 Gene	ID	 Function	 Number	of	
SNPs	





2	 Tb927.2.1380	 LRRP		 46	
7	 Tb927.7.5220	 Protein	kinase	 39	
5	 Tb927.5.2510	 Hypothetical	protein	 37	
B17	 8	 Tb927.8.2390	 29	
3	 Tb927.3.580	 LRRP		 26	
















SNPs	 that	 are	 conserved	between	zymodeme	groups	 indicate	 that	 these	are	part	of	 a	
“core”	 rhodesiense	 genome,	 rather	 than	 responsible	 for	 the	 differences	 in	 clinical	
manifestation.	T.b.	rhodesiense	 is	often	considered	a	host	variant	of	T.	brucei,	with	 the	
transfection	of	T.	brucei	strains	with	SRA	enough	to	confer	resistance	to	human	serum	
(Xong	 et	 al.,	 1998).	 All	 three	 subspecies	 of	 T.	 brucei	 are	 closely	 related	 however	
T.b.brucei	 and	 T.b.	 rhodesiense	are	 more	 closely	 related	 than	 T.b.	 rhodesiense	 to	 T.b.	
gambiense.	Due	 to	 the	 accumulation	of	 random	mutations	 following	T.b.	rhodesiense’s	
divergence	 from	 T.b.	 brucei,	 although	 these	 SNPs	 may	 form	 a	 “core”	 rhodesiense	
genome,	the	majority	of	these	SNPs	are	unlikely	to	have	a	functional	impact.		
	
In	 Figure	3.11A,	 the	 ratio	 of	 heterozygous	 to	 homozygous	 SNPs,	 and	 their	 associated	
counts	 per	 chromosome	 are	 shown	 for	 SNPs	 conserved	 in	 all	 Z310	 and	 B17	 strains.	
Their	chromosomal	location	is	shown	in	Figure	3.11B.	As	seen	in	Figure	3.11A,	there	is	
little	variation	in	the	zygosity	ratio	of	the	SNPs	conserved,	although	there	is	a	greatest	
relative	 number	 of	 heterozygotes	 in	 chromosomes	 8,	 9	 and	 10.	 These	 chromosomes	







Figure	 3.11:	 A	 and	B	 both	 show	 the	 SNPs	 conserved	between	both	 the	B17	 and	 Z310	 zymodeme	
groups	 in	 all	 strains.	 A	 shows	 the	 heterozygote	 to	 homozygote	 ratio	 per	 chromosome,	 and	 the	






In	 Figure	 3.11B,	 it	 is	 evident	 that	 SNPs	 are	 being	 conserved	 genome-wide	within	 all	
these	 rhodesiense	 isolates.	Due	 to	 this,	 and	 the	 high	 degree	 of	 similarity	 between	 all	
three	 subspecies	 of	 T.	 brucei,	 small	 changes	 are	 likely	 to	 be	 responsible	 for	 this	
phenotypic	disparity.	 	 In	Figure	3.12A-C,	 the	chromosomal	 location	of	SNPs	unique	to	
one	 zymodeme	 group	 are	 shown,	 in	 order	 to	 determine	 regions	 dense	 with	 unique	
SNPs.			






































































SNPs	unique	 to	each	set	of	 strains	are	shown	 in	Figure	3.12A.	Those	SNPs	present	 in	
only	B17	strains	are	shown	in	blue,	those	in	Z310	only	shown	in	red.	Due	to	a	greater	
number	of	unique	SNPs	in	Z310,	these	unique	SNPs	are	spread	evenly	throughout	the	
genome,	 however	 the	 SNPs	 unique	 to	 B17	 are	more	 restricted	 to	 specific	 regions.	 In	
particular,	there	is	a	high	density	of	SNPs	unique	to	B17	on	chromosome	8.		Clusters	of	
unique	SNPs	in	B17	are	also	present	on	the	end	of	chromosome	3	and	chromosome	2.		







the	 genome,	 but	 these	 don’t	 form	 dense	 regions	 of	 SNPs	 like	 those	 observed	 in	
chromosome	 8.	 	 The	 occurrence	 of	 low	 density	 additional	 unique	 SNPs	 dispersed	
throughout	the	genome	can	be	accounted	for	by	individual	strain	diversity.		
	
Strain	O	 is	 used	 in	 Figure	 3.12C	 for	 three-way	 zymodeme	 comparison.	As	 previously	
discussed,	 Strain	 O	 has	 a	 greater	 number	 of	 unique	 SNPs,	 and	 appears	 to	 be	 more	


























































































































DAL972	 version	 8.1	 alongside	 gambiense	 strain	 G7.	 SNPs	 found	 for	 each	 strain	 from	





SNPs	 expected	 along	 chromosome	 8.	 In	 comparison	 to	 the	 number	 of	 SNPs	 seen	 in	
Figure	 3.13,	 there	 are	 significantly	 fewer	 SNPs	 in	 chromosome	 8	 for	 all	 three	














In	 order	 to	 appreciate	 the	 functional	 effect	 of	 these	 SNPs	 they	were	 annotated	 using	
SNPeff	 and	 SNPsift.	 This	 was	 first	 used	 to	 ascertain	 whether	 the	 SNPs	 were	
synonymous	or	non-synonymous	and	whether	 the	non-synonymous	SNPs	were	 likely	
to	have	a	deleterious	effect.	These	SNPs	were	then	divided	 into	4	 impact	groups,	 low,	
moderate,	modifier	and	high.	Synonymous	variants	were	considered	to	be	low	impact	
because	they	won’t	change	the	protein	product.	SNPS	considered	moderate	were	those	
that	 were	 unlikely	 to	 significantly	 change	 the	 protein	 produced,	 but	 might	 alter	 its	
















interactions	 for	 instance	with	 other	 proteins.	 Examples	 of	moderate	 impacts	 include	
mutations	causing	missense	variants,	or	deletions	that	do	not	alter	the	reading	frame.	
Variants	 labeled	modifiers	were	 generally	 restricted	 to	non-coding	 regions,	 and	have	
an	impact	on	regulatory	regions	such	as	un-translated	regions	(UTRs).	The	SNPs	with	











Figure	 3.14A-C	 shows	 the	 percentage	 of	 SNPs	 annotated	 as	 described	 above.	 The	
combination	of	strains	used	to	generate	the	SNP	set	are	shown	on	the	left	hand	side	of	
the	figure.	The	first	two	bars	represent	the	SNPs	that	are	unique	to	 just	these	strains.	
The	 following	 bars	 represent	 the	 SNPs	 unique	 to	 an	 individual	 zymodeme	 group,	 for	
Z310	and	B17	 this	 includes	all	 three	 strains,	 for	Z366	 this	 includes	 just	 strain	O.	The	
SNPs	 shared	 between	 zymodeme	 groups	 B17	 and	 Z310	 and	 between	 all	 three	
zymodeme	groups	are	also	shown.		
	




SNPs	 annotated	 across	 strains.	 This	was	 followed	by	 the	moderate	 impact	 SNPs,	 and	
lastly	by	high	impact	SNPs.	High	impact	SNPs	are	shown	on	the	Figure	3.14A,	however	
they	 represent	 such	 a	 small	 proportion	 of	 the	 SNPs	 identified,	 that	 they	 are	 not	
apparent.		
	
In	 Figure	3.14B,	 it	 appears	 that	 the	 ratio	 of	missense,	 nonsense	 and	 silent	mutations	




slightly,	 and	 have	 an	 increased	 number	 of	 missense	 mutations,	 with	 approximately	
50%	missense,	and	a	greater	number	of	nonsense	mutations,	particularly	in	Z366.	
Individual	 SNP	 types	 are	 shown	 in	 Figure	 3.14C	 and	 were	 predominantly	 from	
regulatory	 regions	 causing	 downstream	 and	 upstream	 effects	 across	 all	 strain	
combinations.	 These	 accounted	 for	 approximately	 80%	 of	 the	 SNPs	 annotated.	 	 The	
majority	 of	 the	 other	 SNPs	were	 predicted	 to	 have	 an	 effect	 in	 an	 intergenic	 region,	




data	 and	 so	 aren’t	 evident	 in	Figure	3.14C,	 these	were	 the	 stop	 lost/gained	and	 start	
lost	 events.	 Figures	 3.14A-C	 demonstrate	 no	 significant	 deviations	 in	 the	 SNP	 effects	





In	 order	 to	 determine	 whether	 more	 deleterious	 SNPs	 were	 clustering	 at	 certain	
regions	 of	 the	 genome,	 the	 different	 SNP	 effect	 groups,	 low,	moderate,	 modifier	 and	
high,	 were	 plotted	 for	 strain	 B,	 E	 and	 O	 to	 represent	 groups	 Z310,	 B17	 and	 Z366	
respectively	in	Figure	3.15.	As	before,	the	SNPs	plotted	are	those	unique	to	that	strain.	
Figure	3.15A	contains	SNPs	unique	to	strain	B,	and	all	low,	high	and	modifying	SNPs	are	






strain	 O	 are	 not	 particularly	 clustered	 by	 effect,	 and	 are	 shown	 in	 Figure	 3.15C.	 	 In	
contrast,	 strain	 E	 SNPs	which	 are	 shown	 in	 Figure	 3.15B,	 consist	 of	 fewer	moderate	







































































Figure	 3.15:	 A-C	 show	 the	 localisation	 of	 the	 four	 different	 SNP	 effect	 groups,	 low,	 moderate,	



























































































Fewer	high	 impact	SNPs	were	unique	 to	an	 individual	 strain	or	 zymodeme	group	 than	
were	conserved	across	zymodeme	groups.	No	high	impact	SNPs	were	seen	across	all	B17	




Tb927.10.16400	 is	 in	 a	 different	 position	 to	 that	 shown	 conserved	 between	 all	 seven	 strains.	
**There	are	also	two	high	impact	SNPs	within	gene	Tb927.10.1110,	both	have	stop	gained	effects.	


































































these	 were	 at	 different	 positions.	 Similarly	 gene	 Tb927.10.16400	 contained	 a	 high	
impact	 SNP	 unique	 to	 the	 Z310	 strains	 in	 addition	 to	 the	 one	 conserved	 between	 all	
rhodesiense	strains	seen	in	Table	3.4.	When	looking	at	SNPs	unique	to	one	strain,	strain	
B	has	 fewer	high	 impact	SNPs,	with	 two	 in	hypothetical	proteins,	 compared	 to	 the	 five	
seen	in	strain	E,	three	of	which	are	also	hypothetical	proteins.		
	
Compared	 to	 the	 SNPs	 conserved	 between	 all	T.b.	rhodesiense	 strains,	 which	 allude	 to	
differences	 which	 might	 define	 differences	 in	 virulence	 between	 T.	brucei	 subspecies,	
SNPs	specific	to	particular	rhodesiense	strains	can	elucidate	the	phenotypic	differences	










(Garcia-Salcedo	 et	 al.,	 2004).	 Procyclic	 forms	 do	 undergo	 gross	 malformations	 in	 the	






strain.	 The	 effect	 of	 this	mutation	on	 stumpy	 forms	may	be	 similar	 to	 that	 seen	 in	 the	
procyclics,	 and	 this	 indicates	 that	 perhaps	 Z366	 virulence	 is	 determined	 by	 stumpy	
forms	predominating	the	infection,	as	was	seen	in	B17	strains.		
	
Bloodstream	 forms	 of	 T.	 brucei	 cannot	 synthesize	 sterols	 de	 novo,	 whereas	 procyclic	
forms	 can	 (Coppens	 and	 Courtoy,	 2000).	 Lathosterol	 oxidase	 is	 involved	 in	 sterol	




bloodstream	 forms,	 it	 may	 impact	 on	 the	 insect	 stages	 that	 the	 bloodstream	 forms	
differentiate	into,	affecting	infectivity	(Pérez-Moreno	et	al.,	2012).	There	is	no	available	
microscopy	and	QPCR	data	for	Z366,	and	so	the	relative	bloodstream	form	abundances	




wide	 variety	 of	 cellular	 mechanisms	 (Al-Khodor	 et	 al.,	 2010).	 Despite	 the	 unknown	







leads	 to	an	 increase	 in	arginase	activity,	which	 is	required	 for	colonization	and	growth	
during	 the	 acute	 stages	 of	 infection	 (Beschin	 et	 al.,	 2014)	Kinesins	 are	 known	 to	 have	
functions	in	multiple	pathways	however	many	of	the	kinetoplastid	specific	kinesins	have	
not	 been	 characterized,	 although	 one	 has	 been	 found	 involved	 in	 the	 maintenance	 of	
normal	cell	morphology	and	cytokinesis	(Hu	et	al.,	2012).		Z366	also	has	a	mutation	in	a	
condensin	gene,	and	these	are	responsible	for	the	structural	integrity	and	organization	of	
chromosomes,	 suggesting	 mutations	 in	 multiple	 genes	 involved	 in	 the	 structural	
integrity	of	the	parasite	(Hirano,	2012).			
	
However	 strain	 E	 also	 has	 high	 impact	 mutations	 within	 key	 genes.	 Both	 eukaryotic	














genes	 related	 to	 particular	 pathways	were	 enriched	 for.	 Due	 to	 the	 neutral	model	 of	
evolution,	 the	 majority	 of	 the	 SNPs	 accrued	 are	 most	 likely	 to	 be	 from	 multiple	




the	 P	 value	 assigned,	 the	 larger	 the	 circle.	 The	 least	 unique	 GO	 terms	 have	 been	
collapsed	into	single	GO	terms.		The	relative	distance	between	the	GO	terms	reflects	the	
degree	 of	 similarity	 between	 GO	 terms.	 The	 greatest	 number	 of	 GO	 terms	 were	
assigned	 to	 modified	 and	 low	 effect	 groups.	 This	 analysis	 can	 be	 used	 to	 look	 at	









together.	 However	 the	 most	 enriched	 GO	 term	 was	 autophagy,	 which	 is	 interesting	
because	 an	 increase	 in	 autophagic	 activity	 has	 been	 linked	 to	 differentiation	 of	 the	
parasite	 during	 high	 parasite	 densities,	 and	 this	 strain’s	 infections	 are	 dominated	 by	






Figure	 3.16B.	 In	 the	 uppermost	 left	 of	 the	 plot,	multiple	GO	 terms	 are	 collapsed	 into	
protein	 localization,	 with	 approximately	 a	 third	 of	 the	 GO	 terms	 from	 this	 category	
associated.	 In	 strain	 E,	 the	 non-proliferative	 stages	 dominate	 infection,	 and	multiple	









is	 involved	 in	 the	conversion	of	excess	glucose	(Uzcategui	et	al.,	2004;	Vertommen	et	
al.,	2008).	Rapidly	dividing	forms	will	consume	more	glucose,	and	so	an	upregulation	in	
this	 pathway	 could	 suggests	 there	 is	 a	 greater	 number	 of	 non-proliferative	 forms	
present	 in	 the	 infection.	 As	 seen	 in	 Figure	 3.16C,	 genes	 from	 a	 wider	 variety	 of	
pathways	contain	modified	SNPs	compared	 to	 strains	B	and	E,	however	pathways	do	




Modifying	 effects	 were	 the	 most	 abundant	 SNP	 impact	 group,	 and	 cause	 regulatory	
effects.	GO	terms	for	various	pathways	were	enriched,	showing	which	pathways	these	
modifying	 effects	 are	 impacting.	 Despite	 differences	 between	 each	 strain,	 similar	
pathways	 were	 enriched	 across	 strains	 including	 post	 translational	 protein	
modification	GTPase	activity	and	vesicle	transport.	Although	not	excessively	enriched,	
with	 no	 pathway	 with	 a	 greater	 than	 five	 fold	 enrichment,	 many	 of	 these	 pathways	





There	 were	 fewer	 SNPs	 annotated	 moderate,	 and	 the	 genes	 containing	 these	 were	
assigned	to	24,50	and	9	GO	terms	 in	strains	B,E	and	O	respectively	and	are	shown	 in	








terms	 have	 few	 genes	 allocated	 to	 them.	 However	 pyrimidine	 and	 pseudouridine	
biosynthesis	is	highly	enriched.	Bloodstream	forms	can	synthesize	pyrimidines	de	novo,	
however	they	are	also	capable	of	salvaging	from	exogenous	pyrimidine	sources,	making	
them	more	reliant	on	the	host	(Ali	et	al.,	2013b).	Lack	of	pyrimidines	 is	 lethal	 for	 the	
parasite,	 but	 parasites	 can	 maintain	 an	 infection	 just	 through	 salvage.	 However	
parasites	 incapable	 of	 de	 novo	 synthesis	 have	 been	 shown	 to	 be	 less	 infective	 to	
mammalian	 hosts	 (Ali	 et	 al.,	 2013b)	 .	 Uracil	 uptake	 was	 also	 upregulated	 in	 these	
pyrimidine	 starved	 parasites,	 and	 interestingly	 synthesis	 of	 the	 glycosylated	 isomer,	
uradine,	is	upregulated	in	this	strain	(Ali	et	al.,	2013a).	Z310	strains,	such	as	strain	B	do	
cause	chronic	symptoms,	and	the	long	slenders,	which	predominate	in	infections	with	




In	 strain	E,	 as	 shown	 in	Figure	3.16E,	and	seen	 in	Figure	3.16B,	 the	genes	containing	
these	 SNPs	 cluster,	 with	 enrichment	 seen	 particularly	 in	 lipid	 metabolism,	
macromolecule	 localization,	 and	 in	 particular	 lipid	 transport.	 T.	 brucei	 is	 capable	 of	
synthesizing	its	lipids	de	novo,	however	due	to	the	high	demand	for	glycolipids	for	the	
VSG	coat	in	bloodstream	forms,	T.	brucei	may	scavenge	from	it’s	host	when	these	lipid	
resources	 are	 low,	 and	 the	 parasites	 are	 rapidly	 proliferating	 (van	 Hellemond	 and	
Tielens,	 2006).	 In	 strains	 E,	 non-proliferative	 forms	 are	 more	 abundant,	 and	 so	 the	
parasite	may	be	able	to	facilitate	more	of	its	own	lipid	metabolism.		
	
Transcription	 from	 the	 RNA	 polymerase	 II	 promoter	 is	 also	 enriched,	 and	 this	 is	
complex	mechanism	in	T.	brucei,	partly	due	to	the	trans-splicing	nature	of	the	genome	
(Das	 et	 al.,	 2008).	 However	 again,	 the	 importance	 of	 this	 enrichment	 may	 be	
overestimated	due	to	few	genes	being	assigned	to	this	GO	term.		
	
Fewer	 genes	 caused	 moderate	 effects	 in	 strain	 O,	 as	 is	 evident	 from	 Figure	 3.16F.	
However	the	pathways	that	are	affected	by	these	SNPs	do	cluster.	As	is	seen	with	strain	
B,	 pseudouridine	 synthesis	 is	 potentially	 impacted	 by	 the	 SNPs	 present	within	 these	
genes.	However	the	most	enriched	GO	terms	were	cytoskeleton,	microtubule	and	golgi	
vesicle	transport.	This	is	anticipated	from	the	earlier	analysis	in	which	this	strain	had	






















This	 category	 has	 the	 greatest	 number	 of	 GO	 terms	 associated,	 with	 33,	 66,31	 for	
strains	B,E,	and	O	respectively.	However	the	pathways	affected	by	SNPs	in	this	category	
are	of	 the	 least	 importance,	 because	 the	majority	of	 the	 SNPs	 contained	within	 these	
genes	 are	 non-deleterious.	 However	 it	 is	 interesting	 to	 note	 that	 as	 before,	more	 GO	
terms	cluster	 in	strains	E	and	O	compare	 to	strain	B.	The	majority	of	 these	GO	 terms	
relate	 to	 general	 house	 keeping	 metabolic	 functions,	 such	 as	 lipid	 and	 protein	
metabolism	 and	 pyrimidine	 biosynthesis.	 Neurotransmitter	 and	 cell-to-cell	 signaling,	
as	 shown	 in	 Figure	 3.17A	 refers	 to	 a	 mutation	 in	 syntaxin,	 which	 is	 important	 for	





Figure	 3.17D-E	 show	 the	 GO	 term	 associated	 with	 high	 impact	 SNPs	 in	 strains	 E,	 in	
Figure	3.17D,	 and	 strain	O	 in	Figure	3.17E.	This	 is	because	 there	were	only	 two	high	
impact	 SNPs	 in	 B,	 and	 these	 couldn’t	 be	 assigned	 a	 GO	 term	 because	 they	 had	 no	
functional	 annotation,	 see	Table	3.4.	 For	both	of	 these	 strains,	 the	GO	 terms	were	 all	
primarily	related	to	cell	cycle	control	and	DNA	replication,	both	of	which	are	important	
for	 differentiation.	 The	 differences	 in	 life	 stage	 abundance	 and	 severity	 of	 disease	
between	 zymodeme	 groups	 do	 suggest	 differentiation	 impacting	 on	 virulence,	 and	





As	 previously	 discussed,	 virulence	 has	 been	 defined	 in	 trypanosomes	 in	 a	 variety	 of	
ways,	 however	 little	 attention	 has	 been	 given	 to	 the	 genes	 causing	 these	 phenotypic	
changes	 (Morrison,	 2011).	 Beneath	 are	 three	 genes,	 which	 are	 implicated	 in	 the	
progression	 of	 a	T.	brucei	 infection,	 and	 their	 function.	 Included	within	 the	 sequence	
capture	 design	were	 two	 genes	 known	 to	 be	 important	 virulence	 factors,	 these	were	
the	haptoglobin	haemoglobin	receptor	(HpHbr)	and	oligopeptidase	B.	The	HpHbr	gene	





The	 resistance	 of	T.b.	gambiense	 and	T.b.	rhodesiense	 parasites	 to	 lysis	 by	 the	 host	 is	
done	through	two	different	mechanisms.	T.b.	rhodesiense’s	resistance	strategy	is	better	
understood,	 and	 is	 facilitated	 by	 a	 gene	 specific	 to	T.b.	rhodesiense	strains,	 the	 serum	
resistance	 associated	 protein	 (SRA)	 (Njiru	 et	 al.,	 2004).	 In	 T.b.	 gambiense,	 lysis	 is	
averted	by	altering	the	activity	of	 the	haptoglobin	haemoglobin	receptor.	 Initially	this	
was	thought	to	be	across	all	gambiense	isolates,	however	as	shown	in	2012	by	Symula	




In	susceptible	 trypanosomes,	a	complex	called	 the	 trypanosome	 lysis	 factor	1	(TLF1),	
containing	 the	haptoglobin	 related	protein	 (Hpr)	 and	 the	 lipoprotein,	APOL1,	bind	 to	
the	 surface	 of	 the	 HpHbr	 protein	 and	 are	 internalized	 (Symula	 et	 al.,	 2012).	 	 This	
internalization	 causes	 cell	 death.	 Due	 to	 its	 importance	 in	 resistance,	 this	 gene	 was	
included	in	the	panel	of	genes	used	in	the	target	enrichment	design.		
	
In	 the	haptoglobin	haemoglobin	 receptor,	 there	were	eighteen	SNPs,	 seven	unique	 to	
strain	 B,	 one	 to	 strain	 E,	 ten	 conserved	 between	 both	 zymodeme	 groups.	 The	 SNPs	
unique	 to	 strain	 B	 were	 in	 a	 non-coding	 region	 downstream	 in	 the	 gene,	 and	 had	 a	
modifying	effect.	Strain	E	had	one	unique	SNP,	and	this	was	also	in	a	non-coding	region	






brucei	but	also	 in	Leishmania	 and	T.evansi	(Morty	et	al.,	1999;	2005).	It	 is	 responsible	
for	the	hormonal	downregulation	seen	in	these	infections,	by	lysing	lysine	and	arginine	
peptides	(Kangethe	et	al.,	2012).	As	a	byproduct	of	parasite	death	from	lysis,	multiple	
immunogenic	 products	 are	 released	 into	 the	 host’s	 blood	 and	 lymphatic	 system	
(Kangethe	 et	 al.,	 2012).	 These	 include	 a	 variety	 of	 lipids	 and	 also	 enzymes	 such	 as	
peptidases,	and	lead	to	the	variety	of	symptoms	associated	with	trypanosomiasis.	One	
perpetrator	 in	 this	process	 is	oligopeptidase	B.	 In	particular	 this	has	been	associated	















Cathepsin	 B	 and	 cathepsin	 L,	 also	 known	 as	 brucipain,	 are	 both	 cysteine	 proteases,	
which	 have	 been	 associated	 with	 helping	 to	 establish	 T.	brucei	 infections	 within	 the	




studies	 since	 have	 shown	 knockdown	 of	 cathepsin	 B	 clears	 infection,	 however	
knockdown	of	cathepsin	L	(brucipain)	prolongs	the	lifespan	of	the	infected	mouse,	but	
does	not	clear	the	infection	(Abdulla	et	al.,	2008).	It	has	been	suggested	that	brucipain’s	
function	 is	 to	 aid	 the	 passing	 of	 the	 parasite	 through	 the	 blood-brain	 barrier,	 and	
initiate	the	late	stage	of	the	disease	(Abdulla	et	al.,	2008;	Nikolskaia	et	al.,	2006).	
	
This	gene	was	not	 included	within	 the	 target	 regions,	however	because	 there	 is	WGS	
data	available	for	strains	B	and	E,	mutations	within	this	gene	could	be	observed.	Within	
the	WGS	data,	nine	SNPs	were	conserved	between	B17	(strain	E)	and	Z310	(strain	B),	











both	 traditional	 parasitology	 techniques	 and	 sequence	 data	 in	 order	 to	 try	 and	
elucidate	 mechanistic	 differences	 causing	 the	 difference	 in	 phenotype	 observed	 in	
zymodeme	 groups	B17	 and	 Z310.	As	 previously	 discussed,	 the	 relative	 abundance	 of	
the	short	stumpy	and	long	slender	bloodstream	forms	is	thought	to	be	a	key	factor	in	
determining	 the	 outcome	 of	 an	 infection.	 Short	 stumpy	 forms	 elicit	 a	 stronger	 host	
immune	response	due	to	 the	older	stumpy	 forms	heading	 towards	apoptosis,	and	the	
immunogenic	 compounds	 they	 release	 into	 the	 host	 bloodstream/lymphatic	 system	
upon	 cell	 death.	 However,	 long	 slender	 stages	 are	 highly	 proliferative	 and	 a	 highly	
proliferative	 population,	 such	 as	 those	 observed	 in	 Z310	 infections,	 can	 increase	 the	
burden	on	the	host.	
	
Due	 to	 the	 differences	 in	 parasitaemia	 throughout	 the	 course	 of	 infection	with	 these	
strains,	 and	 the	 associated	 host	 symptoms,	 a	 difference	 in	 the	 abundance	 of	 the	




predominant	 in	 the	 Z310	 strain,	 which	 caused	 a	 very	 acute	 infection	 in	 mice,	 and	
caused	 the	 culling	 of	 individuals	 prior	 to	 schedule,	 suggesting	 a	 higher	 abundance	 of	
slender	stage	parasites	correlates	with	a	more	virulent	infection.	The	stage	abundance	
observed	 in	 microscopy	 data	 was	 confirmed	 using	 qPCR,	 by	 monitoring	 PAD1	
concentrations.	Mutations	 in	 the	PAD1-PAD2	 intergenic	 region	were	 ruled	out	 as	 the	
cause	of	differential	expression	of	PAD1	in	these	strains.		
	
This	 phenotypic	 analysis	 alongside	 the	 metabolomics	 work	 shown	 in	 Chapter	 4	
suggests	 that	 the	 basis	 of	 virulence	 based	 on	 the	 presence	 of	 absence	 of	 a	 chancre	
perhaps	 isn’t	 the	 most	 accurate	 way	 of	 determining	 the	 virulence	 of	 the	 strain.	 In	









enrichment	 was	 seen	 within	 these	 samples,	 however	 due	 to	 the	 original	 low	
parasitaemia,	 the	 number	 of	 parasite	 reads	 within	 the	 sample	 were	 still	 very	 low.	
However	 strain	 G7,	 which	 had	 a	 high	 parasitaemia	 but	 had	 a	 starting	 DNA	
concentration	of	10ngμl-1	was	enriched	successfully,	demonstrating	 the	percentage	of	
the	 total	 DNA	 the	 parasite	 represents,	 not	 the	 DNA	 concentration,	 determines	 the	
success	 of	 the	 sample.	 If	 sequencing	 from	 samples	 with	 very	 low	 parasitaemias,	
successful	 enrichment	 and	 the	 necessary	 amount	 of	 data	 could	 be	 achieved	 through	
deeper	sequencing.		
	
Analysis	 between	 all	 seven	 T.b.	 rhodesiense	 strains	 used	 showed	 a	 high	 degree	
similarity	between	all	strains,	as	expected.	It	also	suggested	a	relatively	uniform	degree	
of	strain	uniqueness,	suggesting	a	“core	rhodesiense	genome”.	Analysis	of	SNPs	unique	





Visualising	 the	 unique	 SNPs	 showed	 clusters	 of	 SNPs	 on	 chromosome	 8,	 however	
mapping	to	the	DAL972	gambiense	reference	showed	a	great	reduction	in	the	number	
of	 SNPs.	 The	 most	 significant	 reduction	 was	 seen	 in	 strain	 B,	 which	 belongs	 to	
zymodeme	 group	 Z310,	 the	 more	 chronic	 of	 the	 zymodeme	 groups,	 suggesting	 a	




fourteen	 genes	 with	 high	 impact	 SNPs	 were	 conserved	 between	 all	 T.b.	 rhodesiense	
strains,	 implicating	 these	 were	 important	 in	 defining	 the	 “core”	 phenotype	 of	 T.b.	
rhodesiense	 strains.	 GO	 term	 analysis	 and	 functional	 annotation	 showed	 several	
pathways	potentially	differentially	regulated	between	the	two	zymodeme	groups	which	
could	 be	 underlying	 causes	 to	 the	 phenotypic	 difference	 seen.	 In	 particular	 vesicle	
transport	was	highly	 enriched.	 Several	GO	 terms	 suggested	other	potential	 pathways	
responsible,	 including	 differences	 in	 pyrmidine	 biosynthesis,	 which	 is	 essential	 for	
growth,	and	had	mutations	 in	genes	within	 this	pathway	 in	strain	B,	which	contained	



































































strains	 from	 the	 zymodeme	 group	 B17	 are	 considered	 more	 virulent	 because	 they	
cause	 a	 chancre	 around	 the	 bite	 site,	 and	 often	 patients	 infected	 with	 these	 strains	
present	with	a	more	acute	infection	which	progress	to	the	secondary	stage	far	quicker.	
In	comparison,	strains	from	the	Z310	zymodeme	group	are	considered	here	to	be	less	
virulent	 because	 the	 patients	 manifest	 a	 more	 chronic	 infection,	 which	 is	 slower	 to	
develop	into	the	second	stage.	Chancres	are	also	absent	in	these	chronic	infections.		
	
The	 evolution	 of	 virulence	 and	 the	 impact	 of	 the	 host-parasite	 relationship	 on	 the	
fitness	 of	 a	 strain	 and	 its	 virulence	 has	 been	 extensively	 studied	 (Tibayrenc,	 2011;	
Black	et	al.,	1983;	Alizon	and	Lion,	2011).	 It	 is	often	a	disadvantageous	strategy	 for	a	
parasite	 to	 be	 highly	 virulent	 because	 this	 reduces	 the	 lifespan	 of	 its	 host	 and	 the	
opportunities	for	the	parasite	to	be	transmitted.	However	differences	in	virulence,	such	
are	 those	 seen	 in	 these	 T.b.rhodesiense	 strains	 have	 been	 observed	 in	 several	
heteroxenous	parasites	(Rigaud	et	al.,	2010).		
	
Genome	 sequencing	 is	 important	 in	 understanding	 the	 potential	 phenotype	 of	 a	
parasite	in	comparative	studies,	however	it	is	a	static,	and	does	not	indicate	the	regions	






In	 this	 chapter,	 infections	with	 these	 two	 strains	 are	 going	 to	 be	 characterized	 using	
two	 key	methods	 in	 an	 attempt	 to	 better	 under	 understand	 how	 transcriptional	 and	
metabolomic	 regulation	 influences	disease	manifestation	This	 chapter	will	be	making	
use	of	two	high	throughput	methodologies,	transcriptomics,	and	metabolomics	in	order	
to	 further	 identify	phenotypic	differences	between	 the	B17	and	Z310	 infections.	This	





due	 to	 differences	 in	 the	 relative	 abundances	 of	 the	 bloodstream	 forms.	 By	 using	
transcriptomic	data,	which	allows	for	investigation	into	the	actively	expressed	regions	
of	the	genome,	and	metabolomics	to	look	at	the	abundance	of	products	produced	as	a	
result	 of	 active	 metabolic	 pathways,	 this	 chapter	 aims	 to	 further	 understand	 the	
regulatory	differences	in	these	strains.	
	
	Hopefully	 by	 combining	 the	 genomic	 data,	 which	 is	 useful	 for	 determining	 the	
virulence	potential	of	a	strain,	transcriptomic	data,	which	determines	what	transcripts	
are	actually	expressed,	and	metabolomic	data,	which	shows	the	abundance	of	protein	
and	non-protein	metabolites,	 a	more	 comprehensive	picture	of	what	 is	 causing	 these	







The	metabolome	 is	 transient	 like	 the	 transcriptome,	and	comprises	of	all	metabolites	
present	at	the	time	of	sampling.	Metabolites	are	products	of	metabolism	and	generally	
less	than	1.4kDa	in	size	(Vincent	and	Barrett,	2015).	Metabolomics	is	a	high	throughput	








develop	 effective	 drug	 regimens.	 	 In	 Plasmodium,	 metabolomics	 was	 used	 to	 better	
understand	 the	 function	 of	 the	 PfCRT	 protein	 (Fidock	 et	 al.,	 2000).	 In	 T.	 brucei,	





	Metabolomic	 studies	 look	 at	 all	 of	 the	 metabolites	 at	 a	 particular	 time,	 however	
metabonomic	 studies	 can	 also	 be	 used	 to	 study	 a	 signature	 change	 in	 metabolites	
(Vincent	and	Barrett,	2015).	This	often	looks	at	just	a	targeted	range	of	metabolites	and	
the	 differences	 between	metabolites	 at	 two	 different	 intervals.	 These	 intervals	 could	






One	 of	 the	 main	 difficulties	 in	 analyzing	 this	 metabolomic	 data	 is	 distinguishing	
between	host	and	parasite	metabolites	because	the	samples	were	from	infected	hosts.	
Due	 to	 the	 nature	 of	T.	brucei,	multiple	 organs	within	 the	 host	 are	 affected,	 and	 so	 a	
whole	variety	of	pathways	are	differentially	regulated.	Due	to	this,	it	is	hard	not	only	to	








et	 al.,	 2015).	 In	 particular,	 this	makes	 the	 identification	 of	 isomers	more	 challenging.	
The	metabolites	identified	are	also	within	a	range,	and	metabolites	of	interest	may	not	




low	molecular	weight	 (MacGregor	 and	Matthews,	 2012).	 It	 is	 highly	unlikely	 that	 SIF	
could	be	 identified	within	 the	metabolomic	data	because	 its	weight	and	structure	are	
unknown,	 however	 it	 is	 believed	 to	 be	 a	 key	 metabolite.	 Although	 the	 detection	 of	
metabolites	 and	 subsequent	 analysis	 has	 improved	 in	 terms	 of	 the	 number	 of	
metabolites	 that	 can	 be	 assigned	 and	 the	 sensitivity,	 not	 all	 metabolites	 can	 be	
identified	 by	 one	 of	 the	 two	 current	 methods	 only	 (Lynn	 et	 al.,	 2015;	 Vincent	 and	
Barrett,	 2015).	 The	 differences	 in	 these	methods	 are	 outlined	 beneath,	 however	 the	







Nuclear	 magnetic	 resonance	 (NMR)	 spectroscopy	 was	 the	 first	 of	 the	 two	 methods	
developed	 for	 metabolite	 detection.	 It	 uses	 the	 spin	 properties	 of	 nuclei,	 most	
commonly	1H	or	13C,	to	generate	a	magnetic	field	and	identify	the	compounds	within	a	
sample	 (Dieterle	 et	 al.,	 2011).	 It	 is	 least	 favoured	 now	 for	 the	 analysis	 of	 complex	







its	 greater	 sensitivity,	 which	 is	 required	 for	 the	 resolution	 of	 complex	 metabolomic	
samples	and	its	ability	to	measure	down	to	femtomolar	and	attomolar	quantities	(Pan	
et	al.,	2007).	The	use	of	MS	was	 limited	until	developments	 in	 liquid	chromatography	
(LC),	which	have	widened	the	capabilities	of	MS	for	metabolomics	when	using	the	two	
techniques	 in	 conjunction.	 Unlike	 NMR,	 sample	 preparation	 grossly	 effects	 signal	
intensity,	 which	 is	 used	 to	 determine	 metabolite	 concentration,	 and	 so	 samples	 are	







IDEOM	 software	 is	 used	 for	 processing	 raw	 LC-MS	 data	 using	 XCMS	 and	mzmatch.R	
tools	to	 identify	metabolites	from	peaks,	and	filtering	raw	data	for	noise	(Smith	et	al.,	
2006;	Scheltema	et	al.,	2011).	Metabolites	are	identified	from	their	retention	times	and	
mass	 and	 compared	 against	 a	metabolite	 database	 (Creek	 et	 al.,	 2012a).	 The	 relative	
abundances	 compared	 to	 a	 control	 and	 the	 confidence	 rating	 of	 the	 identified	







RNA	 sequencing	 (RNAseq)	 allows	 for	 the	 sequencing	 of	 all	 transcripts	 present	 at	 the	
time	 of	 sampling,	 giving	 a	 snapshot	 of	 gene	 expression	 at	 a	 set	 point	 (Wang	 et	 al.,	
2009).	Due	to	the	more	transient	nature	of	the	transcriptome,	this	means	RNAseq	lends	
itself	to	experiments	investigating	how	different	conditions	affect	expression	(Wang	et	
al.,	 2009).	 There	 are	 multiple	 applications	 for	 RNAseq,	 including	 looking	 at	 global	
changes	to	expression	levels,	or	just	particular	pathways,	alternative	splicing	and	post-
transcriptional	modifications.	 Despite	mRNA	 being	 the	 primary	 transcripts	 analysed,	
RNAseq	 can	 be	 tailored	 to	 study	 other	 RNA	 populations	 such	 as	 miRNA	 and	 tRNAs.	
However	within	this	chapter,	the	analysis	will	be	focused	on	mRNA	analysis.	
	
	RNAseq	 has	 now	 superseded	 the	 prior	 technology	 for	 gene	 expression	 studies,	
microarrays	 (Zhao	 et	 al.,	 2014).	 Unlike	microarrays,	 which	 require	 a	 good	 reference	
genome,	RNAseq	can	be	more	readily	applied	 to	 look	at	expression	 in	a	non-targeted	
way	and	is	more	sensitive	 for	SNP	detection.	This	makes	RNAseq	ideal	 for	 identifying	
rare	 mutations,	 which	 would	 go	 unnoticed	 using	 a	 microarray.	 Although	 genomic	
sequencing	 is	 typically	 used	 for	 variant	 detection,	 RNAseq	 can	 also	 be	 used	 in	
validation	 (Wilkerson	 et	 al.,	 2014).	 RNAseq	 can	 also	 be	 used	 to	 improve	 on	 current	









et	al.,	2009).	Total	RNA	 is	 the	starting	point	 for	all	RNAseq	 libraries,	however	 for	 the	
majority,	the	high	percentage	of	ribosomal	RNA	(rRNA),	which	is	typically	over	90%	of	
the	 total	 transcripts,	makes	sequencing	of	 the	 total	RNA	an	unviable	option.	mRNA	 is	
often	 the	RNA	species	of	 interest	 and	 so	methods	 to	 select	 for	 this	 in	 the	 sample	 are	
used	 (Huang	 et	 al.,	 2011).	 The	 two	main	methods	 used	 are	 enrichment	 for	 the	 poly-







Although	 the	 pipeline	 for	 processing	 RNAseq	 data	 will	 vary	 from	 application	 to	
application,	 there	 is	 a	 general	 consensus	 for	 the	 stages	 RNAseq	 data	 needs	 to	 be	
processed	through.	The	data	need	first	 to	be	aligned	to	a	reference	genome,	and	then	


















RNAseq	 data	 can	 be	 assembled	 into	 a	 transcriptome	 in	 a	 de-novo	 or	 genome-guided	
manner.	 As	 the	 name	 suggests,	 de-novo	 assembly	 doesn’t	 require	 a	 reference	 and	
software	 such	 as	 Velvet	 exists	 to	 generate	 the	 de	 novo	 assembly	 (Zerbino,	 2010).	
However	 this	 is	 very	 computationally	 demanding,	 particularly	 for	 short	 reads.	 In	
contrast,	 genome-guided	 assembly	 is	 easier	 and	 far	 less	 computationally	 demanding.	
The	accuracy	of	a	genome-guided	assembly	also	far	exceeds	that	of	de	novo	assemblies,	
which	 are	 often	 ambiguous	 and	 sub-optimal	 (Trapnell	 et	 al.,	 2009).	 If	 a	 genome	
sequence	is	available,	RNAseq	data	can	be	mapped	onto	the	genomic	sequence	using	a	
short	 read	 aligner.	 Although	 there	 undoubtedly	 are	 differences	 between	 the	 genome	
and	 transcriptome,	 RNAseq	 reads	 can	 be	mapped	 to	 either,	 and	 various	 papers	 have	




































There	 are	multiple	mappers	 that	 deal	 with	 RNAseq	 data,	 however	 the	 primary	 ones	
used	for	RNAseq	for	analysis	are	TopHat	and	Bowtie2.	Bowtie2	is	different	to	Bowtie1	
because	 Bowtie1	 was	 intended	 for	 very	 short	 reads	 (up	 to	 25-50	 nucleotide	 reads).	










TopHat	 recognises	 splice	 junctions	 and	 splits	 reads	 across	 these,	 it	 takes	 unaligned	
reads,	and	then	splits	these	at	further	and	further	intervals	until	they	align	(Trapnell	et	
al.,	 2009).	 Bowtie2	 was	 used	 over	 TopHat	 because	 trans-splicing	 is	 ubiquitous	 in	 T.	
brucei,	with	only	one	known	gene	known	to	undergo	cis-splicing,	another	hypothesized,	
and	short	 intergenic	 regions,	 so	 intron	recognition	 is	not	an	 issue	 (Liang	et	al.,	2003;	







variety	 of	 different	 software	 tools.	 In	 order	 to	 observe	 differential	 expression,	 count	
data	related	to	a	transcript	or	gene	ID	is	required.		These	counts	are	used	to	normalise	
the	 data	 and	 identify	 differences	 in	 abundance	 between	 samples	 that	 are	 not	 due	 to	








single	 end	 library,	 or	 dividing	 the	 number	 of	 reads	 by	 two	 in	 a	 paired	 library	 by	
counting	 mapped	 pairs	 as	 one	 fragment.	 This	 count	 type	 is	 harder	 to	 normalise	 in	
situations	 such	 as	 paired	 end	 sequencing,	 whereas	 counts	 per	 gene	 are	 simply	 the	
number	of	reads	per	gene	ID.		
	
Due	 to	 the	 different	 counting	 and	 normalisation	 methods	 for	 RNAseq,	 different	
software	 needed	 for	 each	 application.	 Generally	 the	 workflow	 for	 RPKM/FPKM	
methods	 is	 mapping	 using	 Tophat,	 then	 analysis	 by	 cufflinks,	 which	 generates	 the	
RPKM/FPKM	values	(Trapnell	et	al.,	2009).	Following	processing	through	a	variety	of	
cufflinks	applications	such	as	Cuffmerge	and	Cuffdiff	,	the	data	is	then	visualised	using	
the	 R	 package	 cummeRbound.	 The	 main	 advantage	 of	 using	 cufflinks	 is	 that	 it	 is	
sensitive	 to	detecting	 iso-forms	 in	 the	data.	However	 it	 also	has	 a	more	 conservative	
method,	and	compared	to	HTseq	count,	finds	less	genes		(Anders	et	al.,	2015).		
	
However	 analysis	 can	 also	 be	 done	 using	 per	 gene	 ID	 counts,	 the	most	 popular	 tool	
being	 HTseq	 count.	 As	 with	 the	 other	 analysis	 methods,	 this	 can	 then	 be	 used	 in	








that	overlap	with	exon	co-ordinates.	Unlike	other	 tools	 it	 can	be	used	 to	discriminate	
against	 reads	 that	overlap	 two	genes	and	would	contribute	 to	 the	 frequency	count	of	













In	both	DEseq	and	edgeR,	a	negative	binomial	model	 is	used	 to	best	 fit	 the	degree	of	
variation	 seen	 in	 RNAseq	 data.	 Once	 identified,	 these	 packages	 can	 then	 be	 used	 to	
visualise	 the	DEGs.	 	As	mentioned	previously	 this	 visualization	 can	be	done	 either	 in	




edgeR	 which	 stands	 for	 empirical	 analysis	 of	 differential	 gene	 expression	 in	 R,	 was	
originally	 used	 for	 serial	 analysis	 of	 gene	 expression	 data	 (SAGE),	 but	 has	 now	been	
widely	adopted	for	use	in	RNAseq	analysis	(Robinson	et	al.,	2010).	edgeR	models	data	





Similarly	 to	 edgeR,	 DEseq	 models	 the	 data	 based	 on	 a	 negative	 binomial	 model.	
However	DEseq	is	considered	to	have	a	very	conservative	method	of	DEG	identification	
and	so	 the	 true	positive	 rate	 (TPR)	observed	 is	much	 lower	 than	seen	 in	edgeR.	This	
worsens	 as	more	 outliers,	 such	 as	 very	 highly	 and	 lowly	 expressed	 gene	 counts,	 are	
introduced	to	the	analysis	(Soneson	and	Delorenzi,	2013).	The	main	difference	between	
edgeR	 and	 DEseq	 is	 how	 dispersion	within	 the	model	 is	 dealt	 with.	 In	 edgeR	 this	 is	
done	using	an	individual	dispersion	parameter	to	fit	the	dataset,	whereas	DEseq	uses	a	



















Two	 female	A/J	mice	were	 infected	 intraperitoneally	with	104	parasites	 from	a	blood	
stabilate	of	B17	and	two	female	A/J	mice	were	infected	with	Z310.	This	mouse	strain	is	
particularly	susceptible	to	trypanosome	infection,	which	is	important	in	order	to	obtain	




Blood	 was	 then	 collected	 from	 these	 mice	 and	 104	 parasites	 were	 passaged	 into	
C57BL/6	mice,	five	for	each	isolate.	Mice	were	bled	prior	to	infection	and	25µl	of	blood	
was	 then	 taken	 twice	weekly	 for	metabolomic	 analysis,	 10µl	 of	 blood	was	 also	 taken	




were	culled	 following	 the	 first	peak	of	parasitaemia.	 	The	blood	collected	 for	RNAseq	
analysis	was	obtained	from	another	set	of	infections.	The	infections	for	collecting	blood	

















this	 approximately	 45µl	 of	 particle	 free	 supernatant	 were	 collected	 and	 sent	 to	 the	
University	of	Glasgow	 for	 analysis	by	LC-MS	 (Creek	 et	 al.,	 2012b).	Acetonitrile	 (ACN)	
was	prepared	with	non-infected	mouse	blood	as	a	 control.	Due	 to	 ill	health,	 the	mice	







This	 data	 was	 produced	 by	 LC-MS	 and	 analyzed	 using	 IDEOM	 metabolite	 software	
(Creek	 et	 al.,	 2012b).	 From	 these	 samples,	 579	metabolites	 were	 represented	 in	 the	
confidently	 assigned	 peaks.	 In	 order	 to	 draw	 any	 meaningful	 conclusions	 from	 this	
data,	 a	 small	 subset	 of	metabolites	were	 selected	 based	 on	 a	 number	 of	 parameters.	
Analysis	 was	 done	 in	 two	 ways,	 firstly	 by	 looking	 at	 the	 data	 on	 an	 individual	
metabolite	basis,	 and	 secondly	by	 focusing	on	 the	differential	 regulation	of	pathways	
between	the	samples.	Due	to	 the	nature	of	MS,	 the	metabolites	are	 identified	by	their	
weight,	and	so	distinguishing	isomeric	forms	or	metabolites	with	near	identical	masses	
is	 difficult.	 To	 reduce	 the	 potential	 effect	 of	 this,	 only	 metabolites	 that	 were	 either	
known	or	had	a	greater	than	7	certainty	were	selected,	with	10	representing	a	known	
compound.	 For	 individual	 metabolite	 analysis,	 metabolites	 were	 then	 sorted	 by	
intensity,	selecting	only	those	with	an	intensity	in	at	 least	one	time	point	significantly	
different	to	the	pre-infection	intensity.	The	most	abundant	were	primarily	targeted.	In	





post	 infection.	 For	 Z310,	 this	 was	 not	 the	 case,	 many	 of	 the	 metabolites	 were	 not	
significantly	different	from	the	control,	and	very	few	differed	greatly	in	intensity.	As	a	
result	of	the	different	profiles	for	the	B17	and	Z310	infections,	different	metabolites	of	
“interest”	were	 selected	 for	 each	 strain,	 but	 the	 relative	 intensity	 levels	 in	 the	 other	
strain	 are	 given	 for	 comparison.	 Metabolites	 with	 no	 known	 role	 in	 a	 pathway	 or	




One	 of	 the	 main	 barriers	 to	 analyzing	 this	 data	 is	 that	 many	 of	 the	 changes	 to	 the	
metabolites	can	be	attributed	to	deterioration	in	the	health	of	the	mouse.	For	instance,	
metabolites	 indicating	 damage	 to	 the	 liver	 are	 a	 result	 of	 the	 damage	 caused	 by	 the	
infection,	they	are	not	indicative	of	a	metabolite	that	causes	the	parasite	to	be	virulent	
even	 though	 a	 high	 intensity	 of	 metabolites	 associated	 with	 damage	 to	 the	 liver	 is	
evidence	that	the	parasite	is	more	virulent.	Issues	arise	in	trying	to	distinguish	between	





All	 the	 metabolites	 identified	 were	 compared	 using	 their	 peak	 intensities	 using	
metaboanalyst	 software	 (Xia	 et	 al.,	 2015).	 Individual	 rather	 than	m	 ean	 values	were	
used	 to	 construct	 heatmaps	 showing	 differences	 between	 individuals	 from	 the	 same	
stage	of	infection,	and	between	the	three	sampled	periods.	Heatmaps	were	constructed	




plots	were	used	 to	 see	 the	degree	of	 variability	between	 strains	and	 infection	 stages.	
Dendrograms	were	 also	 constructed	 to	 see	whether	 the	metabolite	profiles	 clustered	
by	day	post	 infection	as	expected.	This	was	done	using	a	Euclidean	distance	measure	
and	by	clustering	using	 	Ward’s	 linkage	method.	Correlations	between	the	treatments	





RNAseq	 was	 done	 to	 tie	 together	 differences	 seen	 in	 the	 genomic	 data	 and	 the	
phenotypic	 data	 (microscopy/QPCR	 and	 metabolomics)	 to	 allow	 for	 a	 greater	
understanding	 of	 the	 mechanisms	 driving	 these	 differences	 in	 phenotype	 between	
these	 two	 sets	 of	 strains.	 	 RNAseq	 allows	 us	 to	 observe	 differences	 at	 the	
transcriptional	level,	whereas	metabolomics	looks	at	differences	in	metabolic	pathway	
products,	 which	 can	 reflect	 differences	 at	 a	 translation	 level.	 The	 number	 of	 genes	
	 165	






Samples	were	 collected	 from	mice	 infected	 as	 described	 in	 section	 4.2.1.	 Blood	 from	
these	mice	 was	 collected	 via	 cardiac	 puncture	 into	 syringes	 containing	 0.1ml	 20mM	
EDTA	to	prevent	coagulation.	The	whole	blood	was	then	was	then	spun	at	6000g	for	2	
minutes,	 the	 plasma	 removed	 and	 resuspended	 in	 an	 equal	 volume	 of	 phosphate	
buffered	 saline	 (PBS).	 Nucleic	 acid	 purification	 lysis	 buffer	 (ABI	 4305895)	 that	 had	
been	already	diluted	1:1	with	PBS	was	then	added	1:1	to	the	resuspended	blood,	mixed	

























extraction	 as	 above.	 RNAseq	 requires	 higher	 quality	 RNA	 than	 other	 downstream	
processes,	and	so	the	Purelink™	RNA	mini	kit	(Life	technologies	12183018A)	was	used	
in	place	of	 the	micro	kit,	because	 this	 could	be	adapted	 to	 isolation	 from	blood	more	
	 166	
easily	 and	 RNA	 extracted	 using	 this	 kit	 was	 less	 degraded	 based	 on	 RNA	 Integrity	
Number	values	(RIN).		
	
Five	 different	 mice	 were	 used	 for	 each	 strain,	 B	 and	 E,	 which	 represent	 zymodeme	
groups	 Z310	 and	 B17,	 and	 samples	 were	 taken	 pre-infection	 as	 controls.	 RNA	 was	
extracted	 using	 the	 purifying	 RNA	 from	 whole	 blood	 protocol.	 For	 optimal	
yield/quality,	100µl	of	processed	blood	was	used	 in	the	first	step	and	resuspended	in	
50µl	 nuclease	 free	 H2O	 in	 the	 last	 step.	 Sample	 volumes	 greater	 than	 this	 led	 to	
insufficient	 cell	 lysis	 and	 clogging	 of	 the	 column.	 Lower	 volumes	 did	 not	 improve	
quality	 but	 greatly	 reduced	 yield.	 	 On	 column	 Purelink™	 DNase	 treatment	 was	
performed.	 Crude	 extracts	 were	 assessed	 for	 quality	 on	 the	 nanodrop	 using	 their	











a	 magnetic	 stand	 until	 the	 solution	 cleared	 (approximately	 2	 minutes).	 The	 clear	
supernatant	was	then	removed	from	the	samples,	and	500µl	of	70%	ethanol	was	added	
to	 clean	 the	 beads	 with	 the	 RNA	 bound.	 After	 30	 seconds	 the	 ethanol	 was	 carefully	
removed	to	prevent	disruption	to	the	beads,	and	the	ethanol	wash	repeated.	After	the	
second	 ethanol	 wash,	 the	 ethanol	 was	 removed,	 and	 the	 beads	 left	 to	 air	 dry.	 To	















eukaryotes-	 low	 input	 (Cambio	 SCL24G),	 which	 comprises	 of	 the	 Ribo-Zero™	 gold	
magnetic	 kit	 and	 Scriptseq	 v2	 Library	 preparation	 kit.	 The	 gold	 Ribo-zero™	 kit	 (low	









The	 rRNA	depleted	 sample	was	 subsequently	 purified	using	RNAclean™	XP	beads,	 as	





rRNA	 depleted	 samples	were	 then	 used	 to	 prepare	 libraries	 for	 Illumina	 sequencing	
using	the	Scriptseq™	v2	RNA	library	preparation	protocol.	The	cDNA	was	purified	using	


















was	 subsequently	 used	 to	 trim	 reads	with	 a	 quality	 score	 of	 less	 than	 20	 and	 reads	
shorter	than	10bp	after	trimming	were	removed.	If	only	one	read	in	a	read	pair	passed	
the	filter,	these	were	rejected	and	not	used	in	the	alignment.	Bowtie	version	2.1.0	was	






al.,	 2015).	 For	 this,	 parameters	 –m	 union,	 -f	 bam,	 -r	 name	 were	 used.	 Union	 mode	
allows	reads	to	be	assigned	to	a	feature	even	if	the	full	length	of	the	read	doesn’t	map	to	
that	 feature.	Reads	mapping	to	more	than	one	feature	are	 labeled	ambiguous	and	not	
included	within	 the	count.	–f	was	used	 to	define	BAM	as	 the	 input	 file	 type,	and	–r	 is	










were	 fitted	using	the	glmFit	 function	and	normalized	 for	differences	 in	read	depth	by	
















DEGs	were	subject	 to	analysis,	not	 just	 the	highly	differentially	expressed	genes.	This	
was	to	see	whether	there	was	a	significant	relationship	between	differential	expression	













three	 post	 infection,	 and	 153	 (61%)	 by	 day	 eight	 post	 infection.	 In	 contrast,	 only	 28	
(11%)	of	these	249	metabolites	were	increased	more	than	five	fold	by	day	three,	and	










secondary	 metabolite	 and	 polyketide	 and	 non	 ribosomal	 peptide	 biosynthesis	
pathways.	
	
Currently	 there	 is	 little	 information	 on	 polyketide	 and	 non-ribosomal	 peptide	
biosynthesis	 in	 trypanosomes,	 however	 the	 function	 of	 these	 in	 other	 eukaryotes	 is	









The	 pathways	 shown	 are	 as	 follows	 left	 to	 right:	 Xenobiotics	 biodegradation	 and	 Metabolism,	
tri,tetra	and	di	peptide		and	peptide	Metabolism,,	Nucleotide	Metabolism,	Metabolism	of	Cofactors	
and	 Vitamins,	 Sterol	 lipid	 Metabolism,	 Sphingolipid	 Metabolism,	 Polyketide	 Metabolism,	
Glycerophospholipid	 Metabolism,	 Glycerolipid	 Metabolism,	 Ganglioside	 Metabolism,	 Fatty	 Acyl	
Metabolism,	 Lipid	 Metabolism,	 Energy	 Metabolism,	 Carbohydrate	 Metabolism,	 Biosynthesis	 of	







































































































































































pre-infection	 concentration	 in	 the	 B17	 strain,	 which	 sharply	 declines	 to	 nearly	 pre-
infection	 levels	by	day	eight,	whereas	 in	 the	Z310	 isolates,	 this	doesn’t	 increase	 from	
the	 pre-infection	 concentration.	 This	 metabolite	 is	 required	 for	 the	 formation	 of	
trypanothione;	 which	 is	 required	 to	 reduce	 oxidative	 stress	 on	 the	 parasites	 during	
infection	(Konwar	et	al.,	2013).	T.	brucei	is	capable	of	scavenging	for	spermidine	but	the	
bloodstream	 concentrations	 of	 spermidine	 are	 very	 low,	 insufficient	 to	 sustain	 blood	
stream	forms	(BSF),	even	at	low	parasitaemias.	Due	to	this,	they	synthesize	their	own	
spermidine,	 which	 is	 then	 converted	 to	 trypanothione	 for	 growth	 (Taylor,	 2008).	
Spermidine’s	 essential	 role	 in	 growth	 has	 led	 to	 research	 into	 designing	 therapies	 to	
prevent	 the	 action	 of	 spermidine	 synthase,	 which	 is	 required	 for	 the	 production	 of	
spermidine	and	is	downstream	of	the	action	of	ornithine	decarboxylase	(ODC)	(Taylor,	
2008).	 Difluromethylornithine	 (DFMO)	 is	 a	 chemotherapy	 agent,	 which	 inhibits	 the	
action	of	ODC	and	 is	 currently	used	 for	 the	 late	 stage	 treatment	of	T.	brucei	 	 (Taylor,	




Z310	 infections	 contain	 predominantly	 highly	 proliferative	 parasites,	 and	 so	 this	
difference	 may	 also	 be	 caused	 by	 a	 higher	 consumption	 rate	 of	 spermidine.	 B17	
infections	 will	 have	 a	 lower	 spermidine	 consumption	 rate	 because	 the	 majority	 of	









One	of	 the	 frequent	uses	of	metabolomics	 is	 to	 identify	 the	global	metabolite	changes	
associated	 with	 a	 disease	 state,	 and	 to	 establish	 the	 “signature”	 changes.	 Metabolite	
samples	were	taken	from	five	mice	for	the	Z310	strain	and	five	for	the	B17	strain,	prior	











the	 mean,	 in	 order	 to	 see	 the	 reproducibility	 of	 these	 metabolite	 changes	 across	
individuals.	 The	 individuals	 were	 clustered	 according	 to	 their	 associated	 metabolite	
intensities,	and	as	shown	in	Figure	4.3-4.8	the	three	states	 investigated,	pre-infection,	
early	 infection/first	 peak	 of	 parasitaemia,	 and	 later	 infection	 cluster,	 suggesting	 key	
metabolite	changes	seen	at	each	of	these	stages,	and	consistently	between	individuals.		
	
Overviews	 of	 this	 “metabolic	 signature”	 are	 shown	 in	 three	 ways,	 firstly	 through	 a	
heatmap	 showing	 the	 differences	 in	 intensities	 for	 each	 stage,	 which	 can	 be	 used	 to	
observe	 whether	 pathways	 are	 generally	 being	 up	 or	 down	 regulated,	 secondly	 by	
correlating	 the	 differences	 between	 individual	 and	 stage,	 to	 see	 the	 degree	 of	
difference,	and	thirdly	by	simplifying	this	variance	and	seeing	how	these	stages	relate	













most	 likely	 to	 be	 the	 host	metabolites	 that	 are	 diminished	 due	 to	 the	 burden	 of	 the	
parasite.	 In	 Z310,	 the	 infection	 predominantly	 consists	 of	 highly	 proliferative	 forms,	





Figure	4.3:	Heatmap	showing	 the	 intensities	of	metabolites	prior	 to	 infection,	at	 the	 first	stage	of	
infection	at	day	three,	and	later	in	infection,	at	day	eight.	Prefixes	day	three,	day	eight	and	pre	refer	
to	 the	stage	the	metabolite	was	collected	at,	and	the	subsequent	number	refers	 to	 the	 individual.	
These	cluster	by	stage	and	are	represented	in	green,	red	and	blue	for	pre-infection,	day	three	and	




In	 the	 Z310	 strain,	 as	mentioned	 in	 Chapter	 3,	 the	 parasitaemia	 peaked	 earlier	 than	
seen	in	the	B17	strain,	and	so	the	high	abundance	of	the	majority	of	metabolites	taken	
at	 day	 three	 is	 not	 surprising.	 	 This	 general	 increase	 in	 abundance	 at	 the	 peak	 of	














































































































































































However	 the	metabolites	 that	 were	 at	 low	 abundance	 by	 day	 three,	 appear	 to	 be	 in	
much	higher	abundance	by	day	eight.	This	metabolite	accumulation	could	be	as	a	result	
of	 parasite	 byproducts	 generated	 by	 the	 predominantly	 highly	 proliferative	 parasite	
population	 observed	 in	 Z310	 infections.	 	 It	 could	 also	 be	 due	 to	 the	 release	 of	
metabolites	following	short	stumpy	cell	death	due	to	the	high	parasitaemia,	or	it	could	
represent	metabolites	 forming	 the	host	 response.	However	as	observed	 in	Chapter	3,	
this	 strain	 has	 a	 smaller	 proportion	 of	 parasites	 differentiating	 into	 short	 stumpy	
stages,	and	so	 if	 these	metabolites	correlated	with	differentiation	 in	the	short	stumpy	
stages,	we	would	expect	this	effect	to	be	more	pronounced	in	strain	B17.		
	
The	 pattern	 of	metabolite	 abundance	 is	 distinct	 between	 the	 early	 and	 late	 stages	 of	
disease,	 however	 the	 later	 stage	of	 the	disease	 gives	 rise	 to	 a	non-uniform	metabolic	
response	 in	 the	 individuals	 compared	 to	 the	 earlier	 stage.	 Although	 the	 overall	
metabolic	 response	 appears	 similar	 in	 the	 later	 stage,	 there	 is	 a	 greater	 degree	 of	
variation	between	the	individuals.	After	sample	collection	at	day	eight,	further	samples	
could	 not	 be	 collected	 due	 to	 the	 deterioration	 in	 health	 and	moribund	 condition	 of	
some	 of	 the	 infected	 individuals.	 At	 this	 stage,	 trypanosomiasis	 can	 cause	 multiple	




was	used	to	cluster	each	sample	 in	Figure	4.4.	This	again	supports	 the	effects	seen	 in	
Figure	4.3,	in	which	the	metabolomic	profile	is	distinct	pre	and	post	infection.	The	area	
shaded	 surrounding	 each	 point	 shows	 the	 95%	 confidence	 intervals	 (CI)	 for	 each	
group.	 	 Despite	 distinct	 clusters	 for	 each	 stage,	 the	 samples	 taken	 at	 day	 three	 do	





















were	 higher	 than	 seen	 pre	 infection	 or	 at	 day	 eight.	 However	 the	 difference	 in	






















































observed	 in	 the	 Z310	 infections,	 consistency	 was	 seen	 both	 between	 individuals	 at	 a	 particular	
stage,	and	 the	stages	were	distinct	 from	each	other.	Due	 to	 the	high	abundance	of	metabolites	at	
days	three	and	eight,	these	cluster	separately	from	pre-infection	metabolites.	
	
As	 before,	 there	 are	 a	 small	 number	 of	metabolites	 that	 are	more	 abundant	 prior	 to	





be	 due	 to	 differences	 in	 the	 host	 response.	 However	 the	 significant	 decrease	 in	
abundance	of	a	high	proportion	of	the	metabolites	at	day	eight	is	likely	to	be	associated	
with	 the	 high	 abundance	 of	 short	 stumpy	 forms	 in	 these	 infections.	 Although	 more	
immunogenic,	 these	stages	of	 the	 life	 cycle	have	entered	 into	cell	 cycle	arrest,	 and	so	




































































































































































































































infection	 and	 both	 post-infection	 stages	 cluster	 separately,	 with	 both	 post-infection	




and	 as	 previously	 seen,	 the	 day	 eight	metabolomic	 profile	 is	more	 variable	 than	 seen	 earlier	 in	
infection	

















































Figure	4.6	 shows	both	 the	metabolic	profile	 for	 infections	with	Z310	and	B17	strains	
alongside	each	other	for	comparison.	As	before,	the	individuals	cluster	per	date	relative	
to	infection,	but	also	by	strain.	One	of	the	pre-infection	B17	mice	clusters	amongst	the	






abundance	 prior	 to	 infection,	 and	 are	 depleted	 once	 infected.	 This	 also	 shows	 a	 more	 global	




























































































































































































































































































































































































































































































































































































































































abundance	prior	 to	 infection,	which	are	most	 likely	 to	be	host	metabolites	which	are	
diminished	 by	 the	 increasing	 burden	 of	 infection.	 In	 both	 infections,	 the	 highest	
abundance	of	metabolites	across	the	majority	of	the	metabolites	identified	is	observed	
at	 day	 three.	 As	 described	 in	 Chapter	 3,	 strain	 Z310	 goes	 into	 the	 first	 peak	 of	
parasitaemia	 first,	 however	 at	 its	 peak	 at	 day	 three,	 the	 abundance	 across	 multiple	
metabolites	 is	much	 lower	 than	 observed	 in	 the	 B17	 strain,	which	 did	 not	 reach	 the	
first	 peak	 of	 parasitaemia	 until	 day	 five.	 Despite	 not	 being	 at	 its	 initial	 peak	 by	 day	
three,	 there	 was	 a	 general	 high	 abundance	 of	 metabolites	 in	 B17,	 however	 this	
dissipated	 by	 day	 eight,	 with	 approximately	 two-thirds	 of	 metabolites	 back	 to	 pre-
infection	 levels.	However	 in	both	strains,	about	a	 third	of	 the	metabolites	maintained	
elevated	levels	into	day	eight	post	infection,	and	these	are	shown	towards	the	bottom	
of	 the	heatmap	in	Figure	4.7.	 It	 is	hard	to	determine	whether	these	are	related	to	the	
host	response,	because	the	host	response	will	be	different	to	both	of	these	strains	due	























both	 strains.	 It	 also	 shows	 that	 Z310	has	 a	much	more	 variable	 late	 stage,	 and	 although	 there	 is	




strains	 the	CIs	of	 these	stages	do	overlap.	 Interestingly	 the	variability	 in	B17	 infected	
mice	 is	 higher	 by	 day	 three,	 but	 this	 does	 not	 increase	 significantly	 by	 day	 eight.	 In	
contrast,	 the	 variability	 in	metabolite	 abundance	 is	 very	 limited	 by	 day	 three	 of	 the	
Z310	 infections,	 but	 increases	 drastically	 by	 day	 eight.	 At	 day	 three	 in	 the	 Z310	
infections,	the	parasite	is	entering	its	first	peak	of	parasitaemia,	however	by	day	eight,	
the	parasite	population	is	still	 largely	comprised	of	long	slender	forms.	The	burden	of	
this	 and	 the	accumulation	of	 trypanosome	specific	metabolites	 as	 a	 result	of	 a	highly	



































of	 infection.	 In	 the	B17	 infections,	by	day	 three	 the	parasites	had	not	yet	reached	 the	
first	peak	of	parasitaemia,	and	short	stumpy	forms	were	predominant	in	this	infection.	
Due	 to	 the	 cell	 cycle	 arrest,	 and	 the	 far	 fewer	 highly	 proliferative	 forms,	 so	 fewer	













In	 mice	 infected	 with	 the	 Z310	 strain,	 fewer	 metabolites	 were	 statistically	 different	
from	the	pre-infected	state,	and	the	intensity	of	statistically	different	metabolites,	even	
the	most	 intense	metabolites,	 were	much	 lower	 than	 those	 seen	 in	 the	 B17	 infected	
mice.	 Table	 4.2	 presents	 a	 list	 of	 metabolites,	 selected	 as	 previously	 described,	 that	
were	 of	 interest.	 As	 previously	mentioned,	metabolites	 of	 interest	were	 identified	 as	
those	with	a	high	confidence,	assigned	function	and	a	high	abundance/	large	difference	
in	 the	 abundance	 observed	 between	 stages.	 As	 indicated	 in	 Table	 4.2,	 some	 of	 these	










the	 B17	 late	 stage	 of	 infections,	 which	 is	 interesting	 as	 this	 strain	 had	 a	 lower	




Other	 metabolites	 of	 interest	 include	 [ST	 methoxy,hydroxy(3:0)]	 2-methoxy-3-
hydroxy-estra-1,3,5(10)-trien-17-one	 3-sulfate,	 which	 is	 a	 regulator	 of	 sterol	 lipid	
production.	Sterol	lipids	are	not	only	necessary	for	parasite	growth,	but	there	is	also	a	





Table	 4.2-	 Shown	 are	 the	metabolites	 of	 interest	 from	mice	 infected	 with	 Z310	 strain.	 These	 either	 had	 a	 high	 abundance	 in	 the	 Z310	 infection	 or	 had	 an	
interesting	differential	pattern	of	abundance	between	the	stages	sampled.	Due	to	the	high	abundance	of	metabolites	in	the	B17	infection,	although	they	have	a	
high	abundance	 in	 the	Z310	 infection,	relative	 to	 the	other	metabolites	 identified,	 the	abundance	observed	 in	B17	 infections	 for	 the	same	metabolite	may	be	
higher.	Metabolites	with	significant	t	test	values	are	shown	in	bold.	
	
	 Z310	 B17	 	
Z310	metab	 Day	3	 	Day	8	 Day	3	 	Day	8	 Function	
[FA	(18:1)]	9Z-octadecenamide	 560.89	 475.66	 578.15	 665.33	 Fatty	amide	production	
[ST	methoxy,hydroxy(3:0)]	2-methoxy-3-
hydroxy-estra-1,3,5(10)-trien-17-one	3-sulfate	
34.28	 4.82	 39.36	 74.79	 Sterol	lipid	production	
3-Oxohexobarbital	 9.36	 11.57	 31.71	 125.97	 Modulator	of	the	neuronal	GABA-A	receptor	
Carnosine	 14.13	 0.20	 23.74	 5.45	 Dipeptide	of	beta-alanine	and	histidine,	it	has	antioxidant,	
antiglycator	and	metal	chelator	properties		
N-Acetyl-D-tryptophan	 18.45	 3.51	 53.64	 11.68	 Amino	acid	derivative	of	D-tryptophan	
Serotonin	 20.67	 1.40	 4.00	 0.42	 Amino	acid/taurine	metabolism	
1H-Imidazole-4-ethanamine	 106.20	 0.91	 11.17	 0.52	 Histidine/amino	acid	metabolism	
5-Acetylamino-6-formylamino-3-methyluracil	 36.89	 0.00	 1.94	 0.00	 Purine	synthesis	and	caffeine	production	
Hypotaurine	 15.57	 0.33	 110.15	 10.22	 Intermediate	of	taurine,	endogenous	neurotransmitter.	
Antioxident	
Inosine	 274.67	 0.62	 3.57	 0.07	 Purine	and	nucleotide	metabolism	
NG,NG-Dimethyl-L-arginine	 4.45	 0.69	 640.76	 349.88	 Inhibitor	of	nitrous	oxide	





unicellular	 organisms,	 the	 most	 well-known	 is	 E.	 histolytica.	 Previous	 work	 has	
demonstrated	a	significant	decrease	in	the	levels	of	serotonin	following	T.b.	gambiense	
infection.	 	 Patients	 infected	 with	 Z310	 strains	 have	 presented	 with	 symptoms	more	
characteristic	 of	 a	T.b.	gambiense	 infection	 than	 a	T.b.	rhodesiense	infection,	 and	with	
these	infections,	although	a	decrease	of	serotonin	was	not	observed,	B17	infected	mice	
had	higher	serotonin	levels	than	those	in	seen	in	the	Z310	infection,	especially	 late	 in	
infection.	 In	 comparison,	 low	 levels	 of	 serotonin	 were	 maintained	 throughout	 the	
course	 of	 infection	 in	 Z310.	 Serotonin	 specific	 neurons	 are	 a	 suspected	 target	 of	 T.	




neural	related	 function,	such	as	serotonin	and	3-Oxohexobarbital	 in	 the	B17	 infection	
(Stibbs,	1984).	
Interestingly,	the	majority	of	metabolites	that	were	found	in	a	higher	concentration	in	
B17	 infected	 mice	 had	 functions	 in	 amino	 acid	 metabolism.	 Due	 to	 the	 higher	
proportion	of	stumpy	forms,	the	B17	strain	is	far	less	proliferative	than	the	Z310	strain.	
As	 a	 result,	 you	would	 expect	 Z310	 to	 synthesize	 purines	 at	 a	 greater	 rate,	 however	
because	T.	brucei	lack	the	ability	to	synthesize	purines	de	novo,	they	utilize	scavenging	
pathways	 instead.	 	 In	 higher	 parasitaemia	 infections,	 such	 as	 Z310,	 the	 demand	 for	
purines	is	far	greater,	and	so	there	are	less	purines	available	in	the	more	proliferative	
population.	Due	to	a	higher	percentage	of	non-proliferative	forms	in	the	acute	isolate,	
there	 is	a	higher	concentration	of	purines	 left	 to	scavenge	because	comparatively,	 the	
demand	is	less.	
	
As	seen	 in	Table	4.2,	 the	most	abundant	metabolite	of	 interest	 is	9Z-octadecenamide.	
As	 previously	 mentioned,	 9Z-ocatadeceanamide	 indicates	 a	 host	 response,	 and	 so	 a	
high	 concentration	 early	 in	 both	 infections	 is	 expected.	 Increases	 in	 N-Acetyl-D-
tryptophan	 in	 the	 B17	 strain	 are	 also	 interesting	 as	 they	 indicate	 differences	 in	
tryptophan	metabolism,	which	has	been	 studied	 in	 trypanosomes	 since	 in	was	noted	
that	trypanosomes	can	metabolise	tryptophan	to	indole-3-ethanol	(tryptophol)	in	vitro		
(Stibbs	 &	 Seed,	 1975).	 Due	 to	 the	 abundance	 of	 non-proliferative	 forms	 in	 the	 B17	
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be	 an	 important	 inhibitor	 of	 nitrous	 oxide,	 and	 nitrous	 oxide	 is	 important	 in	 host	
response	and	controlling	parasites	 in	vivo	(Vincendeau	and	Bouteille,	2006).	 	It	 is	also	
interesting	to	note	the	higher	concentration	of	carnosine	observed	in	the	B17	infections	
compared	 to	 Z310	 as	 carnosine	 is	 considered	 to	 have	 a	 protective	 effect	 against	
oxidative	 damage	 in	 mammals,	 and	 has	 previously	 been	 shown	 to	 reduce	 parasite	
burden	in	S.mansoni	infections	(Soliman	et	al.,	2001).	It	is	hard	to	decipher	whether	the	
higher	 concentration	 in	 carnosine	 early	 in	 the	 B17	 infection	 is	 indicative	 of	 the	 host	
responding	to	the	greater	immunogenicity	of	the	predominantly	stumpy	population,	or	












Table	 4.3:	 .	 This	 shows	 the	 relative	 abundance	 of	 the	 metabolites	 of	 interest	 in	 the	 B17	 strain.	 Metabolites	 selected	 using	 the	 criteria	 of	 confidence	 >7,	 intensity	




	 B17	 Z310	 	
Metabolite	 Day	3	 Day	8	 Day	3	 Day	8	 Function	
Guanidinoacetate	 26.33	 13.81	 0.52	 0.25	 Glycine,	serine	and	
threonine	metabolism	





9.70	 17.15	 0.89	 1.46	 Glycine,	serine	and	
threonine	metabolism	
[PC	(18:0)]	1-octadecanoyl-sn-glycero-3-phosphocholine	 11.12	 5.82	 2.37	 2.19	 Main	phospholipid	of	
nerve	cell	membranes	
N6-Methyl-L‐lysine	 110.39	 836.19	 0	 0	 Amino	acid	metabolism	




9.17	 5.79	 0.92	 0.94	 Amino	acid	metabolism	





As	 was	 observed	 with	 the	 Z310	 infection,	 amino	 acid	 metabolism	 is	 important	 for	
maintaining	 the	 parasite	 population;	 particularly	 as	 the	 Z310	 strain	 is	 highly	
proliferative	and	will	exhaust	its	resources	quicker.	
	
Several	 of	 the	metabolites	 are	 an	 indicator	 of	 the	 greater	 extent	 of	 damage	 typically	
caused	 by	 the	 late	 stage	 of	 the	 disease	 in	 the	 B17	 strain.	 Guanidinoacetate	 is	 an	
intermediate	 in	 the	 synthesis	 of	 creatine,	 which	 occurs	 primarily	 in	 the	 liver	 and	
kidneys	 (Konwar	 et	 al.,	 2013).	 T.	 brucei	 is	 known	 to	 cause	 extensive	 damage	 and	
enlargement	of	 several	organs	 including	 the	 liver	during	 infection,	and	an	 increase	 in	





from	 liver	damage,	 and/or	disorders	 resulting	 in	 an	 accumulation	of	 ammonia	 in	 the	
brain,	 which	 can	 then	 lead	 to	 malfunctions	 in	 the	 regulation	 of	 circadian	 rhythms,	
causing	symptoms	such	as	daytime	sleeping	and	confusion	(Maclean	et	al.,	2012).	Free	
amino	 acids,	 and	 metabolites	 that	 are	 intermediate	 of	 amino	 acid	 metabolism	 have	




Alongside	 amino	 acid	 metabolism,	 carbohydrate	 metabolism	 is	 necessary	 for	
controlling	parasites	as	it	is	required	for	access	to	glucose.	As	such,	factors	controlling	
carbohydrate	 metabolism	 in	 the	 parasite	 have	 long	 been	 considered	 a	 good	 drug	
targets	 (Maclean	 et	 al.,	 2012).	 Differences	 in	 abundance	 of	 metabolites	 involved	 in	
carbohydrate	metabolism	between	these	strains	is	expected	due	to	the	differing	energy	
requirements	 resulting	 from	 predominantly	 proliferative	 and	 non-proliferative	
parasite	populations.	Table	4.3	shows	the	most	abundant	metabolites	of	interest	in	B17	
infections	are	indolelacetate	and	methyloxaloacetate,	which	are	involved	in	tryptophan	















Due	 to	sequencing	directly	 from	an	 infected	host,	 there	 is	a	high	percentage	of	 reads,	





brucei	 were	 Z310	 strains,	 and	 had	 both	 the	 lowest	 number	 of	 actual	 reads	 and	


























































































degree	 of	 dispersion/variation	 of	 a	 gene	 in	 its	 true	 abundance	 between	 biological	
replicates	(McCarthy	et	al.,	2012).	 	 It	 is	expected	that	 there	will	be	a	higher	degree	of	
biological	 variation	 between	 lower	 abundance	 transcripts,	 and	 this	 is	 observed.	
However	this	plateaus	for	the	lower	logged	counts	per	million,	which	reflects	that	the	
majority	of	the	transcripts	seen	had	a	logged	counts	per	million	(logCPM)	of	at	least	4.		





Unlike	Figure	4.15A,	which	 looks	at	variation	between	 libraries,	 this	plot	 looks	at	 the	





this	 distribution.	 Poisson	 distribution	 underestimates	 the	 variation	 seen	 in	 RNAseq	
data,	especially	 in	highly	expressed	data,	as	previously	described	(Anders	and	Huber,	
2010).	This	is	why	a	negative	binomial	model,	as	used	by	edgeR	and	DEseq	is	a	better	
fit	 for	 the	data.	Binned	variances	are	 shown	 in	brown,	 individual	data	points	 in	blue,	





In	 order	 to	 derive	 meaningful	 biological	 conclusions	 from	 the	 RNAseq	 data,	 there	
should	 be	 only	 small	 variations	 in	 the	 transcript	 abundance	 of	 each	 gene	 between	
biological	replicates.	Ideally	there	should	be	a	high	concordance	between	all	replicates	
for	each	of	the	two	strains.	This	is	seen	in	Figure	4.16A	and	B,	with	a	strong	correlation	




Figure	 4.15:	 A	 shows	 the	 biological	 coefficient	 of	 variation	 (BCV)	 in	 relationship	 to	 the	 logged	 count	 per	million	 (logCPM).	 A	 higher	 degree	 of	 variation	 is	
expected	for	lower	abundance	transcripts	and	this	is	observed.	The	plateau	seen	reflects	that	the	majority	of	the	transcripts	had	a	logCPM	value	of	greater	than	













































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Although	 infections	 with	 B17	 and	 Z310	 strains	 lead	 to	 very	 different	 disease	
manifestations,	 they	 are	 both	 genetically	 very	 similar,	 with	 less	 than	 1%	 difference	
between	 T.	brucei	 subspecies,	 and	 less	 in	 instances	 such	 as	 these,	 where	 the	 strains	




on	 BCV	 values	 between	 replicates	 and	 per	 treatment	 group.	 Although	 a	 division	
























separated	 based	 on	 fold	 change	 variance,	 the	 difference	 isn’t	 large,	 and	 so	 a	 relatively	 small	
number	of	differentially	expressed	genes	is	expected.	






























As	 shown	 in	 Table	 4.4,	 8356	 genes	were	 found	 to	 be	 transcriptionally	 active	 in	 both	
strains.	Genes	were	considered	 transcriptionally	active	 if	 they	had	greater	 than	 three	
reads	 per	 million	 across	 all	 samples.	 	 A	 high	 percentage	 of	 these	 (95%)	 were	 not	
differentially	 regulated,	 as	 expected.	 Differential	 expression	 was	 defined	 as	
significantly	higher	expression	compared	to	the	other	strain,	using	the	number	of	reads	
mapped	to	a	gene	as	a	measure	of	expression,	and	accounting	 for	biological	variation	
between	 biological	 replicates.	 No	 data	 is	 available	 to	 provide	 a	 background	 level	 of	








uses	 count	 frequencies	 to	 plot	 logged	 fold	 changes	 and	 average	 abundances	 using	 a	
Bland-Altman	plot	method.	However	unlike	a	MA	plot,	an	epsilon	factor	is	added	prior	
to	 logging	values,	which	allows	 for	easier	 identification	of	genes	with	 similar	 log	 fold	
changes,	which	may	overlap	 in	a	MA	plot.	This	also	allows	 for	 the	 inclusion	of	points	
unique	to	one	condition,	and	these	are	shown	in	yellow.		
	
In	 Figure	 4.18	 you	 can	 see	 that	 the	majority	 of	 genes	 aren’t	 differentially	 regulated.	
Differentially	regulated	genes	(DEG)	are	shown	in	red	and	there	is	a	clustering	of	genes	
that	 have	 only	 a	 slight	 difference	 in	 fold	 change,	 and	 that	 have	 a	 high	 fold	 change	
instead	of	 a	whole	 range	of	 differential	 expression.	This	 effect	 is	 also	 exaggerated	by	
the	 inclusion	 of	 the	 epsilon	 factor	 as	 previously	 mentioned.	 Fold	 change	 values	 are	
assigned	 so	 that	 genes	with	 a	 higher	 expression	 level	 in	 the	 B17	 strains	 are	 given	 a	
minus	value	and	 those	with	a	higher	expression	 level	 in	 the	Z310	strains	are	given	a	




Table	 4.4:	 8,356	 genes	 were	 determined	 as	 transcriptionally	 active	 in	 both	 of	 these	 strains.	
Transcriptionally	inactive	genes	were	determined	as	having	less	than	3	gene	counts	across	these	10	













Figure	 4.18:	 This	 RA	 plot	 shows	 the	 logged	 ratio	 of	 normalized	 expression	 levels	 between	 two	
strains.	Those	in	yellow	are	those	that	are	unique	expression	to	one	strain.	The	fanned	appearance	
is	due	to	the	use	of	an	epsilon	factor	prior	to	 logging	values,	which	prevents	data	from	being	lost	
due	 to	 overlapping,	 and	 exaggerates	 the	 effects	 of	 differential	 expression	 so	 it	 can	 be	 observed	


















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































As	 previously	 mentioned,	 fold	 change	 values	 are	 assigned	 as	 negative	 if	 the	 gene	 is	
upregulated	 in	 the	B17	 strain,	 and	positive	 if	 upregulated	 in	 the	Z310	 strain	 and	 are	
shown	in	Figure	4.19	 in	blue	and	red	respectively.	This	 figure	shows	that	not	only	do	
both	 strains	 have	 near	 identical	 numbers	 of	 differentially	 expressed	 genes,	 they	 also	
have	approximately	equal	fold	change	distributions,	with	similar	numbers	genes	with	a	






identified	 above.	DEGs	 in	blue	 represent	 those	 from	 the	B17	 strain,	 and	 those	 in	 red,	 Z310.	This	

















Fold change of differentially expressed genes








for	 the	 fold	 change	 of	 expression.	 Increases	 in	 B17	 expression	 are	 shown	 in	 blue,	




Several	 of	 these	 chromosomes	 appear	 to	 have	 uninteresting	 patterns	 of	 differential	
gene	expression,	in	particular	chromosomes	2,	4,	6	and	7.	These	chromosomes	do	have	
peaks	 of	 differential	 expression,	 however	 very	 few	 of	 these	 have	 a	 fold	 change	 of	
greater	 than	 five	 fold.	 	 Those	 that	 are	 greater	 than	 five	 fold	 are	 located	 within	 the	
telomeric	regions	of	the	chromosomes	where	we	would	expect	either	greater	sequence	
bias	due	to	the	repetitive	nature	of	the	telomeric	regions	and	VSGs,	which	are	likely	to	















As	 in	Figure	4.20,	blue	peaks	represent	upregulation	 in	B17,	red	represent	upregulation	 in	Z310.	




Chromosomes	3,8,9	 and	11	 all	 show	 clusters	 of	 high	 fold	 change	 at	 the	5’	 end	of	 the	
chromosome.	The	majority	of	 these	genes	are	VSGs.	Short	stumpy	 forms	have	greatly	
reduced	antigenic	variation	because	they	are	 incapable	of	generating	new	variants	on	
account	of	 their	 cell	 cycle	 arrest	 (Turner	and	Barry,	1989;	MacGregor	and	Matthews,	
2012).	 However	 it	 appears	 that	 there	 is	 an	 increased	 number	 of	 differentially	
expressed	 telomeric	 genes	 in	 the	B17	 strain,	which	 has	 a	much	 higher	 abundance	 of	
short	stumpy	forms.	This	suggests	that	perhaps	prior	to	cell	senescence,	the	parasites	
in	 the	 B17	 infection	 underwent	 a	 greater	 number	 of	 VSG	 switches,	 or	 that	 the	
remaining	long	slender	stages	have	an	increased	rate	of	VSG	switching	compared	to	the	
Z310	parasites.	Conversely,	the	Z310	parasites	cause	the	manifestation	of	a	particularly	




complement	 of	 these	 strains	 is	 likely	 to	 be	 different	 to	 those	 seen	 in	 Tb927,	 and	 for	
these	strains	small	sequence	differences	may	be	leading	to	reads	mapping	to	different	
VSGs,	 leading	 to	 these	genes	wrongly	being	 identified	as	differentially	expressed.	The	
DEGs	 of	 most	 interest	 are	 those	 with	 the	 highest	 logged	 fold	 change,	 those	 that	 are	








fold	 changes	 were	 VSGs.	 Beneath	 are	 discussed	 only	 genes	 with	 a	 high	 logged	 fold	







Figure	 4.22	 shows	 the	 function	 of	 each	 of	 the	 differentially	 regulated	 genes	with	 the	
highest	fold	changes	in	B17.	Fourteen	of	the	twenty	shown	are	VSG	genes.		Four	of	the	
remaining	 DEGs	 have	 no	 assigned	 function	 and	 are	 hypothetical.	 As	 seen	 in	 the	
	 200	
previous	 figure,	 the	majority	 of	 these	 genes	 have	 telomeric	 positions	 but	 clusters	 of	
high	 differential	 expression	 are	 not	 seen	 except	 for	 in	 the	 5’	 telomeric	 region	 on	
chromosome	 9.	 Of	 the	 remaining	 genes,	 one	 is	 an	 expression	 site	 associated	 gene,	
ESAG3,	 Tb927.11.20150,	 and	 has	 a	 logged	 fold	 change	 of	 	 ~12.64,	 and	 	 	 the	 other,	
Tb927.9.280,	 is	 a	 transferrin	 receptor.	 ESAG3	 is	 contained	 in	 all	 but	 one	 BES	 site,	





The	 transferrin	 receptor	 is	 required	 by	 the	 parasite	 in	 order	 to	 bind	 and	 internalize	
host	transferrin,	which	is	necessary	for	parasite	growth.	Previous	studies	have	shown	
that	this	is	facilitated	by	expression	site	associated	genes	ESAG6	and	ESAG7	forming	a	
heterodimer	 complex	 (Graham	 and	 Barry,	 1991;	 Chaudhri	 et	 al.,	 1994;	 Steverding,	
2000).	Unlike	some	ESAGs,	ESAG6	and	ESAG7	are	found	only	within	bloodstream	form	
expression	 sites	 (BES).	 The	 structure	 of	 BESs	 remains	 relatively	 constant	 between	
BESs,	with	multiple	copies	of	each	ESAG	within	the	genome,	however	these	still	remain	
poorly	 characterized	 (Hertz-Fowler	 et	 al.,	 2008).	 	Only	one	BES	 is	 active	 at	 any	 time,	
and	 the	 resulting	 transferrin	 receptor	 complex	 has	 been	 known	 to	 have	 an	 altered	




appear	 to	 be	 transcriptionally	 active.	 ESAG6	 and	 ESAG7	 are	 known	 to	 form	 the	
transferrin	receptor	in	order	to	bind	to	host	transferrin,	and	previous	work	has	shown	
transferrin	 is	 not	 bound	 without	 complex	 formation	 (Steverding	 et	 al.,	 1994).		








In	 B17	 strains,	 there	 is	 a	 logged	 10.76	 fold	 increase	 in	 expression	 of	 this	 putative	
transferrin	 receptor	 gene.	 Due	 to	 parasites	 within	 the	 B17	 infection	 being	
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predominantly	 cell	 cycle	 arrested,	 you	would	 anticipate	 their	 iron	 requirement	 to	 be	
lower.	 	However	haemolysis	does	occur	in	trypanosome	infections,	and	this	will	effect	
the	serum	concentrations	of	iron.		Older	stumpy	forms,	which	are	no	longer	capable	of	
being	 transmitted	 to	 a	 tsetse	 are	 highly	 immunogenic,	 in	 part	 due	 to	 the	 products	
released	 by	 them	 as	 a	 result	 of	 apoptosis.	 Stumpy	 stages	 can	 only	 survive	 48	 hours	
after	 differentiation	 before	 cell	 death,	 and	 the	 products	 released	 following	 apoptosis	
can	cause	haemolysis	and	oxidative	damage	(Duszenko	et	al.,	2006).		
	
One	 of	 the	 host’s	 responses	 to	 T.	 brucei	 infections	 is	 to	 starve	 the	 parasite	 of	 iron,	
limiting	 their	 growth.	However	 starving	T.	brucei	 of	 iron	has	been	 shown	 to	 increase	
transferrin	 receptor	 expression	 levels	 3-10	 fold,	 and	 leads	 to	 the	 relocation	 of	 the	
trypanosomal	 transferrin	 receptor	 complex	 to	 the	 parasite	 surface	 instead	 of	 the	
flagellar	pocket	 (Mussmann	et	al.,	2004;	Mehlert	et	al.,	2012).	 In	 chronic	 infections,	 a	
lower	 level	 of	 host	 transferrin	 receptor	 is	 seen,	 and	 in	 these	 infections	T.	brucei	 has	































Gene	 Function	 logCPM	 logFC	 P	value	 FDR	
Tb927.9.1010	 VSG	 8.374067571	 15.21067731	 7.63E-135	 7.27E-131	
Tb927.9.490	 VSG	 5.818099462	 12.68392269	 1.07E-06	 0.000100829	
Tb927.11.20150	 ESAG3	 8.161828957	 12.64405913	 3.04E-11	 6.04E-09	
Tb927.10.5200	 Hypothetical	 5.179299006	 12.0426041	 2.83E-05	 0.001703986	
Tb927.7.140	 VSG	 5.177117541	 12.01481549	 3.78E-09	 5.55E-07	
Tb927.11.20700	 Atypical	VSG	 6.882203019	 11.86385392	 3.55E-05	 0.002089804	
Tb927.11.19060	 VSG	 4.997174894	 11.85521352	 2.27E-06	 0.000189169	
Tb927.8.440	 VSG	 5.032819737	 11.84138605	 1.80E-06	 0.000154133	
Tb927.9.430	 VSG	 4.935823353	 11.79760949	 1.31E-08	 1.76E-06	
Tb927.7.110	 VSG	 4.774057948	 11.62197075	 4.15E-05	 0.002373487	




3.89700739	 10.76116616	 8.94E-05	 0.004437533	
Tb927.9.1240	 VSG	 3.862070807	 10.63143343	 0.000111612	 0.005137912	
Tb927.11.17070	 VSG	 3.651250279	 10.53704469	 0.000144668	 0.0062661	
Tb927.8.490	 Hypothetical	 3.609079756	 10.45223744	 0.000177073	 0.007210826	
Tb927.11.19020	 Hypothetical	 3.415290882	 10.28001567	 0.000146713	 0.006325913	
Tb927.9.830	 VSG	 3.348454732	 10.2162014	 4.27E-07	 4.15E-05	
Tb927.8.100	 VSG	 3.377893574	 10.1986047	 1.07E-05	 0.000737958	
Tb927.1.10	 Hypothetical	 3.312929165	 10.17780536	 0.000157138	 0.006596322	

























As	 above	 Figure	 4.23	 shows	 the	 function	 of	 each	 of	 the	 genes	 with	 the	 highest		
differential	 expression,	 but	 in	 Z310	 strains.	 Although	many	 of	 the	 DEGs	 in	 Z310	 are	
VSGs,	 the	 number	 is	 substantially	 lower	 than	 seen	 in	 B17	 infections.	 Only	 six	 out	 of	
nineteen	 DEGs	 were	 VSGs,	 however	 a	 large	 proportion	 of	 the	 other	 genes	 have	 no	
assigned	 function.	The	 remaining	 three	genes	encode	 for	 an	ATP	dependent	DEAD/H	
helicase,	 a	 phospholipid	ATPase	 and	 calmodulin.	 Unlike	 in	 the	 B17	 strains,	 the	DEGs	









is	 present	 in	 all	 eukaryotes,	 but	 trypanosomal	 calmodulin	 is	 distinct	 from	 host	
calmodulin	(Ruben	and	Patton,	1985).	Calcium	signaling	is	required	for	growth	and	for	
the	 migration	 of	 parasites	 across	 the	 blood	 brain	 barrier	 (Nikolskaia	 et	 al.,	 2006).		
Calcium	 regulation	 has	 also	 been	 shown	 to	 be	 key	 to	 virulence,	 cell	 invasion,	
differentiation	 and	 replication	 and	 stores	 of	 calcium	 are	 sequestered	 in	 T.	 brucei	 in	





brucei’s	 genome,	 another	 of	 the	 genomes	 encoding	 calmodulin,	 Tb927.9.6130,	 is	 also	
upregulated	 in	 Z310,	 albeit	 weakly,	 with	 a	 fold	 change	 increase	 of	 ~1.	 In	 Z310	
infections,	 calmodulin	 expression	 is	 increased	 10.4	 fold.	 This	 may	 be	 due	 to	 higher	
demand	 because	 a	 high	 proportion	 of	 the	 parasites	 in	 Z310	 strains	 are	 highly	
replicative.	 Calcium	 binding	 proteins	 called	 calflagins,	 have	 also	 been	 studied	 and	
shown	 inhibition	 of	 calcium	 signaling	 can	 lead	 to	 prolonged	 host	 survival	 and	 a	
reduction	 of	 parasitaemia	 (Emmer	 et	 al.,	 2010).	 Due	 to	 the	 plethora	 of	 pathways	
calcium	signaling	 is	 involved	in,	which	 include	replication	and	differentiation,	 it	could	
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sequence	 capture	 contained	 a	 conserved	 deleterious	 SNP	 within	 a	 helicase.	 	 As	
mentioned	 in	 Chapter	 3,	 helicases	 are	 central	 to	 many	 core	 processes	 including	
transcription,	 replication	 and	 degradation,	 because	 they	 control	 the	 unwinding	 and	









Phospholipid	 ATPases	 have	 not	 been	 extensively	 studied,	 and	 like	 the	 upregulated	
helicase	 gene,	 their	 action	 is	 dependent	 on	 ATP,	 however	 they	 are	 known	 to	 be	 cell	
surface	associated	(Richmond	et	al.,	2010).	T.	brucei	has	a	dense	phospholipid	coat,	and	
this	allows	the	parasite	to	respond	to	environmental	cues	and	exert	partial	control	over	
metabolites	entering	and	 leaving	 the	 cell	 (Richmond	et	 al.,	 2010).	 	This	was	 the	gene	
with	the	second	highest	fold	change	with	a	13.66	increase	in	Z310	strains.	Similarly	to	
the	 H	 helicase,	 this	 gene	 may	 be	 upregulated	 in	 an	 attempt	 to	 maintain	 a	 highly	
proliferative	parasite	population	because	phospholipids	 constitute	 a	 large	proportion	









































8.160253118	 15.09263794	 9.35E-11	 1.71E-08	
Tb927.11.13000	 Phospholipid	
ATPase	
6.758900435	 13.66454494	 4.64E-57	 8.84E-54	
Tb927.3.3200	 Hypothetical		 6.623608273	 13.54769223	 1.43E-07	 1.51E-05	
Tb927.3.1900	 Hypothetical	 5.879615637	 12.7804061	 1.02E-69	 3.23E-66	
Tb927.9.5000	 Hypothetical	 4.713187787	 11.64150165	 8.84E-07	 8.51E-05	
Tb927.3.5400	 Hypothetical	 4.631026826	 11.53589164	 1.25E-06	 0.000114686	
Tb927.9.340	 VSG	 4.595613865	 11.43813999	 2.53E-05	 0.001574693	
Tb927.9.970	 VSG	 4.388648948	 11.33249247	 4.02E-05	 0.002320893	
Tb927.9.960	 VSG	 4.064870278	 10.95965137	 2.43E-06	 0.000195844	
Tb927.9.5800	 Hypothetical	 3.971747599	 10.871956	 1.18E-08	 1.60E-06	
Tb927.11.17050	 VSG	 3.918345461	 10.86203878	 2.71E-05	 0.001644533	
Tb927.10.12050	 Hypothetical	 3.910662915	 10.79273793	 1.60E-06	 0.000139734	
Tb927.9.9500	 Hypothetical	 3.832520111	 10.75941754	 2.21E-06	 0.000187617	
Tb927.9.10100	 Hypothetical	 7.076387543	 10.46637481	 9.56E-101	 4.55E-97	
Tb927.8.260	 VSG	 3.615013912	 10.45871001	 7.05E-05	 0.003712087	
Tb927.11.13040	 Calmodulin	 3.478579555	 10.39622336	 1.01E-05	 0.000708032	
Tb927.9.11700	 Hypothetical	 3.319560602	 10.24017238	 8.19E-05	 0.004173646	
Tb927.9.1230	 VSG	 3.352236419	 10.19641947	 8.64E-05	 0.004372921	
























of	SNPs	 in	 the	WGS	data	 in	 the	genes	 that	are	differentially	expressed.	The	WGS	data	
did	 not	 identify	 any	 sole	 causal	 variants	 that	 could	 explain	 the	 different	 phenotypes	













Another	 link	between	the	transcriptomic	data	and	the	genomic	data	 is	 iron	transport.	
The	gene	putatively	encoding	a	transferrin	receptor	is	differentially	expressed	between	















A	 shows	 the	 total	 frequency	of	 SNPs	 unique	 to	 either	B17	or	 Z310	 compared	 to	 their	 fold	 change	 in	 the	RNAseq	data.	B	 shows	ony	 the	heterozygous	 SNPs	
















































group,	but	 the	remaining	genes	 fit	 into	nine	pathways.	DEGs	from	B17	were	enriched	





pathway,	 but	 slightly	 increased	 in	 B17	 strains.	 Due	 to	 upregulation	 in	 both	 of	 these	
strains,	 this	 suggests	 that	 different	 parts	 of	 the	 glycolytic	 pathways	 are	 being	



















Figure	 4.25:	DEGs	 from	each	 strain	were	 assigned	 to	 	 KEGG	pathway,	 and	 only	 9	 pathways	were	
significantly	enriched	.	DEGs	from	B17	are	shown	in	blue,	DEGs	from	Z310	are	shown	in	red.	There	



































have	 been	 validated	 to	 be	 part	 of	 the	 glycolytic	 pathways	 in	 T.	 brucei.	 DEGs	 involved	 in	 this	
pathways	are	shown	for	B17	in	blue,	and	for	Z310	in	red.	There	is	no	otherlap	in	the	DEGs	in	each	













Both	 stumpy	 and	 slender	 bloodstream	 stages	 solely	 depend	on	 glycolysis	 to	 produce	
ATP.	 Pyruvate	 is	 the	 primary	 end	 product	 of	 glycolysis,	 however	 bloodstream	 forms	
lack	 a	 functional	 mitochondria	 or	 Krebs	 cycle	 and	 so	 pyruvate	 can	 not	 be	 further	
metabolized,	 it	 can	 only	 be	 excreted	 back	 into	 the	 bloodstream	 to	 prevent	 an	
accumulation	within	 the	 parasite,	which	would	 be	 toxic	 (van	Grinsven	 et	 al.,	 2009b).	
The	upregulation	of	genes	belonging	to	the	pyruvate	metabolism	KEGG	group	suggests	
and	 upregulation	 of	 glycolysis,	 which	 is	 seen	 in	 this	 figure,	 and	 the	 excretion	 of	
pyruvate.	This	agrees	with	previous	observations,	 in	which	acetate	has	been	found	to	
be	 produced	 by	 stumpy	 forms,	 but	 not	 slender,	 and	with	 the	 predominantly	 stumpy	
population	present	in	B17	infections	this	is	unsurprising	(van	Grinsven	et	al.,	2009b).	
	
C5-branched	dibasic	acid	metabolism	 is	by	 far	 the	most	enriched	pathway	within	 the	
DEGs,	with	an	enrichment	in	excess	of	70	fold	in	B17	parasites.	This	pathway	was	also	
shown	 to	 be	 upregulated	 in	 the	 metabolomic	 data.	 Part	 of	 this	 metabolic	 pathway	
involves	the	metabolism	of	pyruvate	and	the	production	of	acetate	(van	Grinsven	et	al.,	
2009b).	This	pathway	is	also	fed	into	by	the	citrate	cycle,	which	is	also	upregulated	in	







Glycine	 and	 serine	 are	 non-essential	 amino	 acids	 and	 trypanosomes	 scavenge	 these	
nutrients	from	their	host.	Threonine	is	an	essential	amino	acid,	and	is	used	both	for	the	
production	of	glycine	and	for	the	production	of	pyruvate	(Linstead	et	al.,	1977).		Given	
the	 upregulation	 of	 pyruvate	metabolism	within	 the	B17	 parasites,	 it	 is	 unsurprising	
that	 glycine,	 serine	 and	 threonine	 metabolism	 is	 also	 upregulated	 within	 these	
parasites.		
	
Interestingly,	proline	metabolism	 is	 increased	 in	Z310	parasites,	 despite	 containing	a	
predominantly	 slender	 population.	 Glucose	 is	 the	 primary	 energy	 source	 for	
bloodstream	 form	 parasites	 and	 proline	 is	 used	 by	 procyclic	 forms	 due	 to	 the	 high	
abundance	of	proline	 in	 tsetse	haemolymph	and	scarce	quantities	of	glucose	(Bursell,	
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1981;	 van	Grinsven	et	 al.,	 2009a).	 	Arginine	metabolism	 is	 also	upregulated,	 and	 this	
has	 previously	 been	 related	 to	 parasite	 killing	 by	 the	 host.	 Trypanosomes	 require	
arginine	 for	 trypanothione,	 polyamine	 and	 DNA	 synthesis	 (Gobert	 et	 al.,	 2000).	
Arginine	 availability	 enables	 the	 host	 to	 increase	 its	 production	 of	 nitric	 oxide	 (NO),	
which	 T.	 brucei	 is	 susceptible	 to	 (Gobert	 et	 al.,	 2000).	 	 Upregulation	 of	 this	 KEGG	





Vitamin	 B6	 metabolism	 is	 the	 second	 most	 upregulated	 pathway	 in	 B17	 parasites,	
however	 little	 research	 has	 been	 done	 on	 the	metabolism	 of	 vitamin	 B6	 in	T.	brucei.	
Vitamin	B6	 is	 synthesized	 by	 all	 complex	 organisms,	 and	 some	protozoa,	 however	T.	
brucei	are	most	likely	to	scavenge	their	requirements	from	the	host.	One	protozoan	has	



















The	assigned	GO	 terms	 from	Z310	 infections	are	 shown	on	 in	Figure	4.26A.	Here	 the	





and	 energy,	 which	 contains	 all	 the	 central	 pathways	 for	 metabolism	 including	





defense	response	 terms	also	shown	 in	Figure	4.27A.	Genes	related	 to	 locomotion	and	
microtubule	 based	processes	were	 also	 enriched,	which	 is	 a	 reflection	 of	 the	 slender	
dominant	population.	Long	slender	stages	are	both	more	motile	due	to	their	elongated	
flagella	 compared	 to	 the	 stumpy	 stages,	 and	will	 require	 structural	 reassortment	 by	
microtubules	due	to	their	constant	replication.	
	
Similarly	 to	 the	 GO	 terms	 enriched	 in	 the	 Z310	 infections,	 there	 are	 a	 variety	 of	 GO	




of	 Figure	 4.27B.	 	 This	 relates	 to	 the	 high	 number	 of	 VSGs	 found	 to	 be	 highly	
differentially	 expressed	 in	 B17.	 	 Other	 significant	 GO	 terms	 of	 interest	 include	 GPI	
anchor	 metabolism,	 acetyl	 coA	 metabolism,	 carboxylic	 acid	 catabolism	 and	 small	
molecule	 catabolism.	 GPI	 anchor	 metabolism	 involves	 the	 mechanism	 for	 attaching	
proteins	 to	 the	 surface	 of	 the	 glycolipid	 bilayer	 covering	 the	 surface	 of	 the	




parasites,	 and	 acetate	 is	 produced	 from	 stumpy	 stages.	 Acetate	 and	 pyruvate	
metabolism	 are	 the	 precursors	 for	 acetyl-coA,	 and	 so	 acetyl	 coA	 metabolism	
enrichment	 reaffirms	 the	 upregulation	 of	 glycolysis	 and	 pyruvate	 metabolism.	
Similarly,	enrichment	in	the	DEGs	related	to	carboxylic	acid	catabolism	reflects	the	C5-
branched	dibasic	acid	metabolism	upregulation	seen	in	the	KEGG	data.	Small	molecule	
catabolism	 is	 the	 breakdown	 of	 small	 molecules	 such	 as	 low	 molecular	 weight	

















Some	 of	 the	 genes	 with	 potential	 functional	 interest	 were	 differentially	 expressed	
between	B17	and	Z310	strains,	but	had	a	lower	fold	change,	and	so	weren’t	included	in	
the	 above	 discussion	 of	 the	 genes	 with	 the	 highest	 fold	 changes.	 Beneath	 is	 a	 brief	
discussion	of	some	of	the	genes	with	a	fold	change	typically	of	less	than	five	fold	which	
are	 of	 interest	 because	 they	 have	 either	 been	 linked	 to	 a	 particularly	 important	
pathway,	have	been	implicated	in	drug	resistance	and	virulence	or	could	be	potentially	
important	in	explaining	the	disparity	in	bloodstream	form	abundances.	All	of	the	genes	





Figure	 4.28:	 This	 shows	 the	 chromosomal	 position	 of	 the	 genes	 discussed	 in	 this	 section.	 Only	
chromosomes	 6-11	 are	 shown	 because	 all	 of	 these	 genes	 were	 located	 within	 this	 region.	































Tb927.11.1100,	was	 a	 cysteine	 peptidase.	 Amino	 acid	 permease	 24	 (AAT6)	was	 also	
upregulated	in	B17,	and	has	linked	to	eflornithine	efficacy	and	resistance	(Alsford	et	al.,	
2012).	 A	 NT10	 purine	 nucleoside	 transporter	 linked	 to	 nufurtimox	 efficacy	 and	










Phospholipase	 A1,	 phosphoglycerate	 mutase,	 pyruvate	 kinase	 1	 and	 pyruvate	
dehydrogenase	are	important	in	glycolysis	and	differentially	expressed.	Unsurprisingly,	
due	 to	 the	 highly	 proliferative	 population	 seen	 in	 Z310	 infections,	 the	 glycolytic	
demand	is	greater	and	so	three	of	these	genes	are	upregulated	in	the	Z310	strains.	One	
of	 these	 is	phospholipase	A1,	which	 is	upregulated	nearly	six	 fold	 in	 the	Z310	strains	
and	 is	 localized	 to	 the	 glycosome	 (Smith	 and	Buetikofer,	 2010;	Guether	 et	 al.,	 2014).	
The	other	two	that	are	upregulated	in	Z310	to	a	lesser	extent	are	pyruvate	kinase	1	and	
phosphoglycerate	 mutase.	 Both	 are	 important	 in	 glycolysis	 and	 phosphoglycerate	
mutase	has	been	implicated	in	virulence	in	Leishmania	(Chevalier	et	al.,	2000;	Mercaldi	






As	 described	 in	 Chapter	 3,	 the	 parasite	 population	 in	 B17	 infections	 is	 comprised	
largely	 of	 non-proliferative	 bloodstream	 forms,	 whereas	 Z310	 infections	 contain	
primarily	 highly	 proliferative	 bloodstream	 forms.	 The	 stumpy	 stages	 are	 less	 motile	
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than	 the	 long	slender	stages	on	account	of	 their	shortened	 flagellum,	and	evidence	of	
this	is	seen	in	the	comparatively	higher	levels	of	paraflagellar	components,	PFC17	and	
PFC19,	 in	 Z310	 strains	 (Portman	 and	 Gull,	 2010).	 PAD2	 is	 a	 stumpy	 stage	 specific	
marker,	 is	 also	 increased	 in	 B17	 infections,	 and	 this	 correlates	 with	 the	 QPCR	 and	
microscopy	 data	 in	 Chapter	 3.	 Stumpy	 stage	 parasites	 have	 approximately	 48	 hours	
before	 cell	 death,	 but	 the	 parasitaemia	 in	 B17	 infections	 does	 not	 stay	 at	 low	 levels	
despite	only	a	small	proportion	of	the	parasites	being	capable	of	replication	(Duszenko	
et	al.,	2006).	Interestingly,	in	B17,	gene	translationally	controlled	tumor	protein	(TCTP)	





Transcriptomic	 data	 and	 metabolomic	 data	 can	 both	 give	 a	 snapshot	 of	 a	 biological	
system,	which	 is	 generally	 transient.	 Transcripts	 are	 continually	 produced,	 regulated	
and	 degraded,	 similarly	 to	 in	 metabolomics	 in	 which	 metabolomic	 pathways	 are	
constantly	 regulated,	 and	 the	 products	 continually	 produced	 and	 degraded	 at	 a	 non-
constant	 rate.	 Metabolomic	 data	 has	 a	 much	 lower	 resolution	 in	 comparison	 to	
transcriptomic	 data,	with	 less	 than	 1000	metabolites	 that	 can	 be	 identified,	 less	 that	
can	 be	 confirmed.	 In	 comparison,	 transcriptomic	 data	 can	 be	 used	 to	 look	 at	 all	
transcriptionally	 active	 genes,	 which	 in	 these	 experiments	 was	 over	 8000	 genes.	




data	 is	 key,	 one	 for	 showing	 reproducibility	 of	 the	 data,	 and	 two	 to	 improve	 any	
analysis	derived	using	both	methods	in	conjunction.		
	





The	 QPCR	 and	 microscopy	 data	 within	 Chapter	 3	 demonstrated	 that	 B17	 infections	
contained	 predominantly	 non-proliferative	 stage	 bloodstream	 forms,	 although	
proliferative	 stages	were	 also	present.	 	Due	 to	 the	nature	 of	 these	 stumpy	 forms,	we	
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would	anticipate	them	to	have	reduced	metabolic	activities,	although	they	are	known	to	
be	more	 immunogenic	 to	 the	host.	This	 is	 supported	by	both	 the	 transcriptomic	data	
and	metabolomic	data.	There	are	many	more	highly	abundant	metabolites	seen	in	B17	
infections,	however	 this	appears	 to	be	 the	result	of	 the	hosts	 response	 to	 these	more	
immunogenic	 stages,	 rather	 than	 an	 upregulation	 in	 the	 pathways	 of	 the	 parasite.	
Several	metabolites	 of	 host	 origin	 show	 the	damaging	 effect	 of	 the	host	mounting	 an	
immune	response	against	 the	parasite,	with	metabolites	consistent	with	 liver	damage	
present	among	others.	However	in	the	RNAseq	data,	a	relatively	equal	number	of	genes	
were	 differentially	 expressed,	with	 neither	 parasite	 strain	 illustrating	 unusually	 high	
levels	of	differential	expression.		
	
There	were	several	overlaps	 in	 the	metabolomic	data	and	 transcriptomic	data,	which	
were	consistent;	the	most	important	of	these	is	glycolysis.	Glycolysis	was	shown	to	be	
upregulated	 in	 both	 metabolomic	 and	 transcriptomic	 data.	 Other	 consistencies	
included	 the	 upregulation	 of	 glycine,	 serine	 and	 threonine	 metabolism	 and	 C5	
branched	dibasic	acid	metabolism,	which	was	 found	 to	be	higher	 in	 the	B17	strain	 in	
both	sets	of	data.	Tryptophan	metabolism	was	also	found	to	be	higher	in	B17	infections	
in	 both	 datasets,	 with	 increased	 amounts	 of	 indole-3-ethanol	 (tryptophol)	 found	 in	
metabolomic	 data	 and	 indole-	 containing	 metabolism	 in	 B17’s	 DEGs.	 Tryptophan	 is	
tryptophol’s	precursor,	and	tryptophol	is	used	by	the	parasite	to	induce	sleep	within	its	






Both	 the	metabolomic	and	 transcriptomic	data	were	useful	 in	providing	more	 insight	







Importantly,	 each	 strain	 was	 distinctive	 enough	 that	 they	 gave	 rise	 to	 a	 different	
metabolomic	 signature,	 and	 B17	 and	 Z310	 infected	 individuals	 clustered	 separately.	
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From	 the	 disease	manifestation,	 you	would	 presume	 that	 the	metabolites	 of	 infected	
individuals	would	vary	significantly	from	pre-infected	individuals,	and	this	is	observed.		
The	 pre-infection	 metabolomic	 profile	 is	 very	 different	 to	 the	 post	 infection	 profile.	






of	 metabolites	 belonging	 to	 pathways.	 In	 this	 instance,	 both	 ways	 were	 applied.	 In	
individual	analysis	confidently	 identified	metabolites	with	 the	highest	abundance	and	
metabolites	 with	 the	 largest	 differences	 between	 stages	 were	 used	 and	 in	 pathway	
analysis	 the	 upregulation	 of	 pathways	 was	 derived	 from	 the	 abundances	 of	 several	
metabolites	from	the	same	pathway,	to	look	at	the	overall	state	of	regulation.	
	
This	 chapter	 also	demonstrated	 that	RNAseq	 can	be	done	directly	 from	 infected	host	
blood	 samples	 and	 yield	 a	 good	 depth	 of	 coverage	 and	 a	 high	 percentage	 of	 reads	
belonging	to	the	parasite.	However	these	samples	were	taken	from	high	parasitaemia	
infections	at	the	first	peak	of	parasitaemia,	and	so	the	percentage	of	usable	reads	from	
a	 low	parasitaemia	 infection	may	yield	unusable	data.	For	each	strain	there	were	 five	











more	 centric	 regions	 of	 the	 chromosome.	 Unfortunately,	 many	 of	 these	 highly	










GO	 term	 analysis	 on	 the	DEGs	 gave	 similar	 findings,	with	multiple	 functional	 groups	
assigned	to	DEGs	but	only	a	few	were	significantly	enriched.	As	with	the	KEGG	analysis	
it	shows	that	gluconeogenesis	and	carbohydrate	metabolism	was	enriched	in	Z310,	and	
it	 also	 reflected	 that	 the	 highest	 fold	 change	 DEGs	 were	 in	 VSGs,	 with	 antigenic	
variation	enriched	for	significantly,	particularly	in	B17,	where	there	was	a	significantly	
higher	 number	 of	 VSGs	 upregulated.	 This	 higher	 number	 of	 VSGs	 in	 a	 highly	 non-
proliferative	population	could	suggest	either	that	the	remaining	long	slender	forms	in	
the	 B17	 infection	 switch	 at	 a	 higher	 frequency	 than	 seen	 in	 Z310	 or	 that	 the	 Z310	
parasites	 switch	 particularly	 slowly.	 However	 as	 previously	 discussed,	 this	 is	 more	







previous	 section.	 However	 having	 analysis	 combined	 from	 both	 data	 sets	 was	
invaluable,	with	metabolomics	providing	additional	information	on	the	host	response,	
and	 transcriptomics	 for	 increasing	 the	 data	 resolution	 which	 enables	 you	 to	 look	 at	

















rhodesiense	 strains,	 in	 an	 attempt	 to	 elucidate	 the	 genetic	 mechanisms	 driving	 the	
differences	 in	 disease	 manifestation	 in	 both	 natural	 and	 experimental	 infection.	 As	
previously	 stated,	 virulence	 is	 not	 easily	 characterized,	 and	 in	 parasitic	 infections	
attempts	 predominantly	 rely	 on	 using	 key	 phenotypic	 differences	 rather	 than	
understanding	 the	 genetic	 mechanisms.	 Previous	 studies	 phenotyped	 these	 strains	




due	 to	both	 the	 reduction	 in	 cost	 and	chemistry	 improvements,	parasitology	projects	
are	being	guided	away	 from	these	 traditional	 low	throughput	methodologies	 towards	
OMIC	technologies	and	from	studying	strains	in	isolation	to	population	studies.			
	
This	 project	 utilized	 technological	 advances	 to	 decipher	 these	 strains	 at	 a	 genomic,	
transcriptomic	 and	metabolomic	 level,	 in	 an	 attempt	 to	 increase	 the	 power	 of	 these	
analyses	 by	 using	 all	 methods	 in	 combination.	 Individually,	 these	 technologies	 have	
provided	us	with	 great	 insights	 into	 the	 genetic	mechanisms	 in	T.	brucei,	 however	 in	





Chapter	 two	 discussed	 the	 feasibility	 of	 sequencing	 directly	 from	 blood	 in	 place	 of	
whole	genome	sequencing	from	cultured	parasites.	This	was	done	through	the	design	
of	an	enrichment	array	covering	approximately	12%	of	the	Tb927	genome,	and	nesting	
a	 subsequent	 enrichment	design	within	 the	original	 target	 region.	Minute	volumes	of	
blood	were	applied	to	Whatman	FTA™	cards	and	successfully	enriched	and	sequenced.		
As	 previously	mentioned,	 this	 not	 only	 circumvents	multiple	 logistical	 issues	 arising	
from	the	CAT3	nature	of	the	parasite,	but	also	allows	for	the	sequencing	of	previously	
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the	 time	 of	 design,	 with	 subsequent	 re-annotation	 of	 several	 of	 the	 genes	 included	
within	the	first	design.	This	was	reflected	in	the	probes	ordered	for	the	second	design	
and	 allowed	 for	 capture	 of	 the	UTR	 regions	 of	 genes,	which	may	have	not	 been	 fully	
targeted	in	the	first	design.		The	availability	of	whole	genome	sequence	data	for	two	of	
these	 strains	 enabled	 the	 validation	 of	 variants	 and	 the	 robustness	 of	 enrichment	
sequencing	to	be	investigated.	Seven	strains	were	used	in	the	first	design,	sixteen	in	the	
second,	 however	 only	 the	 two	which	whole	 genome	 sequence	 data	was	 available	 for	
could	be	analyzed	 in	 this	way.	All	 seven	strains	enriched	well	within	 the	 first	design,	
and	 the	 strains	 used	 in	 both	 designs	 were	 also	 successfully	 enriched.	 Unfortunately,	
despite	enrichment,	 strain	B17	did	perform	poorly	 in	 the	second	design	compared	 to	
the	 other	 six	 strains	 used	 in	 both.	 This	 analysis	 could’ve	 been	 improved	 if	WGS	data	
was	available	for	the	other	strains	used	in	these	designs.		
	




in	 the	 enrichment	 data	 compared	 to	 the	 WGS	 data,	 indicating	 a	 greater	 sensitivity,	
which	is	what	we	would	anticipate	from	Illumina	versus	SOLiD	chemistry.	Despite	the	
parasite	 originally	 representing	 only	 less	 than	 0.1%	 of	 the	 sample,	 not	 only	was	 the	
enrichment	 substantial,	 but	 the	 data	 did	 not	 appear	 to	 suffer	 from	 allelic	 drop	 out	










in	 the	 enriched	 data	 still	 resulted	 in	 a	 significant	 enrichment.	 However,	 this	 still	
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represented	 only	 a	 small	 proportion	 of	 the	 dataset	 (~1%)	 and	 so	 a	 greater	 depth	 of	
sequencing	would	be	required	to	make	use	of	this	data.		
	








seven	 strains,	 which	 were	 used	 both	 in	 the	 first	 and	 second	 capture	 design.	 Three	
strains	were	 available	 for	 zymodeme	groups	B17	and	Z310,	however	only	one	 strain	
was	 available	 for	 the	 intermediate	 phenotype.	 Strain	 availability	 is	 the	main	 limiting	
factor	 in	 this	 analysis,	 as	 more	 strains	 would	 make	 inferences	 on	 variants	 seen	 in	
individuals	 and	 variants	 conserved	 across	 zymodeme	 groups	more	 valid.	 Due	 to	 the	
lack	 of	 a	 T.b.	 rhodesiense	 reference	 and	 the	 inferior	 quality	 of	 the	 DAL	 reference,	





greater	 number	 of	 non-conserved	 SNPs	 could	 be	 used	 to	 understand	 inter/intra	
zymodeme	variation.		
	




clear	 causal	mutation	 could	 be	 identified.	 However	multiple	 SNPs	were	 found	 in	 the	
transmembrane	 component	 of	 ferric	 reductase,	which	 suggested	 iron	 regulation	was	
potentially	important	in	generating	this	phenotype.	This	idea	was	further	supported	in	
Chapter	4,	 by	 the	greater	 than	 ten	 fold	 increase	 in	 transferrin	 receptor	 expression	 in	
B17.	Data	within	this	chapter	indicated	that	the	phenotypic	differences	observed	were	







Chapter	 4	 used	 both	 transcriptomic	 and	metabolomic	 analysis	 to	 further	 phenotype	
these	 strains.	 Variants	 called	 from	 the	 genomic	 data	 and	 the	 difference	 in	 the	
bloodstream	 form	 abundance	 discussed	 in	 Chapter	 3	 indicated	 that	 few	 genotypic	
differences	were	responsible	for	the	severe	difference	in	phenotype	observed	and	that	
differential	 regulation	 was	 more	 likely	 to	 be	 driving	 the	 phenotypes	 generated.	 As	
suggested	 by	 the	 genomic	 data,	 only	 a	 small	 subset	 of	 genes	 were	 differentially	
regulated.	Not	all	 genes	are	 transcriptionally	 active	and	 there	are	 substantially	 fewer	






by	 using	 transcriptomic	 data	 in	 conjunction,	 I	 could	 identify	 pathways	 that	 were	
differentially	upregulated	 in	 the	RNAseq	data	and	the	metabolomic	data,	and	observe	
whether	SNPs	were	also	 identified	 in	 these	genes.	The	highest	differential	expression	
was	 observed	 primarily	 in	 VSG	 genes,	 however	 as	 previously	 discussed,	 this	 is	more	
likely	 to	be	 an	artefact	 of	mapping	 to	 the	Tb927	 reference	 than	biologically	 relevant.	
However	 multiple	 differentially	 expressed	 genes	 were	 also	 identified	 which	 had	
previously	been	associated	with	virulence.		
	
The	 RNAseq	 data	 and	 metabolomic	 data	 were	 largely	 consistent	 and	 showed	




greater	 conclusions	 could	 have	 been	 drawn	 if	 transcriptomic	 and	 metabolomic	 data	
was	 available	 for	 more	 than	 the	 first	 peak	 of	 parasitaemia,	 as	 RNAseq	 libraries	
generated	from	samples	taken	at	the	late	stage	of	disease	could	provide	useful	insights	






The	 combined	 use	 of	 multiple	 OMIC	 approaches	 within	 this	 body	 of	 work	 has	
highlighted	 several	 potential	 mechanistic	 differences,	 which	 could	 be	 driving	 the	
disparity	in	virulence	observed	in	these	strains.	No	causal	variant	or	regulatory	process	
regulating	 this	 phenotype	 can	 conclusively	 be	 identified	 from	 this	 work,	 however	
multiple	 deleterious	 variants	 identified	within	 Chapter	 3	 and	 differentially	 regulated	
genes	 identified	 in	Chapter	4,	suggest	several	mechanisms	which	may	be	driving	this.		
The	 microscopy	 and	 QPCR	 data	 highlighted	 the	 extreme	 differences	 in	 bloodstream	
form	abundance	observed	 in	 these	 two	strains	and	 suggested	mechanisms	 regulating	
differentiation	 could	 be	 regulating	 the	 phenotype.	 Stumpy	 forms	 predominating	 B17	
infections	 correlates	 with	 the	 chronic	 nature	 of	 the	 strain	 and	 chancre	 presence	
observed	because	 stumpy	 forms	 illicit	 a	 greater	 immune	 response,	 and	have	 reduced	
motility,	 which	 could	 lead	 to	 the	 chancre	 formation.	 This	 also	 agrees	 with	 the	
metabolomic	data,	because	despite	the	reduced	metabolic	capabilities	of	stumpy	forms,	
a	 higher	 abundance	 of	 metabolites	 are	 observed	 compared	 to	 Z310	 infection,	
suggesting	host	response.	Iron	is	essential	for	parasite	growth,	and	the	high	density	of	
SNPs	 found	 in	 iron	 regulatory	 pathways	 and	 the	 high	 fold	 changes	 observed	 in	 the	












































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Additional	 appendices	 are	 given	 in	 the	 format	 of	 excel	 spreadsheets	 for	 the	
metabolomics	data	and	for	additional	 information	for	the	differential	gene	expression	






This	provides	 the	LC-MS	 intensity	data	 for	 all	 of	 the	metabolites	 that	were	 identified	







This	provides	 the	LC-MS	 intensity	data	 for	 all	 of	 the	metabolites	 that	were	 identified	





This	 contains	 the	 intensity	 data,	 and	 additional	 information,	 such	 as	 the	 KEGG	
pathways	associated	with	these	metabolites	for	the	B17	infection.	Standard	metabolites	
used	 for	 calibration	 are	 highlighted	 in	 yellow	 in	 the	metabolite	 ID	 column.	 Averaged	
intensities	 across	 individuals	 for	 each	metabolite	 are	 given	 in	 the	 comparison	 sheet.	






This	 contains	 the	 intensity	 data,	 and	 additional	 information,	 such	 as	 the	 KEGG	
pathways	 associated	 with	 these	 metabolites	 for	 the	 Z310	 infection.	 Standard	
metabolites	used	for	calibration	are	highlighted	in	yellow	in	the	metabolite	ID	column.	
Averaged	intensities	across	individuals	for	each	metabolite	are	given	in	the	comparison	
sheet.	 High	 intensities	 relative	 to	 the	 control	 are	 given	 in	 red.	 Intensities	 with	 no	






This	 contains	 gene	 ID	 information	 as	 given	 in	 appendices	 A16	 and	 A17	 for	 the	
differentially	expressed	genes	,	and	includes	information	such	as	the	logged	fold	counts	






	 WGS	data	 Enriched	data	 Percentage	similarity	(%)	compared	to	WGS	
First	Design	 Second	Design	 First	Design	 Second	Design		 First	Design	 Second	Design		
	 Z310	 B17	 Z310	 B17	 Z310	 B17	 Z310	 B17	 Z310	 B17	 Z310	 B17	
SNPs	called	in	target	
region	




















































































































	 Zymodeme		 Strain	 Number	of	mapped	reads	 Number	of	unmapped	
reads	
%	Mapped	
Design	one	 Z310	 B	 4,760,494	 2,710,694	 64	
M	 3,159,047	 3,738,119	 46	
T	 1,194,061	 4,609,905	 21	
Z366	 O	 3,533,578	 3,0159,86	 54	
B17	 K	 1,445,293	 3612983	 29	
E	 3,785,095	 2,878,297	 57	
N	 3,463,064	 2,720,802	 56	
	
Design	two		
Z310	 B	 31,648,671	 6,789,877	 82	
M	 24,731,217	 11,209,339	 69	
T	 39,880,822	 11,344,354	 78	
Z366	 O	 12,033,683	 13,225,031	 48	
B17	 K	 13,423,808	 12,283,470	 52	
E	 4,328,556	 25,019,710	 15	
N	 22,901,561	 16,722,543	 58	
Unknown	 G1	 127,092	 20,983,344	 1	
G2	 269,602	 36,472,240	 1	
G3	 164,378	 23,394,980	 1	
G4	 193,342	 28,911,314	 1	
G5	 432,178	 33,611,120	 1	
G6	 258,136	 34,348,612	 1	
G7	 20,984,509	 5,618,953	 79	
G9	 842,923	 34,764,987	 2	






















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































	Appendix	 5:	 Raw	 parasite	 counts	 from	 tail	 snip	 bleeds	 during	 infections	 used	 for	 microscopy	
screening	and	QPCR	data.	These	were	counts	taken	from	5µl	volumes,	per	ml	parasitaemia	is	200	x	




per	stage,	 the	percentage	of	parasites	 in	 this	stage	 is	also	given.	Counts	beneath	20	are	shown	 in	
bold	 and	 represent	 a	 parasitaemia	 of	 less	 than	 4000	 parasites	 per	 ml.	 Individuals	 B1-B5	 were	




B1	 B2	 B3	 B4	 B5	 E1	 E2	 E3	 E4	 E5	
3	 SS	counts	 2	 5	 3	 1	 1	 No	parasites	detected	
SS	percentage	 6.45	 8.93	 7.69	 3.45	 2.56	
LS	counts	 29	 51	 35	 25	 34	
LS	percentage	 93.54	 91.07	 89.74	 86.21	 87.18	
I	counts	 0	 0	 1	 3	 4	
I	percentage	 0	 0	 2.56	 10.34	 10.26	
Total	count	 31	 56	 39	 29	 39	
4	 SS	counts	 3	 3	 0	 0	 3	
SS	percentage	 5.56	 6.67	 0	 0	 7.5	
LS	counts	 51	 42	 50	 38	 36	
LS	percentage	 94.44	 93.33	 100	 100	 90	
I	counts	 0	 0	 0	 0	 1	
I	percentage	 0	 0	 0	 0	 2.5	
Total	count	 54	 45	 50	 38	 40	
5	 SS	counts	 2	 2	 3	 3	 3	 6	 0	 0	 3	 0	
SS	percentage	 5.71	 5.71	 7.69	 8.57	 10	 85.71	 0	 0	 75	 0	
LS	counts	 32	 32	 33	 31	 25	 1	 0	 0	 0	 0	
LS	percentage	 91.43	 91.43	 84.62	 88.57	 83.33	 14.29	 0	 0	 0	 0	
I	counts	 1	 1	 3	 1	 2	 0	 0	 0	 1	 0	
I	percentage	 2.86	 2.86	 7.69	 2.86	 6.67	 0	 0	 0	 25	 0	
Total	count	 35	 35	 39	 35	 30	 7	 0	 0	 4	 0	
6	 SS	counts	 3	 1	 3	 1	 0	 21	 1	 7	 37	 34	




LS	counts	 19	 6	 33	 10	 1	 6	 0	 1	 4	 3	
LS	percentage	 86.36	 85.71	 84.62	 90.91	 100	 18.18	 0	 12.5	 9.76	 8.11	
I	counts	 0	 0	 3	 0	 0	 6	 0	 0	 0	 0	
I	percentage	 0	 0	 7.69	 0	 0	 18.18	 0	 0	 0	 0	
Total	count	 22	 7	 39	 11	 1	 33	 1	 8	 41	 37	
7	 SS	counts	 0	 No	parasites	detected	 30	 25	 35	 50	 50	






LS	counts	 1	 3	 5	 3	 0	 3	
LS	percentage	 100	 9.09	 14.7
1	
7.32	 0	 5.66	
I	counts	 0	 0	 4	 3	 0	 0	
I	percentage	 0	 0	 11.7
6	
7.32	 0	 0	
Total	count	 1	 33	 34	 41	 50	 53	
8	 SS	counts	 7	 5	 No	parasites	detected	 0	 30	 0	 2	 7	
SS	percentage	 46.67	 71.43	 0	 96.7
7	
0	 100	 100	
LS	counts	 7	 1	 0	 1	 0	 0	 0	
LS	percentage	 46.67	 14.29	 0	 3.23	 0	 0	 0	
I	counts	 1	 1	 0	 0	 0	 0	 0	
I	percentage	 6.67	 14.29	 0	 0	 0	 0	 0	
Total	count	 15	 7	 0	 31	 0	 2	 7	
9	 SS	counts	 7		 5	 4	 1	 4	 1	 No	parasites	detected	
SS	percentage	 53.85	 15.63	 28.57	 50	 11.76	 100	
LS	counts	 6	 20	 10	 1	 30	 0	
LS	percentage	 46.15	 62.5	 71.43	 50	 88.24	 0	
I	counts	 0	 7	 0	 0	 0	 0	
I	percentage	 0	 21.88	 0	 0	 0	 0	






Appendix	 6:	 Short	 stumpy	 (SS),	 long	 slender	 (LS)	 and	 intermediate	 (I)	 relative	 percentages	 per	
individual	 and	 averaged	 are	 given	 below	 and	based	 on	 data	 from	appendix	 5.	 Individuals	B1-B5	
were	infected	with	Z310	parasites,	strain	B,	E1-E5,	with	B17	parasites,	strain	E.	Instances	where	no	
parasites	were	counted	are	indicated.	*No	parasites	were	detected	in	some	of	the	individuals,	and	






B1	 B2	 B3	 B4	 B5	 E1	 E2	 E3	 E4	 E5	
3	 SS	percentage	 6.45	 8.93	 7.69	 3.45	 2.56	 No	parasites	detected		
Average	SS	percentage	 5.8	
LS	percentage	 93.54	 91.07	 89.74	 86.21	 87.18	
Average	LS	percentage	 89.6	
I	percentage	 0	 0	 2.56	 10.34	 10.26	
Average	I	percentage	 4.6	
4	 SS	percentage	 5.56	 6.67	 0	 0	 7.5	
Average	SS	percentage	 4.0	
LS	percentage	 94.44	 93.33	 100	 100	 90	
Average	LS	percentage	 95.5	
I	percentage	 0	 0	 0	 0	 2.5	
Average	I	percentage	 0.5	
5	 SS	percentage	 5.71	 5.71	 7.69	 8.57	 10	 85.71	 0	 0	 75	 0	
Average	SS	percentage	 7.5	 80.4*	
LS	percentage	 91.43	 91.43	 84.62	 88.57	 83.33	 14.29	 0	 0	 0	 0	
Average	LS	percentage	 87.9	 7.1*	
I	percentage	 2.86	 2.86	 7.69	 2.86	 6.67	 0	 0	 0	 25	 0	
Average	I	percentage	 4.6	 12.5*	






LS	percentage	 86.36	 85.71	 84.62	 90.91	 100	 18.18	 0	 12.5	 9.76	 8.11	
Average	LS	percentage	 89.6	 9.7	
	



























LS	percentage	 46.67	 14.29	 0	 3.23	 0	 0	 0	
Average	LS	percentage	 30.5*	 1.1	
I	percentage	 6.67	 14.29	 0	 0	 0	 0	 0	
Average	I	percentage	 10.4*	 0	
9	 SS	percentage	 53.85	 15.63	 28.57	 50	 11.76	 No	parasites	detected**	(One	SS	
counted	in	one	E1	mouse)	Average	SS	percentage	 32.0	
LS	percentage	 46.15	 62.5	 71.43	 50	 88.24	
Average	LS	percentage	 63.6	
	







Appendix	 7:	 Parasitaemia	 per	 individual	 and	 averaged	 values	 are	 given	 below	 for	 the	 infected	
animals	 discussed	 in	 Chapter	 2,	 which	 were	 used	 to	 generate	 QPCR	 and	 metabolomic	 data	 and	
observe	 the	 relative	 abundances	 of	 SS:LS	 stages.	 Individuals	 B1-B5	 were	 infected	 with	 Z310	









	 B1	 B2	 B3	 B4	 B5	 E1	 E2	 E3	 E4	 E5	
3	 	 6200	 11200	 7800	 5800	 7800	 0	 0	 0	 0	 0	
Mean	 7760	 0	
4	 	 10800	 9000	 10000	 7600	 8000	 0	 0	 0	 0	 0	
Mean	 9080	 0	
5	 	 7000	 7000	 7800	 7000	 6000	 1400	 0	 0	 800	 0	
Mean	 6960	 440	
6	 	 4400	 1400	 7800	 2200	 200	 6600	 200	 1600	 8200	 7400	
Mean	 3200	 4800	
7	 	 200	 0	 0	 0	 0	 6600	 6800	 8200	 10000	 10600	
Mean	 40	 8440	
8	 	 3000	 1400	 0	 0	 0	 0	 6200	 0	 400	 1400	
Mean	 880	 1600	






































	 High	 Low	 Moderate	 Modifier	 Missense	 Nonsense	 Silent	
	 Count	 %	 Count	 %	 Count	 %	 Count	 %	 Count	 %	 Count	 %	 Count	 %	
SNPs	common	to	all	B17	and	
Z310	strains	
14	 0.027	 4,593	 8.789	 3,309	 6.332	 44,430	 84.852	 3,314	 41.865	 9	 0.114	 4,593	 58.022	
SNPs	common	to	all	Z366,	B17	
and	Z310	strains	
11	 0.023	 4,178	 8.884	 2,942	 6.256	 39,899	 84.837	 2,947	 41.327	 6	 0.084	 4,178	 58.589	
SNPs	unique	to	Z310	strains	 2	 0.02	 545	 5.403	 425	 4.213	 9,115	 90.364	 425	 43.724	 2	 0.206	 545	 56.07	
SNPs	unique	to	B17	strains	 -	 -	 223	 7.981	 166	 5.941	 2,405	 86.077	 166	 42.674	 -	 -	 223	 57.326	
SNPs	unique	to	Z366	strain	 15	 0.132	 608	 5.332	 635	 5.569	 10,144	 88.967	 636	 50.556	 14	 1.113	 608	 48.331	
SNPs	unique	to	B	strain	 2	 0.016	 535	 4.298	 440	 3.535	 11,470	 92.151	 440	 45.036	 2	 0.205	 535	 54.759	















































Downstream	 Count	 20,849	 18,722	 4,088	 1,071	 4,748	 5,140	 1,889	
	 %	 39.898	 39.809	 40.527	 38.332	 41.642	 41.295	 38.418	
Intergenic	 Count	 3,261	 2,934	 1,174	 209	 1,082	 1,718	 456	
	 %	 6.24	 6.239	 11.639	 7.48	 9.49	 13.803	 9.274	
Missense	 Count	 3,309	 2,942	 425	 166	 635	 440	 323	
	 %	 6.332	 6.256	 4.213	 5.941	 5.569	 3.535	 6.569	
Start	lost	 Count	 -	 -	 -	 -	 1	 -	 1	
	 %	 -	 -	 -	 -	 0.009	 -	 0.02	
Stop	gained	 Count	 9	 6	 2	 -	 14	 2	 4	
	 %	 0.017	 0.013	 0.02	 -	 0.123	 0.016	 0.081	
Stop	lost	 Count	 5	 5	 -	 -	 -	 -	 -	
	 %	 0.01	 0.011	 -	 -	 -	 -	 -	
Stop	retained	 Count	 9	 9	 -	 -	 4	 -	 1	
	 %	 0.017	 0.019	 -	 -	 0.035	 -	 0.02	
Synonymous	 Count	 4,584	 4,169	 545	 223	 604	 535	 285	
	 %	 8.772	 8.865	 5.403	 7.981	 5.297	 4.298	 5.796	
Upstream	 Count	 20,230	 18,243	 3,854	 1,125	 4,314	 4,612	 1,958	




































Region	 Downstream	 	 Exon	 Intergenic	 Upstream	
	 Count	 %	 Count	 %	 Count	 %	 Count	 %	
SNPs	common	to	all	B17	and	Z310	strains	 20,849	 40	 7,908	 15	 3,261	 6	 20,230	 39	
SNPs	common	to	all	Z366,	B17	and	Z310	strains	 18,722	 40	 7,123	 15	 2,934	 6	 18,243	 39	
SNPs	unique	to	Z310	strains	 4,088	 40	 972	 10	 1,174	 12	 3,853	 38	
SNPs	unique	to	B17	strains	 1,071	 38	 389	 14	 209	 8	 1,125	 40	
SNPs	unique	to	Z366	strain	 4,748	 41	 1,253	 11	 1,082	 9	 4516	 39	
SNPs	unique	to	B	strain	 5,140	 41	 977	 8	 1,718	 14	 4,612	 37	




at	 days	 three	 and	 eight	 post	 infection.	 Intensities	 are	 relative	 to	 the	 pre-infection	 data	 for	 each	
strain,	which	is	set	to	zero.	This	data	was	used	to	generate	the	heatmap	Figure	4.2.	
	
Pathway	 Z310	Day	3	 Z310	Day	8	 B17	Day	3	 B17	Day	8	
Xenobiotics	Metabolism	 0.92	 1.32	 5.2	 12.56	
Tri-peptide	Metabolism	 1.06	 0.47	 22.35	 19.02	
Di-peptide	Metabolism	 1.53	 0.59	 53.67	 31.12	
Di-peptide	Metabolism	 2.37	 1.95	 17.7	 23.97	
Peptide	Metabolism	 36.85	 12.91	 81.59	 26.57	
Nucleotide	Metabolism	 16.73	 0.71	 55.97	 57.86	
Cofactors	and	Vitamins	Metabolism	 1.07	 0.47	 30.98	 45.54	
Sterol	lipid	Metabolism	 4.15	 2.66	 55.31	 175.43	
Sphingolipid	Metabolism	 1.45	 1.63	 37.76	 26.56	
Polyketides	Metabolism	 2.04	 0.75	 1.51	 2.72	
Glycerophospholipid	Metabolism	 2.61	 1.64	 26.61	 17.17	
Glycerolipid	Metabolism	 1.07	 0.82	 2.32	 1.85	
Ganglioside	Metabolism	 0	 5.59	 1.25	 7.06	
Fatty	Acyl	Metabolism	 21.37	 17.57	 38.07	 52.45	
Lipid	Metabolism	 1.65	 1.27	 10.65	 9.98	
Energy	Metabolism	 2.58	 0.82	 8.43	 5.01	
Carbohydrate	Metabolism	 1.01	 0.67	 74.73	 25.09	
Secondary	Metabolites	Biosynthesis	 8.34	 0.56	 3.7	 3	
Polyketides	and	Nonribosomal	Peptide	Biosynthesis	 0	 0.22	 0	 0	





















































































Sample	ID	 Total	reads	 Reads	mapped	 Reads	unmapped	 Percentage	mapped	
(%)	
Z310	 	
B1_1_3	 113,912,156	 91,344,446	 22,567,710	 80	
B1_3_2_7	 67,409,372	 33,659,766	 33,749,606	 50	
B4_1_2	 76,946,188	 32,737,410	 44,208,778	 43	
B5_1_1	 8,1581,426	 64,033,896	 17,547,530	 79	
B1_4_2_6	 130,625,146	 93,556,915	 37,068,231	 72	
B17	 	
E1_1_2_5	 91,557,138	 73,457,264	 18,099,874	 80	
E4_1_4	 77,343,632	 53,644,089	 23,699,543	 69	
E3_1_5	 97,804,766	 73,025,999	 24,778,767	 75	
E1_1_7	 78,493,866	 61,148,015	 17,345,851	 78	





Gene	ID	 Fold	Change		 Gene	ID	 Fold	Change	 Gene	ID	 Fold	Change	
Tb927.3.2600	 15.09	 Tb927.5.4180	 4.72	 Tb927.9.740	 1.23	
Tb927.11.13000	 13.66	 Tb927.11.17180	 4.70	 Tb927.8.6710	 1.21	
Tb927.3.3200	 13.55	 Tb927.10.7920	 4.58	 Tb927.9.6170	 1.18	
Tb927.3.1900	 12.78	 Tb11.v5.0932	 4.42	 Tb927.11.14840	 1.17	
Tb927.9.5000	 11.64	 Tb927.7.440	 4.41	 Tb927.8.6660	 1.17	
Tb927.3.5400	 11.54	 Tb927.3.3400	 4.39	 Tb927.3.5370	 1.17	
Tb927.9.340	 11.44	 Tb927.4.5740	 4.38	 Tb927.8.6240	 1.15	
Tb927.9.970	 11.33	 Tb927.10.660	 4.19	 Tb927.3.2310	 1.14	
Tb927.9.960	 10.96	 Tb927.9.3000	 4.12	 Tb927.5.4010	 1.14	
Tb927.9.5800	 10.87	 Tb927.10.2770	 4.10	 Tb927.4.4690	 1.14	
Tb927.11.17050	 10.86	 Tb927.2.6280	 4.05	 Tb927.1.2670	 1.14	
Tb927.10.12050	 10.79	 Tb09.v4.0024	 4.00	 Tb927.8.6940	 1.13	
Tb927.9.9500	 10.76	 Tb08.27P2.400	 3.67	 Tb927.10.13100	 1.13	
Tb927.9.10100	 10.47	 Tb927.7.150	 3.60	 Tb927.4.2740	 1.13	
Tb927.8.260	 10.46	 Tb927.7.2020	 3.46	 Tb927.7.3420	 1.11	
Tb927.11.13040	 10.40	 Tb927.10.5700	 3.41	 Tb927.10.1040	 1.10	
Tb927.9.11700	 10.24	 Tb05.5K5.420	 3.35	 Tb927.2.5660	 1.10	
Tb927.9.1230	 10.20	 Tb11.v5.0790	 3.19	 Tb927.4.2450	 1.10	
Tb927.10.13080	 10.17	 Tb927.9.16460	 3.18	 Tb927.10.13110	 1.07	
Tb927.3.380	 10.15	 Tb927.5.1420	 3.06	 Tb927.5.1740	 1.06	
Tb927.11.20260	 9.84	 Tb927.6.360	 2.90	 Tb927.4.4700	 1.06	
Tb927.8.120	 9.78	 Tb927.11.17170	 2.89	 Tb927.10.14500	 1.03	
Tb927.5.410	 9.72	 Tb927.6.5530	 2.75	 Tb927.8.710	 1.02	
Tb927.11.17080	 9.37	 Tb05.5K5.240	 2.71	 Tb927.11.9860	 0.99	
Tb927.11.20400	 9.33	 Tb11.v5.0487	 2.60	 Tb927.10.10140	 0.99	
Tb927.9.9400	 9.10	 Tb11.v5.0675	 2.58	 Tb927.11.7470	 0.99	
Tb927.8.190	 9.08	 Tb927.1.1820	 2.50	 Tb927.10.12820	 0.98	
Tb927.1.3000	 9.06	 Tb927.11.950	 2.43	 Tb927.11.10940	 0.98	
Tb927.3.1000	 9.06	 Tb927.8.7890	 2.42	 Tb927.8.6430	 0.97	
Tb927.11.2070	 8.97	 Tb927.5.4470	 2.41	 Tb927.8.2780	 0.97	
Tb927.11.20730	 8.73	 Tb927.11.780	 2.30	 Tb927.1.3830	 0.96	
Tb927.10.500	 8.72	 Tb927.6.3390	 2.27	 Tb927.11.11210	 0.96	
Tb927.8.340	 8.67	 Tb927.11.12020	 2.21	 Tb927.9.6130	 0.96	
Tb927.3.250	 8.58	 Tb927.10.10590	 2.14	 Tb927.11.16550	 0.96	
Tb927.9.1150	 8.58	 Tb927.9.16640	 2.13	 Tb927.11.14880	 0.95	
Tb927.10.13010	 8.27	 Tb11.v5.0710	 2.07	 Tb927.5.2940	 0.94	
	 270	
Tb927.11.20570	 8.26	 Tb927.6.350	 2.05	 Tb927.11.7350	 0.93	
Tb927.9.160	 8.24	 Tb927.8.3500	 1.93	 Tb927.3.5010	 0.93	
Tb927.11.19050	 8.21	 Tb927.8.5440	 1.89	 Tb927.11.10810	 0.93	
Tb927.5.4630	 7.83	 Tb927.6.440	 1.87	 Tb927.10.830	 0.92	
Tb927.5.4380	 7.77	 Tb927.7.1990	 1.87	 Tb927.11.3250	 0.92	
Tb927.11.18220	 6.59	 Tb927.10.10920	 1.86	 Tb927.11.1430	 0.92	
Tb927.6.140	 6.50	 Tb05.5K5.210	 1.83	 Tb927.11.14300	 0.92	
Tb927.1.4000	 6.42	 Tb927.3.5830	 1.80	 Tb927.3.3040	 0.92	
Tb927.10.380	 6.32	 Tb927.9.5130	 1.77	 Tb927.3.930	 0.91	
Tb10.v4.0172	 6.31	 Tb927.10.14160	 1.70	 Tb927.6.400	 0.91	
Tb927.11.20090	 6.12	 Tb927.8.6760	 1.56	 Tb927.8.3850	 0.91	
Tb927.10.750	 6.08	 Tb927.9.4730	 1.52	 Tb927.10.5400	 0.90	
Tb927.11.19430	 5.65	 Tb927.6.410	 1.47	 Tb927.3.3270	 0.90	
Tb927.9.12700	 5.63	 Tb927.1.2680	 1.46	 Tb927.4.4040	 0.89	
Tb927.6.5550	 5.58	 Tb927.10.14140	 1.45	 Tb927.10.8930	 0.88	
Tb927.4.250	 5.47	 Tb927.8.7970	 1.40	 Tb927.1.4890	 0.87	
Tb927.11.17120	 5.43	 Tb927.8.5460	 1.38	 Tb927.4.870	 0.86	
Tb927.9.16920	 5.24	 Tb927.7.6840	 1.37	 Tb927.10.9570	 0.86	
Tb927.10.16530	 5.23	 Tb927.1.3470	 1.32	 Tb927.3.2960	 0.85	
Tb927.9.17850	 5.17	 Tb927.8.5010	 1.29	 Tb927.7.6690	 0.85	
Tb11.v5.1046	 4.95	 Tb927.2.2770	 1.29	 Tb927.11.6550	 0.84	
Tb927.5.280	 4.90	 Tb927.11.7710	 1.29	 Tb927.11.4180	 0.84	
Tb927.3.550	 4.86	 Tb927.10.2190	 1.28	 Tb927.10.7930	 0.80	
Tb927.9.17390	 4.83	 Tb927.11.14030	 1.27	 Tb927.7.1310	 0.80	
Tb09.v4.0200	 4.76	 Tb927.11.3630	 1.26	 Tb927.3.5020	 0.75	
Tb09.v4.0031	 4.75	 Tb927.4.4580	 1.25	 Tb927.4.3740	 0.72	
























Gene	ID	 Fold	Change	 Gene	ID	 Fold	Change	 Gene	ID	 Fold	Change	
Tb927.9.1010	 15.21	 Tb927.6.5490	 4.45	 Tb927.8.730	 1.65	
Tb927.9.490	 12.68	 Tb927.3.520	 4.29	 Tb927.11.1300	 1.65	
Tb927.11.20150	 12.64	 Tb927.4.5580	 4.25	 Tb927.1.1000	 1.62	
Tb927.10.5200	 12.04	 Tb927.5.230	 4.24	 Tb927.5.2160	 1.60	
Tb927.7.140	 12.01	 Tb10.v4.0227	 4.05	 Tb927.7.4270	 1.54	
Tb927.11.20700	 11.86	 Tb927.9.16220	 3.94	 Tb927.11.7060	 1.52	
Tb927.11.19060	 11.86	 Tb927.10.15070	 3.80	 Tb927.7.5950	 1.50	
Tb927.8.440	 11.84	 Tb10.v4.0174	 3.77	 Tb927.10.2360	 1.50	
Tb927.9.430	 11.80	 Tb927.9.7340	 3.76	 Tb927.11.5860	 1.48	
Tb927.7.110	 11.62	 Tb10.v4.0214	 3.72	 Tb927.3.4180	 1.45	
Tb927.9.300	 11.61	 Tb09.v4.0082	 3.64	 Tb927.8.1390	 1.44	
Tb927.9.280	 10.76	 Tb927.7.170	 3.40	 Tb927.7.2640	 1.43	
Tb927.9.1240	 10.63	 Tb927.9.730	 3.32	 Tb927.4.3940	 1.42	
Tb927.11.17070	 10.54	 Tb927.6.5280	 3.20	 Tb927.3.3750	 1.39	
Tb927.8.490	 10.45	 Tb927.11.2690	 3.08	 Tb927.7.6330	 1.37	
Tb927.11.19020	 10.28	 Tb927.9.7470	 3.00	 Tb927.7.6340	 1.35	
Tb927.9.830	 10.22	 Tb927.8.6750	 2.96	 Tb927.8.6930	 1.34	
Tb927.8.100	 10.20	 Tb09.v4.0151	 2.93	 Tb927.7.7430	 1.30	
Tb927.1.10	 10.18	 Tb927.7.5930	 2.92	 Tb927.8.760	 1.29	
Tb927.3.390	 10.10	 Tb927.10.3210	 2.91	 Tb927.11.12040	 1.25	
Tb927.5.210	 10.00	 Tb927.9.7370	 2.89	 Tb927.6.2740	 1.24	
Tb927.11.20160	 9.59	 Tb927.7.5940	 2.89	 Tb927.5.3950	 1.22	
Tb927.11.18050	 9.58	 Tb927.11.10530	 2.75	 Tb927.10.7700	 1.21	
Tb927.9.440	 9.41	 Tb927.9.7450	 2.75	 Tb927.10.14860	 1.19	
Tb927.9.510	 9.39	 Tb927.10.16430	 2.73	 Tb927.11.9820	 1.17	
Tb927.8.430	 9.32	 Tb927.11.11680	 2.72	 Tb927.10.12840	 1.17	
Tb927.11.20550	 9.06	 Tb927.11.18980	 2.66	 Tb927.2.3370	 1.16	
Tb927.11.20210	 8.85	 Tb927.9.7460	 2.61	 Tb927.6.2790	 1.16	
Tb927.3.330	 8.84	 Tb927.9.5910	 2.55	 Tb927.2.4370	 1.14	
Tb927.2.6220	 8.66	 Tb927.7.2660	 2.52	 Tb927.3.1380	 1.12	
Tb927.11.15060.2	 8.66	 Tb927.11.12710	 2.50	 Tb927.10.7570	 1.12	
Tb927.11.19710	 8.57	 Tb927.9.680	 2.48	 Tb927.9.10400	 1.10	
Tb927.3.180	 8.39	 Tb927.3.2230	 2.39	 Tb927.10.12700	 1.10	
Tb927.3.350	 8.15	 Tb927.3.560	 2.39	 Tb927.8.7530	 1.09	
Tb927.11.20110	 8.02	 Tb927.10.7410	 2.33	 Tb927.10.2370	 1.08	
Tb927.11.20230	 7.77	 Tb927.4.2240	 2.33	 Tb927.7.4390	 1.08	
Tb927.10.5220	 7.31	 Tb927.11.2010	 2.26	 Tb927.8.5450	 1.07	
Tb927.9.330	 7.29	 Tb927.6.1520	 2.20	 Tb927.6.4750	 1.07	
Tb927.9.1050	 7.09	 Tb927.3.5760	 2.18	 Tb927.8.8070	 1.06	
	 272	
Tb927.10.5250	 7.09	 Tb927.3.1790	 2.17	 Tb927.7.180	 1.05	
Tb927.3.490	 7.09	 Tb927.11.9980	 2.16	 Tb927.11.4700	 1.04	
Tb927.3.190	 7.00	 Tb927.8.1130	 2.16	 Tb927.7.3520	 1.04	
Tb927.9.16040	 6.74	 Tb927.9.15310	 2.14	 Tb927.9.8580	 1.02	
Tb927.4.5530	 6.43	 Tb927.11.9030	 2.14	 Tb927.8.8320	 1.02	
Tb927.11.19730	 6.43	 Tb927.10.12260	 2.10	 Tb927.8.6060	 1.02	
Tb10.v4.0139	 6.41	 Tb927.11.1450	 2.09	 Tb927.8.7150	 1.00	
Tb927.3.480	 6.28	 Tb927.9.5920	 2.08	 Tb927.9.6310	 0.99	
Tb927.11.1100	 6.20	 Tb927.9.5900	 2.07	 Tb927.8.3770	 0.99	
Tb927.11.19720	 6.00	 Tb927.9.1520	 2.07	 Tb927.10.11220	 0.99	
Tb927.4.5790	 5.89	 Tb927.9.720	 2.06	 Tb927.10.12240	 0.98	
Tb927.9.770	 5.86	 Tb927.7.3970	 2.04	 Tb927.9.7830	 0.98	
Tb927.1.5340	 5.70	 Tb927.9.15290	 2.01	 Tb927.3.3330	 0.98	
Tb927.3.270	 5.47	 Tb927.5.2260	 1.98	 Tb927.8.6450	 0.97	
Tb927.11.20220	 5.43	 Tb927.9.5950	 1.91	 Tb927.11.7900	 0.95	
Tb927.6.110	 5.33	 Tb927.3.5820	 1.87	 Tb927.7.6600	 0.95	
Tb927.9.16880	 5.26	 Tb927.10.2350	 1.81	 Tb927.7.5550	 0.95	
Tb927.11.20320	 5.11	 Tb927.7.7500	 1.80	 Tb927.11.6280	 0.94	
Tb927.4.5400	 5.07	 Tb927.9.15300	 1.78	 Tb927.8.6770	 0.93	
Tb927.5.5400	 4.91	 Tb927.7.210	 1.77	 Tb927.8.1780	 0.92	
Tb927.9.12500	 4.70	 Tb927.9.5940	 1.75	 Tb927.10.1030	 0.90	
Tb11.v5.0518	 4.65	 Tb927.11.16730	 1.74	 Tb927.10.3770	 0.89	
Tb927.11.20330	 4.57	 Tb927.10.14630	 1.69	 Tb927.4.2630	 0.84	
Tb927.4.170	 4.50	 Tb11.v5.0752	 1.69	 Tb927.9.7670	 0.82	
	
